id	sid	tid	token	lemma	pos
bam-12993	1	1	layout	layout	NOUN
bam-12993	1	2	1	1	NUM
bam-12993	1	3	vitamin	vitamin	NOUN
bam-12993	1	4	d	d	NOUN
bam-12993	1	5	receptor	receptor	NOUN
bam-12993	1	6	gene	gene	NOUN
bam-12993	1	7	polymorphisms	polymorphism	NOUN
bam-12993	1	8	in	in	ADP
bam-12993	1	9	patients	patient	NOUN
bam-12993	1	10	with	with	ADP
bam-12993	1	11	relapsing	relapse	VERB
bam-12993	1	12	multiple	multiple	ADJ
bam-12993	1	13	sclerosis	sclerosis	NOUN
bam-12993	1	14	eur	eur	PROPN
bam-12993	1	15	j	j	PROPN
bam-12993	1	16	transl	transl	PROPN
bam-12993	1	17	myol	myol	ADV
bam-12993	1	18	35	35	NUM
bam-12993	1	19	(	(	PUNCT
bam-12993	1	20	1	1	NUM
bam-12993	1	21	)	)	PUNCT
bam-12993	1	22	12993	12993	NUM
bam-12993	1	23	,	,	PUNCT
bam-12993	1	24	2025	2025	NUM
bam-12993	1	25	doi	doi	NOUN
bam-12993	1	26	:	:	PUNCT
bam-12993	1	27	10.4081	10.4081	NUM
bam-12993	1	28	/	/	SYM
bam-12993	1	29	ejtm.2024.12993	ejtm.2024.12993	NOUN
bam-12993	1	30	multiple	multiple	ADJ
bam-12993	1	31	sclerosis	sclerosis	NOUN
bam-12993	1	32	(	(	PUNCT
bam-12993	1	33	ms	ms	NOUN
bam-12993	1	34	)	)	PUNCT
bam-12993	1	35	is	be	AUX
bam-12993	1	36	the	the	DET
bam-12993	1	37	predominant	predominant	ADJ
bam-12993	1	38	nontraumatic	nontraumatic	ADJ
bam-12993	1	39	debilitating	debilitate	VERB
bam-12993	1	40	condition	condition	NOUN
bam-12993	1	41	that	that	SCONJ
bam-12993	1	42	impacts	impact	VERB
bam-12993	1	43	young	young	ADJ
bam-12993	1	44	adults.1	adults.1	PROPN
bam-12993	1	45	the	the	DET
bam-12993	1	46	incidence	incidence	NOUN
bam-12993	1	47	and	and	CCONJ
bam-12993	1	48	prevalence	prevalence	NOUN
bam-12993	1	49	of	of	ADP
bam-12993	1	50	ms	ms	PROPN
bam-12993	1	51	are	be	AUX
bam-12993	1	52	increasing	increase	VERB
bam-12993	1	53	in	in	ADP
bam-12993	1	54	developed	develop	VERB
bam-12993	1	55	and	and	CCONJ
bam-12993	1	56	developing	develop	VERB
bam-12993	1	57	countries	country	NOUN
bam-12993	1	58	,	,	PUNCT
bam-12993	1	59	the	the	DET
bam-12993	1	60	main	main	ADJ
bam-12993	1	61	cause	cause	NOUN
bam-12993	1	62	of	of	ADP
bam-12993	1	63	which	which	PRON
bam-12993	1	64	is	be	AUX
bam-12993	1	65	unclear.2	unclear.2	ADJ
bam-12993	1	66	according	accord	VERB
bam-12993	1	67	to	to	ADP
bam-12993	1	68	the	the	DET
bam-12993	1	69	speed	speed	NOUN
bam-12993	1	70	of	of	ADP
bam-12993	1	71	disease	disease	NOUN
bam-12993	1	72	progression	progression	NOUN
bam-12993	1	73	,	,	PUNCT
bam-12993	1	74	there	there	PRON
bam-12993	1	75	are	be	VERB
bam-12993	1	76	four	four	NUM
bam-12993	1	77	clinical	clinical	ADJ
bam-12993	1	78	stages	stage	NOUN
bam-12993	1	79	of	of	ADP
bam-12993	1	80	ms	ms	NOUN
bam-12993	1	81	,	,	PUNCT
bam-12993	1	82	which	which	PRON
bam-12993	1	83	are	be	AUX
bam-12993	1	84	:	:	PUNCT
bam-12993	1	85	rrms	rrm	NOUN
bam-12993	1	86	,	,	PUNCT
bam-12993	1	87	secondary	secondary	ADJ
bam-12993	1	88	progressive	progressive	ADJ
bam-12993	1	89	type	type	NOUN
bam-12993	1	90	,	,	PUNCT
bam-12993	1	91	relapsing	relapse	VERB
bam-12993	1	92	-	-	PUNCT
bam-12993	1	93	progressive	progressive	ADJ
bam-12993	1	94	type	type	NOUN
bam-12993	1	95	,	,	PUNCT
bam-12993	1	96	and	and	CCONJ
bam-12993	1	97	primary	primary	ADJ
bam-12993	1	98	progressive	progressive	ADJ
bam-12993	1	99	type	type	NOUN
bam-12993	1	100	.	.	PUNCT
bam-12993	2	1	rrms	rrm	NOUN
bam-12993	2	2	is	be	AUX
bam-12993	2	3	the	the	DET
bam-12993	2	4	most	most	ADV
bam-12993	2	5	common	common	ADJ
bam-12993	2	6	clinical	clinical	ADJ
bam-12993	2	7	type	type	NOUN
bam-12993	2	8	of	of	ADP
bam-12993	2	9	ms	ms	NOUN
bam-12993	2	10	and	and	CCONJ
bam-12993	2	11	is	be	AUX
bam-12993	2	12	characterized	characterize	VERB
bam-12993	2	13	by	by	ADP
bam-12993	2	14	many	many	ADJ
bam-12993	2	15	symptoms	symptom	NOUN
bam-12993	2	16	in	in	ADP
bam-12993	2	17	attacks	attack	NOUN
bam-12993	2	18	and	and	CCONJ
bam-12993	2	19	complete	complete	ADJ
bam-12993	2	20	recovery	recovery	NOUN
bam-12993	2	21	between	between	ADP
bam-12993	2	22	attacks.3	attacks.3	VERB
bam-12993	2	23	the	the	DET
bam-12993	2	24	most	most	ADV
bam-12993	2	25	significant	significant	ADJ
bam-12993	2	26	risk	risk	NOUN
bam-12993	2	27	factors	factor	NOUN
bam-12993	2	28	for	for	ADP
bam-12993	2	29	ms	ms	NOUN
bam-12993	2	30	may	may	AUX
bam-12993	2	31	be	be	AUX
bam-12993	2	32	a	a	DET
bam-12993	2	33	combination	combination	NOUN
bam-12993	2	34	of	of	ADP
bam-12993	2	35	genetic	genetic	ADJ
bam-12993	2	36	and	and	CCONJ
bam-12993	2	37	environmental	environmental	ADJ
bam-12993	2	38	factors	factor	NOUN
bam-12993	2	39	.	.	PUNCT
bam-12993	3	1	moreover	moreover	ADV
bam-12993	3	2	,	,	PUNCT
bam-12993	3	3	vitamin	vitamin	NOUN
bam-12993	3	4	d	d	NOUN
bam-12993	3	5	deficiency	deficiency	NOUN
bam-12993	3	6	is	be	AUX
bam-12993	3	7	a	a	DET
bam-12993	3	8	determining	determine	VERB
bam-12993	3	9	risk	risk	NOUN
bam-12993	3	10	factor	factor	NOUN
bam-12993	3	11	as	as	ADV
bam-12993	3	12	well	well	ADV
bam-12993	3	13	as	as	ADP
bam-12993	3	14	a	a	DET
bam-12993	3	15	frequently	frequently	ADV
bam-12993	3	16	reported	report	VERB
bam-12993	3	17	environmental	environmental	ADJ
bam-12993	3	18	factor	factor	NOUN
bam-12993	3	19	in	in	ADP
bam-12993	3	20	the	the	DET
bam-12993	3	21	etiology	etiology	NOUN
bam-12993	3	22	of	of	ADP
bam-12993	3	23	ms	ms	PROPN
bam-12993	3	24	,	,	PUNCT
bam-12993	3	25	regardless	regardless	ADV
bam-12993	3	26	of	of	ADP
bam-12993	3	27	latitude	latitude	NOUN
bam-12993	3	28	and	and	CCONJ
bam-12993	3	29	viral	viral	ADJ
bam-12993	3	30	infections.4	infections.4	PROPN
bam-12993	3	31	in	in	ADP
bam-12993	3	32	recent	recent	ADJ
bam-12993	3	33	years	year	NOUN
bam-12993	3	34	,	,	PUNCT
bam-12993	3	35	there	there	PRON
bam-12993	3	36	has	have	AUX
bam-12993	3	37	been	be	AUX
bam-12993	3	38	a	a	DET
bam-12993	3	39	lot	lot	NOUN
bam-12993	3	40	of	of	ADP
bam-12993	3	41	evidence	evidence	NOUN
bam-12993	3	42	that	that	PRON
bam-12993	3	43	shows	show	VERB
bam-12993	3	44	that	that	SCONJ
bam-12993	3	45	vitamin	vitamin	NOUN
bam-12993	3	46	d	d	NOUN
bam-12993	3	47	can	can	AUX
bam-12993	3	48	play	play	VERB
bam-12993	3	49	a	a	DET
bam-12993	3	50	role	role	NOUN
bam-12993	3	51	in	in	ADP
bam-12993	3	52	the	the	DET
bam-12993	3	53	pathogenesis	pathogenesis	NOUN
bam-12993	3	54	of	of	ADP
bam-12993	3	55	ms	ms	PROPN
bam-12993	3	56	,	,	PUNCT
bam-12993	3	57	disease	disease	NOUN
bam-12993	3	58	courses	course	NOUN
bam-12993	3	59	,	,	PUNCT
bam-12993	3	60	and	and	CCONJ
bam-12993	3	61	duration.5	duration.5	PROPN
bam-12993	3	62	abstract	abstract	NOUN
bam-12993	3	63	the	the	DET
bam-12993	3	64	relationship	relationship	NOUN
bam-12993	3	65	between	between	ADP
bam-12993	3	66	the	the	DET
bam-12993	3	67	vitamin	vitamin	NOUN
bam-12993	3	68	d	d	NOUN
bam-12993	3	69	receptor	receptor	NOUN
bam-12993	3	70	(	(	PUNCT
bam-12993	3	71	vdr	vdr	NOUN
bam-12993	3	72	)	)	PUNCT
bam-12993	3	73	gene	gene	NOUN
bam-12993	3	74	and	and	CCONJ
bam-12993	3	75	many	many	ADJ
bam-12993	3	76	pathogenic	pathogenic	ADJ
bam-12993	3	77	pathways	pathway	NOUN
bam-12993	3	78	in	in	ADP
bam-12993	3	79	relapsing	relapse	VERB
bam-12993	3	80	-	-	PUNCT
bam-12993	3	81	remitting	remit	VERB
bam-12993	3	82	multiple	multiple	ADJ
bam-12993	3	83	sclerosis	sclerosis	NOUN
bam-12993	3	84	(	(	PUNCT
bam-12993	3	85	rrms	rrm	NOUN
bam-12993	3	86	)	)	PUNCT
bam-12993	3	87	remains	remain	VERB
bam-12993	3	88	unclear	unclear	ADJ
bam-12993	3	89	.	.	PUNCT
bam-12993	4	1	given	give	VERB
bam-12993	4	2	the	the	DET
bam-12993	4	3	significance	significance	NOUN
bam-12993	4	4	of	of	ADP
bam-12993	4	5	the	the	DET
bam-12993	4	6	topic	topic	NOUN
bam-12993	4	7	,	,	PUNCT
bam-12993	4	8	we	we	PRON
bam-12993	4	9	conducted	conduct	VERB
bam-12993	4	10	this	this	DET
bam-12993	4	11	study	study	NOUN
bam-12993	4	12	to	to	PART
bam-12993	4	13	explore	explore	VERB
bam-12993	4	14	the	the	DET
bam-12993	4	15	correlation	correlation	NOUN
bam-12993	4	16	between	between	ADP
bam-12993	4	17	vitamin	vitamin	NOUN
bam-12993	4	18	d	d	NOUN
bam-12993	4	19	receptor	receptor	NOUN
bam-12993	4	20	gene	gene	NOUN
bam-12993	4	21	polymorphisms	polymorphism	NOUN
bam-12993	4	22	and	and	CCONJ
bam-12993	4	23	clinical	clinical	ADJ
bam-12993	4	24	and	and	CCONJ
bam-12993	4	25	inflammatory	inflammatory	ADJ
bam-12993	4	26	factors	factor	NOUN
bam-12993	4	27	in	in	ADP
bam-12993	4	28	patients	patient	NOUN
bam-12993	4	29	suffering	suffer	VERB
bam-12993	4	30	from	from	ADP
bam-12993	4	31	relapsing	relapse	VERB
bam-12993	4	32	-	-	PUNCT
bam-12993	4	33	remitting	remit	VERB
bam-12993	4	34	multiple	multiple	ADJ
bam-12993	4	35	sclerosis	sclerosis	NOUN
bam-12993	4	36	.	.	PUNCT
bam-12993	5	1	the	the	DET
bam-12993	5	2	current	current	ADJ
bam-12993	5	3	research	research	NOUN
bam-12993	5	4	is	be	AUX
bam-12993	5	5	a	a	DET
bam-12993	5	6	case	case	NOUN
bam-12993	5	7	/	/	SYM
bam-12993	5	8	control	control	NOUN
bam-12993	5	9	study	study	NOUN
bam-12993	5	10	conducted	conduct	VERB
bam-12993	5	11	based	base	VERB
bam-12993	5	12	on	on	ADP
bam-12993	5	13	the	the	DET
bam-12993	5	14	helsinki	helsinki	PROPN
bam-12993	5	15	ethical	ethical	PROPN
bam-12993	5	16	principles	principle	NOUN
bam-12993	5	17	.	.	PUNCT
bam-12993	6	1	rrms	rrm	NOUN
bam-12993	6	2	disease	disease	NOUN
bam-12993	6	3	was	be	AUX
bam-12993	6	4	confirmed	confirm	VERB
bam-12993	6	5	based	base	VERB
bam-12993	6	6	on	on	ADP
bam-12993	6	7	history	history	NOUN
bam-12993	6	8	,	,	PUNCT
bam-12993	6	9	clinical	clinical	ADJ
bam-12993	6	10	symptoms	symptom	NOUN
bam-12993	6	11	,	,	PUNCT
bam-12993	6	12	radiological	radiological	ADJ
bam-12993	6	13	signs	sign	NOUN
bam-12993	6	14	and	and	CCONJ
bam-12993	6	15	neurologist	neurologist	ADJ
bam-12993	6	16	diagnosis	diagnosis	NOUN
bam-12993	6	17	.	.	PUNCT
bam-12993	7	1	the	the	DET
bam-12993	7	2	research	research	NOUN
bam-12993	7	3	population	population	NOUN
bam-12993	7	4	consisted	consist	VERB
bam-12993	7	5	of	of	ADP
bam-12993	7	6	healthy	healthy	ADJ
bam-12993	7	7	people	people	NOUN
bam-12993	7	8	and	and	CCONJ
bam-12993	7	9	patients	patient	NOUN
bam-12993	7	10	with	with	ADP
bam-12993	7	11	rrms	rrm	NOUN
bam-12993	7	12	who	who	PRON
bam-12993	7	13	were	be	AUX
bam-12993	7	14	referred	refer	VERB
bam-12993	7	15	to	to	ADP
bam-12993	7	16	hazrat	hazrat	PROPN
bam-12993	7	17	rasool	rasool	PROPN
bam-12993	7	18	akram	akram	PROPN
bam-12993	7	19	hospital	hospital	NOUN
bam-12993	7	20	between	between	ADP
bam-12993	7	21	2021	2021	NUM
bam-12993	7	22	and	and	CCONJ
bam-12993	7	23	2023	2023	NUM
bam-12993	7	24	.	.	PUNCT
bam-12993	8	1	for	for	ADP
bam-12993	8	2	each	each	DET
bam-12993	8	3	person	person	NOUN
bam-12993	8	4	participating	participate	VERB
bam-12993	8	5	in	in	ADP
bam-12993	8	6	the	the	DET
bam-12993	8	7	study	study	NOUN
bam-12993	8	8	(	(	PUNCT
bam-12993	8	9	rrms	rrm	NOUN
bam-12993	8	10	patient	patient	ADJ
bam-12993	8	11	and	and	CCONJ
bam-12993	8	12	healthy	healthy	ADJ
bam-12993	8	13	)	)	PUNCT
bam-12993	8	14	,	,	PUNCT
bam-12993	8	15	five	five	NUM
bam-12993	8	16	milliliters	milliliter	NOUN
bam-12993	8	17	of	of	ADP
bam-12993	8	18	peripheral	peripheral	ADJ
bam-12993	8	19	blood	blood	NOUN
bam-12993	8	20	containing	contain	VERB
bam-12993	8	21	the	the	DET
bam-12993	8	22	anticoagulant	anticoagulant	ADJ
bam-12993	8	23	edta	edta	NOUN
bam-12993	8	24	was	be	AUX
bam-12993	8	25	collected	collect	VERB
bam-12993	8	26	.	.	PUNCT
bam-12993	9	1	polymerase	polymerase	NOUN
bam-12993	9	2	chain	chain	NOUN
bam-12993	9	3	reaction	reaction	NOUN
bam-12993	9	4	was	be	AUX
bam-12993	9	5	performed	perform	VERB
bam-12993	9	6	using	use	VERB
bam-12993	9	7	two	two	NUM
bam-12993	9	8	specific	specific	ADJ
bam-12993	9	9	and	and	CCONJ
bam-12993	9	10	appropriate	appropriate	ADJ
bam-12993	9	11	oligonucleotide	oligonucleotide	NOUN
bam-12993	9	12	primers	primer	NOUN
bam-12993	9	13	.	.	PUNCT
bam-12993	10	1	the	the	DET
bam-12993	10	2	restriction	restriction	NOUN
bam-12993	10	3	fragment	fragment	NOUN
bam-12993	10	4	length	length	NOUN
bam-12993	10	5	polymorphism	polymorphism	NOUN
bam-12993	10	6	technique	technique	NOUN
bam-12993	10	7	was	be	AUX
bam-12993	10	8	used	use	VERB
bam-12993	10	9	,	,	PUNCT
bam-12993	10	10	one	one	NUM
bam-12993	10	11	of	of	ADP
bam-12993	10	12	the	the	DET
bam-12993	10	13	standard	standard	ADJ
bam-12993	10	14	methods	method	NOUN
bam-12993	10	15	for	for	ADP
bam-12993	10	16	identifying	identify	VERB
bam-12993	10	17	polymorphisms	polymorphism	NOUN
bam-12993	10	18	.	.	PUNCT
bam-12993	11	1	statistical	statistical	ADJ
bam-12993	11	2	analysis	analysis	NOUN
bam-12993	11	3	was	be	AUX
bam-12993	11	4	performed	perform	VERB
bam-12993	11	5	using	use	VERB
bam-12993	11	6	spss	spss	PROPN
bam-12993	11	7	software	software	NOUN
bam-12993	11	8	version	version	NOUN
bam-12993	11	9	23	23	NUM
bam-12993	11	10	.	.	PUNCT
bam-12993	12	1	the	the	DET
bam-12993	12	2	odds	odd	NOUN
bam-12993	12	3	ratio	ratio	NOUN
bam-12993	12	4	and	and	CCONJ
bam-12993	12	5	95	95	NUM
bam-12993	12	6	%	%	NOUN
bam-12993	12	7	confidence	confidence	NOUN
bam-12993	12	8	limits	limit	NOUN
bam-12993	12	9	were	be	AUX
bam-12993	12	10	calculated	calculate	VERB
bam-12993	12	11	.	.	PUNCT
bam-12993	13	1	the	the	DET
bam-12993	13	2	snp	snp	PROPN
bam-12993	13	3	analyzer	analyzer	PROPN
bam-12993	13	4	software	software	NOUN
bam-12993	13	5	was	be	AUX
bam-12993	13	6	used	use	VERB
bam-12993	13	7	to	to	PART
bam-12993	13	8	analyze	analyze	VERB
bam-12993	13	9	the	the	DET
bam-12993	13	10	allele	allele	NOUN
bam-12993	13	11	frequency	frequency	NOUN
bam-12993	13	12	of	of	ADP
bam-12993	13	13	each	each	DET
bam-12993	13	14	polymorphism	polymorphism	NOUN
bam-12993	13	15	in	in	ADP
bam-12993	13	16	healthy	healthy	ADJ
bam-12993	13	17	and	and	CCONJ
bam-12993	13	18	rrms	rrm	VERB
bam-12993	13	19	individuals	individual	NOUN
bam-12993	13	20	and	and	CCONJ
bam-12993	13	21	compare	compare	VERB
bam-12993	13	22	the	the	DET
bam-12993	13	23	values	value	NOUN
bam-12993	13	24	.	.	PUNCT
bam-12993	14	1	prism	prism	NOUN
bam-12993	14	2	version	version	NOUN
bam-12993	14	3	5	5	NUM
bam-12993	14	4	software	software	NOUN
bam-12993	14	5	was	be	AUX
bam-12993	14	6	used	use	VERB
bam-12993	14	7	to	to	PART
bam-12993	14	8	draw	draw	VERB
bam-12993	14	9	diagrams	diagram	NOUN
bam-12993	14	10	.	.	PUNCT
bam-12993	15	1	in	in	ADP
bam-12993	15	2	the	the	DET
bam-12993	15	3	present	present	ADJ
bam-12993	15	4	study	study	NOUN
bam-12993	15	5	,	,	PUNCT
bam-12993	15	6	a	a	DET
bam-12993	15	7	statistically	statistically	ADV
bam-12993	15	8	significant	significant	ADJ
bam-12993	15	9	difference	difference	NOUN
bam-12993	15	10	was	be	AUX
bam-12993	15	11	observed	observe	VERB
bam-12993	15	12	between	between	ADP
bam-12993	15	13	the	the	DET
bam-12993	15	14	percentage	percentage	NOUN
bam-12993	15	15	of	of	ADP
bam-12993	15	16	foki	foki	ADJ
bam-12993	15	17	genotypes	genotype	NOUN
bam-12993	15	18	in	in	ADP
bam-12993	15	19	rrms	rrm	NOUN
bam-12993	15	20	patients	patient	NOUN
bam-12993	15	21	and	and	CCONJ
bam-12993	15	22	healthy	healthy	ADJ
bam-12993	15	23	individuals	individual	NOUN
bam-12993	15	24	.	.	PUNCT
bam-12993	16	1	foki	foki	ADJ
bam-12993	16	2	polymorphism	polymorphism	NOUN
bam-12993	16	3	showed	show	VERB
bam-12993	16	4	a	a	DET
bam-12993	16	5	significantly	significantly	ADV
bam-12993	16	6	increased	increase	VERB
bam-12993	16	7	risk	risk	NOUN
bam-12993	16	8	with	with	ADP
bam-12993	16	9	an	an	DET
bam-12993	16	10	odds	odd	NOUN
bam-12993	16	11	ratio	ratio	NOUN
bam-12993	16	12	of	of	ADP
bam-12993	16	13	7.28	7.28	NUM
bam-12993	16	14	in	in	ADP
bam-12993	16	15	patients	patient	NOUN
bam-12993	16	16	with	with	ADP
bam-12993	16	17	the	the	DET
bam-12993	16	18	ff	ff	NOUN
bam-12993	16	19	genotype	genotype	NOUN
bam-12993	16	20	compared	compare	VERB
bam-12993	16	21	to	to	ADP
bam-12993	16	22	healthy	healthy	ADJ
bam-12993	16	23	individuals	individual	NOUN
bam-12993	16	24	.	.	PUNCT
bam-12993	17	1	apai	apai	NOUN
bam-12993	17	2	,	,	PUNCT
bam-12993	17	3	taqi	taqi	NOUN
bam-12993	17	4	,	,	PUNCT
bam-12993	17	5	and	and	CCONJ
bam-12993	17	6	bsmi	bsmi	NOUN
bam-12993	17	7	were	be	AUX
bam-12993	17	8	not	not	PART
bam-12993	17	9	significantly	significantly	ADV
bam-12993	17	10	different	different	ADJ
bam-12993	17	11	between	between	ADP
bam-12993	17	12	the	the	DET
bam-12993	17	13	two	two	NUM
bam-12993	17	14	groups	group	NOUN
bam-12993	17	15	.	.	PUNCT
bam-12993	18	1	based	base	VERB
bam-12993	18	2	on	on	ADP
bam-12993	18	3	the	the	DET
bam-12993	18	4	findings	finding	NOUN
bam-12993	18	5	of	of	ADP
bam-12993	18	6	the	the	DET
bam-12993	18	7	present	present	ADJ
bam-12993	18	8	study	study	NOUN
bam-12993	18	9	,	,	PUNCT
bam-12993	18	10	foki	foki	ADJ
bam-12993	18	11	polymorphism	polymorphism	NOUN
bam-12993	18	12	showed	show	VERB
bam-12993	18	13	a	a	DET
bam-12993	18	14	significant	significant	ADJ
bam-12993	18	15	risk	risk	NOUN
bam-12993	18	16	increase	increase	NOUN
bam-12993	18	17	in	in	ADP
bam-12993	18	18	rrms	rrm	NOUN
bam-12993	18	19	patients	patient	NOUN
bam-12993	18	20	with	with	ADP
bam-12993	18	21	ff	ff	NOUN
bam-12993	18	22	genotype	genotype	NOUN
bam-12993	18	23	compared	compare	VERB
bam-12993	18	24	to	to	ADP
bam-12993	18	25	healthy	healthy	ADJ
bam-12993	18	26	individuals	individual	NOUN
bam-12993	18	27	.	.	PUNCT
bam-12993	19	1	key	key	ADJ
bam-12993	19	2	words	word	NOUN
bam-12993	19	3	:	:	PUNCT
bam-12993	19	4	relapsing	relapse	VERB
bam-12993	19	5	multiple	multiple	ADJ
bam-12993	19	6	sclerosis	sclerosis	NOUN
bam-12993	19	7	,	,	PUNCT
bam-12993	19	8	vitamin	vitamin	NOUN
bam-12993	19	9	d	d	NOUN
bam-12993	19	10	,	,	PUNCT
bam-12993	19	11	gene	gene	NOUN
bam-12993	19	12	polymorphisms	polymorphism	NOUN
bam-12993	19	13	.	.	PUNCT
bam-12993	20	1	eur	eur	PROPN
bam-12993	20	2	j	j	PROPN
bam-12993	20	3	transl	transl	PROPN
bam-12993	20	4	myol	myol	ADV
bam-12993	20	5	35	35	NUM
bam-12993	20	6	(	(	PUNCT
bam-12993	20	7	1	1	NUM
bam-12993	20	8	)	)	PUNCT
bam-12993	20	9	12993	12993	NUM
bam-12993	20	10	,	,	PUNCT
bam-12993	20	11	2025	2025	NUM
bam-12993	20	12	doi	doi	NOUN
bam-12993	20	13	:	:	PUNCT
bam-12993	20	14	10.4081	10.4081	NUM
bam-12993	20	15	/	/	SYM
bam-12993	20	16	ejtm.2024.12993	ejtm.2024.12993	NOUN
bam-12993	20	17	vitamin	vitamin	NOUN
bam-12993	20	18	d	d	NOUN
bam-12993	20	19	receptor	receptor	NOUN
bam-12993	20	20	gene	gene	NOUN
bam-12993	20	21	polymorphisms	polymorphism	NOUN
bam-12993	20	22	in	in	ADP
bam-12993	20	23	patients	patient	NOUN
bam-12993	20	24	with	with	ADP
bam-12993	20	25	relapsing	relapse	VERB
bam-12993	20	26	multiple	multiple	ADJ
bam-12993	20	27	sclerosis	sclerosis	NOUN
bam-12993	20	28	maryam	maryam	PROPN
bam-12993	20	29	milanifard,1	milanifard,1	PROPN
bam-12993	21	1	soraya	soraya	PROPN
bam-12993	21	2	mehrabi,2	mehrabi,2	PROPN
bam-12993	21	3	reza	reza	PROPN
bam-12993	21	4	ahadi,3	ahadi,3	VERB
bam-12993	21	5	mohsen	mohsen	PROPN
bam-12993	21	6	nabiuni,4	nabiuni,4	PROPN
bam-12993	21	7	samaneh	samaneh	PROPN
bam-12993	21	8	azimi	azimi	PROPN
bam-12993	21	9	souteh,5	souteh,5	PROPN
bam-12993	21	10	mohammad	mohammad	PROPN
bam-12993	21	11	taghi	taghi	PROPN
bam-12993	21	12	joghataei2,3,6	joghataei2,3,6	PROPN
bam-12993	21	13	1department	1department	NUM
bam-12993	21	14	of	of	ADP
bam-12993	21	15	anatomy	anatomy	NOUN
bam-12993	21	16	,	,	PUNCT
bam-12993	21	17	school	school	NOUN
bam-12993	21	18	of	of	ADP
bam-12993	21	19	medicine	medicine	NOUN
bam-12993	21	20	,	,	PUNCT
bam-12993	21	21	iran	iran	PROPN
bam-12993	21	22	university	university	PROPN
bam-12993	21	23	of	of	ADP
bam-12993	21	24	medical	medical	ADJ
bam-12993	21	25	sciences	sciences	PROPN
bam-12993	21	26	,	,	PUNCT
bam-12993	21	27	tehran	tehran	PROPN
bam-12993	21	28	,	,	PUNCT
bam-12993	21	29	iran	iran	PROPN
bam-12993	21	30	;	;	PUNCT
bam-12993	22	1	2department	2department	NUM
bam-12993	22	2	of	of	ADP
bam-12993	22	3	neuroscience	neuroscience	NOUN
bam-12993	22	4	,	,	PUNCT
bam-12993	22	5	faculty	faculty	NOUN
bam-12993	22	6	of	of	ADP
bam-12993	22	7	advanced	advanced	ADJ
bam-12993	22	8	technologies	technology	NOUN
bam-12993	22	9	in	in	ADP
bam-12993	22	10	medicine	medicine	NOUN
bam-12993	22	11	,	,	PUNCT
bam-12993	22	12	iran	iran	PROPN
bam-12993	22	13	university	university	PROPN
bam-12993	22	14	of	of	ADP
bam-12993	22	15	medical	medical	ADJ
bam-12993	22	16	sciences	sciences	PROPN
bam-12993	22	17	,	,	PUNCT
bam-12993	22	18	tehran	tehran	PROPN
bam-12993	22	19	,	,	PUNCT
bam-12993	22	20	iran	iran	PROPN
bam-12993	22	21	;	;	PUNCT
bam-12993	22	22	3department	3department	NUM
bam-12993	22	23	of	of	ADP
bam-12993	22	24	anatomical	anatomical	ADJ
bam-12993	22	25	sciences	science	NOUN
bam-12993	22	26	,	,	PUNCT
bam-12993	22	27	school	school	NOUN
bam-12993	22	28	of	of	ADP
bam-12993	22	29	medicine	medicine	NOUN
bam-12993	22	30	,	,	PUNCT
bam-12993	22	31	iran	iran	PROPN
bam-12993	22	32	university	university	PROPN
bam-12993	22	33	of	of	ADP
bam-12993	22	34	medical	medical	ADJ
bam-12993	22	35	sciences	sciences	PROPN
bam-12993	22	36	,	,	PUNCT
bam-12993	22	37	tehran	tehran	PROPN
bam-12993	22	38	,	,	PUNCT
bam-12993	22	39	iran	iran	PROPN
bam-12993	22	40	;	;	PUNCT
bam-12993	22	41	4department	4department	NUM
bam-12993	22	42	of	of	ADP
bam-12993	22	43	neurosurgery	neurosurgery	NOUN
bam-12993	22	44	,	,	PUNCT
bam-12993	22	45	iran	iran	PROPN
bam-12993	22	46	university	university	PROPN
bam-12993	22	47	of	of	ADP
bam-12993	22	48	medical	medical	ADJ
bam-12993	22	49	sciences	sciences	PROPN
bam-12993	22	50	,	,	PUNCT
bam-12993	22	51	tehran	tehran	PROPN
bam-12993	22	52	,	,	PUNCT
bam-12993	22	53	iran	iran	PROPN
bam-12993	22	54	;	;	PUNCT
bam-12993	22	55	5department	5department	NUM
bam-12993	22	56	of	of	ADP
bam-12993	22	57	radiology	radiology	NOUN
bam-12993	22	58	,	,	PUNCT
bam-12993	22	59	school	school	NOUN
bam-12993	22	60	of	of	ADP
bam-12993	22	61	medicine	medicine	NOUN
bam-12993	22	62	,	,	PUNCT
bam-12993	22	63	iran	iran	PROPN
bam-12993	22	64	university	university	PROPN
bam-12993	22	65	of	of	ADP
bam-12993	22	66	medical	medical	ADJ
bam-12993	22	67	sciences	sciences	PROPN
bam-12993	22	68	,	,	PUNCT
bam-12993	22	69	tehran	tehran	PROPN
bam-12993	22	70	,	,	PUNCT
bam-12993	22	71	iran	iran	PROPN
bam-12993	22	72	;	;	PUNCT
bam-12993	22	73	6cellular	6cellular	NUM
bam-12993	22	74	and	and	CCONJ
bam-12993	22	75	molecular	molecular	ADJ
bam-12993	22	76	research	research	NOUN
bam-12993	22	77	center	center	NOUN
bam-12993	22	78	,	,	PUNCT
bam-12993	22	79	iran	iran	PROPN
bam-12993	22	80	university	university	PROPN
bam-12993	22	81	of	of	ADP
bam-12993	22	82	medical	medical	ADJ
bam-12993	22	83	sciences	sciences	PROPN
bam-12993	22	84	,	,	PUNCT
bam-12993	22	85	tehran	tehran	PROPN
bam-12993	22	86	,	,	PUNCT
bam-12993	22	87	iran	iran	PROPN
bam-12993	22	88	.	.	PUNCT
bam-12993	23	1	this	this	DET
bam-12993	23	2	article	article	NOUN
bam-12993	23	3	is	be	AUX
bam-12993	23	4	distributed	distribute	VERB
bam-12993	23	5	under	under	ADP
bam-12993	23	6	the	the	DET
bam-12993	23	7	terms	term	NOUN
bam-12993	23	8	of	of	ADP
bam-12993	23	9	the	the	DET
bam-12993	23	10	creative	creative	ADJ
bam-12993	23	11	commons	common	NOUN
bam-12993	23	12	attribution	attribution	NOUN
bam-12993	23	13	noncommercial	noncommercial	ADJ
bam-12993	23	14	license	license	NOUN
bam-12993	23	15	(	(	PUNCT
bam-12993	23	16	cc	cc	NOUN
bam-12993	23	17	by	by	ADP
bam-12993	23	18	-	-	PUNCT
bam-12993	23	19	nc	nc	PROPN
bam-12993	23	20	4.0	4.0	NUM
bam-12993	23	21	)	)	PUNCT
bam-12993	23	22	which	which	PRON
bam-12993	23	23	permits	permit	VERB
bam-12993	23	24	any	any	DET
bam-12993	23	25	noncommercial	noncommercial	ADJ
bam-12993	23	26	use	use	NOUN
bam-12993	23	27	,	,	PUNCT
bam-12993	23	28	distribution	distribution	NOUN
bam-12993	23	29	,	,	PUNCT
bam-12993	23	30	and	and	CCONJ
bam-12993	23	31	reproduction	reproduction	NOUN
bam-12993	23	32	in	in	ADP
bam-12993	23	33	any	any	DET
bam-12993	23	34	medium	medium	NOUN
bam-12993	23	35	,	,	PUNCT
bam-12993	23	36	provided	provide	VERB
bam-12993	23	37	the	the	DET
bam-12993	23	38	original	original	ADJ
bam-12993	23	39	author(s	author(s	NOUN
bam-12993	23	40	)	)	PUNCT
bam-12993	23	41	and	and	CCONJ
bam-12993	23	42	source	source	NOUN
bam-12993	23	43	are	be	AUX
bam-12993	23	44	credited	credit	VERB
bam-12993	23	45	.	.	PUNCT
bam-12993	24	1	1	1	NUM
bam-12993	24	2	vitamin	vitamin	NOUN
bam-12993	24	3	d	d	NOUN
bam-12993	24	4	receptor	receptor	NOUN
bam-12993	24	5	gene	gene	NOUN
bam-12993	24	6	polymorphisms	polymorphism	NOUN
bam-12993	24	7	in	in	ADP
bam-12993	24	8	patients	patient	NOUN
bam-12993	24	9	with	with	ADP
bam-12993	24	10	relapsing	relapse	VERB
bam-12993	24	11	multiple	multiple	ADJ
bam-12993	24	12	sclerosis	sclerosis	NOUN
bam-12993	24	13	eur	eur	PROPN
bam-12993	24	14	j	j	PROPN
bam-12993	24	15	transl	transl	PROPN
bam-12993	24	16	myol	myol	ADV
bam-12993	24	17	35	35	NUM
bam-12993	24	18	(	(	PUNCT
bam-12993	24	19	1	1	NUM
bam-12993	24	20	)	)	PUNCT
bam-12993	24	21	12993	12993	NUM
bam-12993	24	22	,	,	PUNCT
bam-12993	24	23	2025	2025	NUM
bam-12993	24	24	doi	doi	NOUN
bam-12993	24	25	:	:	PUNCT
bam-12993	24	26	10.4081	10.4081	NUM
bam-12993	24	27	/	/	SYM
bam-12993	24	28	ejtm.2024.12993	ejtm.2024.12993	PRON
bam-12993	24	29	the	the	DET
bam-12993	24	30	relationship	relationship	NOUN
bam-12993	24	31	between	between	ADP
bam-12993	24	32	the	the	DET
bam-12993	24	33	vitamin	vitamin	NOUN
bam-12993	24	34	d	d	NOUN
bam-12993	24	35	receptor	receptor	NOUN
bam-12993	24	36	(	(	PUNCT
bam-12993	24	37	vdr	vdr	NOUN
bam-12993	24	38	)	)	PUNCT
bam-12993	24	39	gene	gene	NOUN
bam-12993	24	40	and	and	CCONJ
bam-12993	24	41	many	many	ADJ
bam-12993	24	42	pathogenic	pathogenic	ADJ
bam-12993	24	43	pathways	pathway	NOUN
bam-12993	24	44	in	in	ADP
bam-12993	24	45	rrms	rrm	NOUN
bam-12993	24	46	remains	remain	VERB
bam-12993	24	47	unclear	unclear	ADJ
bam-12993	24	48	.	.	PUNCT
bam-12993	25	1	insufficient	insufficient	ADJ
bam-12993	25	2	vitamin	vitamin	NOUN
bam-12993	25	3	d	d	NOUN
bam-12993	25	4	and	and	CCONJ
bam-12993	25	5	issues	issue	NOUN
bam-12993	25	6	with	with	ADP
bam-12993	25	7	vdr	vdr	NOUN
bam-12993	25	8	gene	gene	NOUN
bam-12993	25	9	expression	expression	NOUN
bam-12993	25	10	can	can	AUX
bam-12993	25	11	decrease	decrease	VERB
bam-12993	25	12	kisspectin	kisspectin	PROPN
bam-12993	25	13	10	10	NUM
bam-12993	25	14	levels	level	NOUN
bam-12993	25	15	in	in	ADP
bam-12993	25	16	the	the	DET
bam-12993	25	17	blood	blood	NOUN
bam-12993	25	18	and	and	CCONJ
bam-12993	25	19	inhibit	inhibit	VERB
bam-12993	25	20	the	the	DET
bam-12993	25	21	maturation	maturation	NOUN
bam-12993	25	22	of	of	ADP
bam-12993	25	23	t	t	PROPN
bam-12993	25	24	lymphocytes	lymphocyte	NOUN
bam-12993	25	25	,	,	PUNCT
bam-12993	25	26	increasing	increase	VERB
bam-12993	25	27	the	the	DET
bam-12993	25	28	likelihood	likelihood	NOUN
bam-12993	25	29	of	of	ADP
bam-12993	25	30	an	an	DET
bam-12993	25	31	ms	ms	PROPN
bam-12993	25	32	recurrence.6	recurrence.6	PROPN
bam-12993	25	33	all	all	DET
bam-12993	25	34	known	know	VERB
bam-12993	25	35	biological	biological	ADJ
bam-12993	25	36	effects	effect	NOUN
bam-12993	25	37	of	of	ADP
bam-12993	25	38	vitamin	vitamin	NOUN
bam-12993	26	1	d	d	NOUN
bam-12993	26	2	require	require	VERB
bam-12993	26	3	vdr	vdr	NOUN
bam-12993	26	4	,	,	PUNCT
bam-12993	26	5	which	which	PRON
bam-12993	26	6	is	be	AUX
bam-12993	26	7	present	present	ADJ
bam-12993	26	8	in	in	ADP
bam-12993	26	9	macrophages	macrophage	NOUN
bam-12993	26	10	,	,	PUNCT
bam-12993	26	11	monocytes	monocyte	NOUN
bam-12993	26	12	,	,	PUNCT
bam-12993	26	13	t	t	PROPN
bam-12993	26	14	/	/	SYM
bam-12993	26	15	b	b	NOUN
bam-12993	26	16	cells	cell	NOUN
bam-12993	26	17	,	,	PUNCT
bam-12993	26	18	and	and	CCONJ
bam-12993	26	19	dendritic	dendritic	ADJ
bam-12993	26	20	cells	cell	NOUN
bam-12993	26	21	.	.	PUNCT
bam-12993	27	1	structurally	structurally	ADV
bam-12993	27	2	,	,	PUNCT
bam-12993	27	3	this	this	DET
bam-12993	27	4	receptor	receptor	NOUN
bam-12993	27	5	is	be	AUX
bam-12993	27	6	placed	place	VERB
bam-12993	27	7	in	in	ADP
bam-12993	27	8	the	the	DET
bam-12993	27	9	family	family	NOUN
bam-12993	27	10	of	of	ADP
bam-12993	27	11	steroid	steroid	NOUN
bam-12993	27	12	receptors	receptor	NOUN
bam-12993	27	13	,	,	PUNCT
bam-12993	27	14	which	which	PRON
bam-12993	27	15	exerts	exert	VERB
bam-12993	27	16	the	the	DET
bam-12993	27	17	effect	effect	NOUN
bam-12993	27	18	of	of	ADP
bam-12993	27	19	vitamin	vitamin	NOUN
bam-12993	27	20	d	d	NOUN
bam-12993	27	21	by	by	ADP
bam-12993	27	22	intracellularly	intracellularly	ADV
bam-12993	27	23	regulating	regulate	VERB
bam-12993	27	24	several	several	ADJ
bam-12993	27	25	genes.7	genes.7	NOUN
bam-12993	27	26	there	there	PRON
bam-12993	27	27	are	be	VERB
bam-12993	27	28	9	9	NUM
bam-12993	27	29	exons	exon	NOUN
bam-12993	27	30	in	in	ADP
bam-12993	27	31	the	the	DET
bam-12993	27	32	vdr	vdr	NOUN
bam-12993	27	33	gene	gene	NOUN
bam-12993	27	34	,	,	PUNCT
bam-12993	27	35	and	and	CCONJ
bam-12993	27	36	each	each	DET
bam-12993	27	37	one	one	NOUN
bam-12993	27	38	has	have	VERB
bam-12993	27	39	several	several	ADJ
bam-12993	27	40	polymorphisms	polymorphism	NOUN
bam-12993	27	41	.	.	PUNCT
bam-12993	28	1	foki	foki	ADJ
bam-12993	28	2	rflp	rflp	PROPN
bam-12993	28	3	is	be	AUX
bam-12993	28	4	in	in	ADP
bam-12993	28	5	exon	exon	NOUN
bam-12993	28	6	2	2	NUM
bam-12993	28	7	,	,	PUNCT
bam-12993	28	8	bsmi	bsmi	NOUN
bam-12993	28	9	and	and	CCONJ
bam-12993	28	10	apai	apai	NOUN
bam-12993	28	11	are	be	AUX
bam-12993	28	12	in	in	ADP
bam-12993	28	13	intron	intron	ADJ
bam-12993	28	14	8	8	NUM
bam-12993	28	15	,	,	PUNCT
bam-12993	28	16	and	and	CCONJ
bam-12993	28	17	taqi	taqi	ADJ
bam-12993	28	18	rflp	rflp	NOUN
bam-12993	28	19	is	be	AUX
bam-12993	28	20	in	in	ADP
bam-12993	28	21	exon	exon	NOUN
bam-12993	28	22	9	9	NUM
bam-12993	28	23	.	.	PUNCT
bam-12993	29	1	so	so	ADV
bam-12993	29	2	,	,	PUNCT
bam-12993	29	3	the	the	DET
bam-12993	29	4	4	4	NUM
bam-12993	29	5	known	know	VERB
bam-12993	29	6	polymorphisms	polymorphism	NOUN
bam-12993	29	7	of	of	ADP
bam-12993	29	8	vitamin	vitamin	NOUN
bam-12993	29	9	d	d	NOUN
bam-12993	29	10	receptor	receptor	NOUN
bam-12993	29	11	(	(	PUNCT
bam-12993	29	12	vdr	vdr	NOUN
bam-12993	29	13	)	)	PUNCT
bam-12993	29	14	are	be	AUX
bam-12993	29	15	:	:	PUNCT
bam-12993	29	16	bsmi	bsmi	NOUN
bam-12993	29	17	(	(	PUNCT
bam-12993	29	18	a	a	PRON
bam-12993	29	19	/	/	SYM
bam-12993	29	20	g	g	NOUN
bam-12993	29	21	)	)	PUNCT
bam-12993	29	22	,	,	PUNCT
bam-12993	29	23	taqi(t	taqi(t	NOUN
bam-12993	29	24	/	/	SYM
bam-12993	29	25	c	c	NOUN
bam-12993	29	26	)	)	PUNCT
bam-12993	29	27	,	,	PUNCT
bam-12993	29	28	apai	apai	NOUN
bam-12993	29	29	(	(	PUNCT
bam-12993	29	30	a	a	X
bam-12993	29	31	/	/	SYM
bam-12993	29	32	c	c	NOUN
bam-12993	29	33	)	)	PUNCT
bam-12993	29	34	in	in	ADP
bam-12993	29	35	the	the	DET
bam-12993	29	36	3	3	NUM
bam-12993	29	37	’	'	PUNCT
bam-12993	29	38	region	region	NOUN
bam-12993	29	39	of	of	ADP
bam-12993	29	40	the	the	DET
bam-12993	29	41	vdr	vdr	NOUN
bam-12993	29	42	gene	gene	NOUN
bam-12993	29	43	,	,	PUNCT
bam-12993	29	44	and	and	CCONJ
bam-12993	29	45	foki(a	foki(a	ADJ
bam-12993	29	46	)	)	PUNCT
bam-12993	29	47	polymorphism	polymorphism	NOUN
bam-12993	29	48	(	(	PUNCT
bam-12993	29	49	c	c	NOUN
bam-12993	29	50	)	)	PUNCT
bam-12993	29	51	in	in	ADP
bam-12993	29	52	exon	exon	NOUN
bam-12993	29	53	2.8	2.8	NUM
bam-12993	29	54	the	the	DET
bam-12993	29	55	vitamin	vitamin	NOUN
bam-12993	29	56	d	d	NOUN
bam-12993	29	57	receptor	receptor	NOUN
bam-12993	29	58	gene	gene	NOUN
bam-12993	29	59	is	be	AUX
bam-12993	29	60	located	locate	VERB
bam-12993	29	61	on	on	ADP
bam-12993	29	62	the	the	DET
bam-12993	29	63	long	long	ADJ
bam-12993	29	64	arm	arm	NOUN
bam-12993	29	65	of	of	ADP
bam-12993	29	66	chromosome	chromosome	NOUN
bam-12993	29	67	12	12	NUM
bam-12993	29	68	.	.	PUNCT
bam-12993	30	1	vitamin	vitamin	NOUN
bam-12993	30	2	d	d	NOUN
bam-12993	30	3	’s	’s	PART
bam-12993	30	4	main	main	ADJ
bam-12993	30	5	function	function	NOUN
bam-12993	30	6	is	be	AUX
bam-12993	30	7	to	to	PART
bam-12993	30	8	regulate	regulate	VERB
bam-12993	30	9	calcium	calcium	NOUN
bam-12993	30	10	homeostasis	homeostasis	NOUN
bam-12993	30	11	,	,	PUNCT
bam-12993	30	12	bone	bone	NOUN
bam-12993	30	13	formation	formation	NOUN
bam-12993	30	14	,	,	PUNCT
bam-12993	30	15	and	and	CCONJ
bam-12993	30	16	resorption	resorption	NOUN
bam-12993	30	17	,	,	PUNCT
bam-12993	30	18	but	but	CCONJ
bam-12993	30	19	it	it	PRON
bam-12993	30	20	also	also	ADV
bam-12993	30	21	has	have	VERB
bam-12993	30	22	other	other	ADJ
bam-12993	30	23	effects	effect	NOUN
bam-12993	30	24	on	on	ADP
bam-12993	30	25	the	the	DET
bam-12993	30	26	immune	immune	ADJ
bam-12993	30	27	system	system	NOUN
bam-12993	30	28	.	.	PUNCT
bam-12993	31	1	this	this	DET
bam-12993	31	2	vitamin	vitamin	NOUN
bam-12993	31	3	suppresses	suppress	VERB
bam-12993	31	4	lymphocyte	lymphocyte	ADJ
bam-12993	31	5	proliferation	proliferation	NOUN
bam-12993	31	6	and	and	CCONJ
bam-12993	31	7	immunoglobulin	immunoglobulin	NOUN
bam-12993	31	8	production.9	production.9	PROPN
bam-12993	31	9	this	this	DET
bam-12993	31	10	vitamin	vitamin	NOUN
bam-12993	31	11	also	also	ADV
bam-12993	31	12	inhibits	inhibit	VERB
bam-12993	31	13	the	the	DET
bam-12993	31	14	activity	activity	NOUN
bam-12993	31	15	of	of	ADP
bam-12993	31	16	the	the	DET
bam-12993	31	17	pro	pro	ADJ
bam-12993	31	18	-	-	ADJ
bam-12993	31	19	inflammatory	inflammatory	ADJ
bam-12993	31	20	factor	factor	NOUN
bam-12993	31	21	nfkappab	nfkappab	NOUN
bam-12993	31	22	as	as	ADV
bam-12993	31	23	well	well	ADV
bam-12993	31	24	as	as	ADP
bam-12993	31	25	the	the	DET
bam-12993	31	26	production	production	NOUN
bam-12993	31	27	of	of	ADP
bam-12993	31	28	various	various	ADJ
bam-12993	31	29	cytokines	cytokine	NOUN
bam-12993	31	30	,	,	PUNCT
bam-12993	31	31	such	such	ADJ
bam-12993	31	32	as	as	ADP
bam-12993	31	33	interleukin	interleukin	NOUN
bam-12993	31	34	2	2	NUM
bam-12993	31	35	and	and	CCONJ
bam-12993	31	36	12	12	NUM
bam-12993	31	37	and	and	CCONJ
bam-12993	31	38	interferon	interferon	ADJ
bam-12993	31	39	gamma.10	gamma.10	NOUN
bam-12993	31	40	the	the	DET
bam-12993	31	41	presence	presence	NOUN
bam-12993	31	42	of	of	ADP
bam-12993	31	43	nuclear	nuclear	ADJ
bam-12993	31	44	and	and	CCONJ
bam-12993	31	45	membrane	membrane	NOUN
bam-12993	31	46	vdrs	vdr	NOUN
bam-12993	31	47	in	in	ADP
bam-12993	31	48	fat	fat	ADJ
bam-12993	31	49	cells	cell	NOUN
bam-12993	31	50	suggests	suggest	VERB
bam-12993	31	51	that	that	SCONJ
bam-12993	31	52	extra	extra	ADJ
bam-12993	31	53	fat	fat	NOUN
bam-12993	31	54	may	may	AUX
bam-12993	31	55	change	change	VERB
bam-12993	31	56	the	the	DET
bam-12993	31	57	vdr	vdr	NOUN
bam-12993	31	58	,	,	PUNCT
bam-12993	31	59	making	make	VERB
bam-12993	31	60	it	it	PRON
bam-12993	31	61	harder	hard	ADV
bam-12993	31	62	for	for	SCONJ
bam-12993	31	63	the	the	DET
bam-12993	31	64	body	body	NOUN
bam-12993	31	65	to	to	PART
bam-12993	31	66	absorb	absorb	VERB
bam-12993	31	67	vitamin	vitamin	NOUN
bam-12993	31	68	d	d	NOUN
bam-12993	31	69	and	and	CCONJ
bam-12993	31	70	raising	raise	VERB
bam-12993	31	71	the	the	DET
bam-12993	31	72	risk	risk	NOUN
bam-12993	31	73	of	of	ADP
bam-12993	31	74	ms	ms	PROPN
bam-12993	31	75	.	.	PROPN
bam-12993	32	1	this	this	PRON
bam-12993	32	2	is	be	AUX
bam-12993	32	3	still	still	ADV
bam-12993	32	4	being	be	AUX
bam-12993	32	5	studied	study	VERB
bam-12993	32	6	.	.	PUNCT
bam-12993	33	1	on	on	ADP
bam-12993	33	2	the	the	DET
bam-12993	33	3	other	other	ADJ
bam-12993	33	4	hand	hand	NOUN
bam-12993	33	5	,	,	PUNCT
bam-12993	33	6	vitamin	vitamin	NOUN
bam-12993	33	7	d	d	NOUN
bam-12993	33	8	has	have	VERB
bam-12993	33	9	an	an	DET
bam-12993	33	10	anti	anti	ADJ
bam-12993	33	11	-	-	ADJ
bam-12993	33	12	inflammatory	inflammatory	ADJ
bam-12993	33	13	effect	effect	NOUN
bam-12993	33	14	on	on	ADP
bam-12993	33	15	fat	fat	ADJ
bam-12993	33	16	cells.11,12	cells.11,12	NOUN
bam-12993	33	17	obesity	obesity	NOUN
bam-12993	33	18	in	in	ADP
bam-12993	33	19	early	early	ADJ
bam-12993	33	20	life	life	NOUN
bam-12993	33	21	is	be	AUX
bam-12993	33	22	associated	associate	VERB
bam-12993	33	23	with	with	ADP
bam-12993	33	24	an	an	DET
bam-12993	33	25	increased	increase	VERB
bam-12993	33	26	risk	risk	NOUN
bam-12993	33	27	of	of	ADP
bam-12993	33	28	developing	develop	VERB
bam-12993	33	29	multiple	multiple	ADJ
bam-12993	33	30	sclerosis	sclerosis	NOUN
bam-12993	33	31	(	(	PUNCT
bam-12993	33	32	ms).13	ms).13	PROPN
bam-12993	33	33	given	give	VERB
bam-12993	33	34	the	the	DET
bam-12993	33	35	significance	significance	NOUN
bam-12993	33	36	of	of	ADP
bam-12993	33	37	the	the	DET
bam-12993	33	38	topic	topic	NOUN
bam-12993	33	39	,	,	PUNCT
bam-12993	33	40	we	we	PRON
bam-12993	33	41	conducted	conduct	VERB
bam-12993	33	42	this	this	DET
bam-12993	33	43	study	study	NOUN
bam-12993	33	44	to	to	PART
bam-12993	33	45	explore	explore	VERB
bam-12993	33	46	the	the	DET
bam-12993	33	47	correlation	correlation	NOUN
bam-12993	33	48	between	between	ADP
bam-12993	33	49	vitamin	vitamin	NOUN
bam-12993	33	50	d	d	NOUN
bam-12993	33	51	receptor	receptor	NOUN
bam-12993	33	52	gene	gene	NOUN
bam-12993	33	53	polymorphisms	polymorphism	NOUN
bam-12993	33	54	and	and	CCONJ
bam-12993	33	55	clinical	clinical	ADJ
bam-12993	33	56	and	and	CCONJ
bam-12993	33	57	inflammatory	inflammatory	ADJ
bam-12993	33	58	factors	factor	NOUN
bam-12993	33	59	in	in	ADP
bam-12993	33	60	patients	patient	NOUN
bam-12993	33	61	suffering	suffer	VERB
bam-12993	33	62	from	from	ADP
bam-12993	33	63	relapsingremitting	relapsingremitte	VERB
bam-12993	33	64	multiple	multiple	ADJ
bam-12993	33	65	sclerosis	sclerosis	NOUN
bam-12993	33	66	.	.	PUNCT
bam-12993	34	1	materials	material	NOUN
bam-12993	34	2	and	and	CCONJ
bam-12993	34	3	methods	method	NOUN
bam-12993	34	4	the	the	DET
bam-12993	34	5	current	current	ADJ
bam-12993	34	6	research	research	NOUN
bam-12993	34	7	is	be	AUX
bam-12993	34	8	a	a	DET
bam-12993	34	9	case	case	NOUN
bam-12993	34	10	/	/	SYM
bam-12993	34	11	control	control	NOUN
bam-12993	34	12	study	study	NOUN
bam-12993	34	13	that	that	PRON
bam-12993	34	14	was	be	AUX
bam-12993	34	15	conducted	conduct	VERB
bam-12993	34	16	based	base	VERB
bam-12993	34	17	on	on	ADP
bam-12993	34	18	the	the	DET
bam-12993	34	19	ethical	ethical	ADJ
bam-12993	34	20	principles	principle	NOUN
bam-12993	34	21	of	of	ADP
bam-12993	34	22	helsinki14	helsinki14	PROPN
bam-12993	34	23	and	and	CCONJ
bam-12993	34	24	was	be	AUX
bam-12993	34	25	approved	approve	VERB
bam-12993	34	26	by	by	ADP
bam-12993	34	27	the	the	DET
bam-12993	34	28	medical	medical	ADJ
bam-12993	34	29	ethics	ethic	NOUN
bam-12993	34	30	department	department	PROPN
bam-12993	34	31	of	of	ADP
bam-12993	34	32	iran	iran	PROPN
bam-12993	34	33	university	university	PROPN
bam-12993	34	34	of	of	ADP
bam-12993	34	35	medical	medical	ADJ
bam-12993	34	36	sciences	science	NOUN
bam-12993	34	37	with	with	ADP
bam-12993	34	38	no	no	PROPN
bam-12993	34	39	.	.	PUNCT
bam-12993	35	1	ir.iums.fmd	ir.iums.fmd	PROPN
bam-12993	35	2	.	.	PUNCT
bam-12993	36	1	rec.1401.429	rec.1401.429	PROPN
bam-12993	36	2	.	.	PUNCT
bam-12993	37	1	rrms	rrm	NOUN
bam-12993	37	2	disease	disease	NOUN
bam-12993	37	3	was	be	AUX
bam-12993	37	4	confirmed	confirm	VERB
bam-12993	37	5	based	base	VERB
bam-12993	37	6	on	on	ADP
bam-12993	37	7	history	history	NOUN
bam-12993	37	8	,	,	PUNCT
bam-12993	37	9	clinical	clinical	ADJ
bam-12993	37	10	signs	sign	NOUN
bam-12993	37	11	,	,	PUNCT
bam-12993	37	12	radiological	radiological	ADJ
bam-12993	37	13	signs	sign	NOUN
bam-12993	37	14	,	,	PUNCT
bam-12993	37	15	and	and	CCONJ
bam-12993	37	16	neurologist	neurologist	NOUN
bam-12993	37	17	’s	’s	PART
bam-12993	37	18	diagnosis	diagnosis	NOUN
bam-12993	37	19	.	.	PUNCT
bam-12993	38	1	the	the	DET
bam-12993	38	2	research	research	NOUN
bam-12993	38	3	population	population	NOUN
bam-12993	38	4	consisted	consist	VERB
bam-12993	38	5	of	of	ADP
bam-12993	38	6	healthy	healthy	ADJ
bam-12993	38	7	people	people	NOUN
bam-12993	38	8	and	and	CCONJ
bam-12993	38	9	patients	patient	NOUN
bam-12993	38	10	with	with	ADP
bam-12993	38	11	rrms	rrm	NOUN
bam-12993	38	12	referring	refer	VERB
bam-12993	38	13	to	to	ADP
bam-12993	38	14	hazrat	hazrat	PROPN
bam-12993	38	15	rasool	rasool	PROPN
bam-12993	38	16	akram	akram	PROPN
bam-12993	38	17	hospital	hospital	NOUN
bam-12993	38	18	between	between	ADP
bam-12993	38	19	2021	2021	NUM
bam-12993	38	20	and	and	CCONJ
bam-12993	38	21	2023	2023	NUM
bam-12993	38	22	who	who	PRON
bam-12993	38	23	met	meet	VERB
bam-12993	38	24	the	the	DET
bam-12993	38	25	criteria	criterion	NOUN
bam-12993	38	26	for	for	ADP
bam-12993	38	27	entering	enter	VERB
bam-12993	38	28	the	the	DET
bam-12993	38	29	research	research	NOUN
bam-12993	38	30	.	.	PUNCT
bam-12993	39	1	inclusion	inclusion	NOUN
bam-12993	39	2	criteria	criterion	NOUN
bam-12993	39	3	the	the	DET
bam-12993	39	4	study	study	NOUN
bam-12993	39	5	included	include	VERB
bam-12993	39	6	patients	patient	NOUN
bam-12993	39	7	with	with	ADP
bam-12993	39	8	relapsing	relapse	VERB
bam-12993	39	9	-	-	PUNCT
bam-12993	39	10	remitting	remit	VERB
bam-12993	39	11	multiple	multiple	ADJ
bam-12993	39	12	sclerosis	sclerosis	NOUN
bam-12993	39	13	(	(	PUNCT
bam-12993	39	14	rrms	rrm	NOUN
bam-12993	39	15	)	)	PUNCT
bam-12993	39	16	who	who	PRON
bam-12993	39	17	have	have	AUX
bam-12993	39	18	been	be	AUX
bam-12993	39	19	diagnosed	diagnose	VERB
bam-12993	39	20	with	with	ADP
bam-12993	39	21	mcdonald	mcdonald	PROPN
bam-12993	39	22	’s	’s	PART
bam-12993	39	23	2017	2017	NUM
bam-12993	39	24	criteria,15	criteria,15	NOUN
bam-12993	39	25	both	both	CCONJ
bam-12993	39	26	female	female	ADJ
bam-12993	39	27	and	and	CCONJ
bam-12993	39	28	male	male	ADJ
bam-12993	39	29	gender	gender	NOUN
bam-12993	39	30	,	,	PUNCT
bam-12993	39	31	age	age	NOUN
bam-12993	39	32	group	group	NOUN
bam-12993	39	33	from	from	ADP
bam-12993	39	34	18	18	NUM
bam-12993	39	35	to	to	PART
bam-12993	39	36	65	65	NUM
bam-12993	39	37	years	year	NOUN
bam-12993	39	38	.	.	PUNCT
bam-12993	40	1	we	we	PRON
bam-12993	40	2	also	also	ADV
bam-12993	40	3	included	include	VERB
bam-12993	40	4	newly	newly	ADV
bam-12993	40	5	admitted	admit	VERB
bam-12993	40	6	patients	patient	NOUN
bam-12993	40	7	using	use	VERB
bam-12993	40	8	no	no	DET
bam-12993	40	9	drugs	drug	NOUN
bam-12993	40	10	in	in	ADP
bam-12993	40	11	the	the	DET
bam-12993	40	12	relapse	relapse	NOUN
bam-12993	40	13	phase	phase	NOUN
bam-12993	40	14	and	and	CCONJ
bam-12993	40	15	patients	patient	NOUN
bam-12993	40	16	only	only	ADV
bam-12993	40	17	treated	treat	VERB
bam-12993	40	18	with	with	ADP
bam-12993	40	19	intron	intron	ADJ
bam-12993	40	20	beta	beta	NOUN
bam-12993	40	21	and	and	CCONJ
bam-12993	40	22	with	with	SCONJ
bam-12993	40	23	a	a	DET
bam-12993	40	24	gap	gap	NOUN
bam-12993	40	25	of	of	ADP
bam-12993	40	26	at	at	ADV
bam-12993	40	27	least	least	ADV
bam-12993	40	28	3	3	NUM
bam-12993	40	29	months	month	NOUN
bam-12993	40	30	from	from	ADP
bam-12993	40	31	the	the	DET
bam-12993	40	32	relapse	relapse	NOUN
bam-12993	40	33	phase	phase	NOUN
bam-12993	40	34	were	be	AUX
bam-12993	40	35	evaluated	evaluate	VERB
bam-12993	40	36	.	.	PUNCT
bam-12993	41	1	patients	patient	NOUN
bam-12993	41	2	were	be	AUX
bam-12993	41	3	examined	examine	VERB
bam-12993	41	4	by	by	ADP
bam-12993	41	5	a	a	DET
bam-12993	41	6	specialist	specialist	NOUN
bam-12993	41	7	in	in	ADP
bam-12993	41	8	terms	term	NOUN
bam-12993	41	9	of	of	ADP
bam-12993	41	10	plaques	plaque	NOUN
bam-12993	41	11	in	in	ADP
bam-12993	41	12	mri	mri	NOUN
bam-12993	41	13	,	,	PUNCT
bam-12993	41	14	disability	disability	NOUN
bam-12993	41	15	progress	progress	NOUN
bam-12993	41	16	status	status	NOUN
bam-12993	41	17	,	,	PUNCT
bam-12993	41	18	and	and	CCONJ
bam-12993	41	19	blood	blood	NOUN
bam-12993	41	20	markers	marker	NOUN
bam-12993	41	21	at	at	ADP
bam-12993	41	22	least	least	ADJ
bam-12993	41	23	in	in	ADP
bam-12993	41	24	two	two	NUM
bam-12993	41	25	four	four	NUM
bam-12993	41	26	-	-	PUNCT
bam-12993	41	27	month	month	NOUN
bam-12993	41	28	intervals	interval	NOUN
bam-12993	41	29	.	.	PUNCT
bam-12993	42	1	the	the	DET
bam-12993	42	2	participants	participant	NOUN
bam-12993	42	3	showed	show	VERB
bam-12993	42	4	an	an	DET
bam-12993	42	5	edss	edss	NOUN
bam-12993	42	6	between	between	ADP
bam-12993	42	7	1	1	NUM
bam-12993	42	8	and	and	CCONJ
bam-12993	42	9	3	3	NUM
bam-12993	42	10	.	.	PUNCT
bam-12993	43	1	the	the	DET
bam-12993	43	2	patients	patient	NOUN
bam-12993	43	3	did	do	AUX
bam-12993	43	4	not	not	PART
bam-12993	43	5	take	take	VERB
bam-12993	43	6	vitamin	vitamin	NOUN
bam-12993	43	7	d	d	NOUN
bam-12993	43	8	in	in	ADP
bam-12993	43	9	the	the	DET
bam-12993	43	10	preceding	precede	VERB
bam-12993	43	11	6	6	NUM
bam-12993	43	12	months	month	NOUN
bam-12993	43	13	.	.	PUNCT
bam-12993	44	1	exclusion	exclusion	NOUN
bam-12993	44	2	criteria	criterion	NOUN
bam-12993	44	3	we	we	PRON
bam-12993	44	4	included	include	VERB
bam-12993	44	5	the	the	DET
bam-12993	44	6	following	follow	VERB
bam-12993	44	7	categories	category	NOUN
bam-12993	44	8	:	:	PUNCT
bam-12993	44	9	i	i	X
bam-12993	44	10	)	)	PUNCT
bam-12993	44	11	patients	patient	NOUN
bam-12993	44	12	in	in	ADP
bam-12993	44	13	other	other	ADJ
bam-12993	44	14	phases	phase	NOUN
bam-12993	44	15	of	of	ADP
bam-12993	44	16	rrms	rrm	NOUN
bam-12993	44	17	except	except	SCONJ
bam-12993	44	18	relapse	relapse	NOUN
bam-12993	44	19	;	;	PUNCT
bam-12993	44	20	ii	ii	X
bam-12993	44	21	)	)	PUNCT
bam-12993	44	22	patients	patient	NOUN
bam-12993	44	23	with	with	ADP
bam-12993	44	24	diabetes	diabetes	NOUN
bam-12993	44	25	,	,	PUNCT
bam-12993	44	26	liver	liver	NOUN
bam-12993	44	27	disorders	disorder	NOUN
bam-12993	44	28	(	(	PUNCT
bam-12993	44	29	cirrhosis	cirrhosis	NOUN
bam-12993	44	30	and	and	CCONJ
bam-12993	44	31	types	type	NOUN
bam-12993	44	32	of	of	ADP
bam-12993	44	33	hepatitis	hepatitis	NOUN
bam-12993	44	34	)	)	PUNCT
bam-12993	44	35	,	,	PUNCT
bam-12993	44	36	kidney	kidney	NOUN
bam-12993	44	37	disorders	disorder	NOUN
bam-12993	44	38	(	(	PUNCT
bam-12993	44	39	kidney	kidney	NOUN
bam-12993	44	40	failure	failure	NOUN
bam-12993	44	41	)	)	PUNCT
bam-12993	44	42	,	,	PUNCT
bam-12993	44	43	congestive	congestive	ADJ
bam-12993	44	44	heart	heart	NOUN
bam-12993	44	45	failure	failure	NOUN
bam-12993	44	46	,	,	PUNCT
bam-12993	44	47	high	high	ADJ
bam-12993	44	48	blood	blood	NOUN
bam-12993	44	49	pressure	pressure	NOUN
bam-12993	44	50	,	,	PUNCT
bam-12993	44	51	and	and	CCONJ
bam-12993	44	52	cancer	cancer	NOUN
bam-12993	44	53	;	;	PUNCT
bam-12993	44	54	iii	iii	X
bam-12993	44	55	)	)	PUNCT
bam-12993	44	56	patients	patient	NOUN
bam-12993	44	57	taking	take	VERB
bam-12993	44	58	other	other	ADJ
bam-12993	44	59	drugs	drug	NOUN
bam-12993	44	60	.	.	PUNCT
bam-12993	45	1	sample	sample	NOUN
bam-12993	45	2	size	size	NOUN
bam-12993	45	3	determination	determination	NOUN
bam-12993	45	4	the	the	DET
bam-12993	45	5	required	require	VERB
bam-12993	45	6	sample	sample	NOUN
bam-12993	45	7	size	size	NOUN
bam-12993	45	8	for	for	ADP
bam-12993	45	9	the	the	DET
bam-12993	45	10	present	present	ADJ
bam-12993	45	11	study	study	NOUN
bam-12993	45	12	was	be	AUX
bam-12993	45	13	calculated	calculate	VERB
bam-12993	45	14	through	through	ADP
bam-12993	45	15	the	the	DET
bam-12993	45	16	ratio	ratio	NOUN
bam-12993	45	17	comparison	comparison	NOUN
bam-12993	45	18	formula	formula	NOUN
bam-12993	45	19	of	of	ADP
bam-12993	45	20	two	two	NUM
bam-12993	45	21	independent	independent	ADJ
bam-12993	45	22	groups	group	NOUN
bam-12993	45	23	.	.	PUNCT
bam-12993	46	1	considering	consider	VERB
bam-12993	46	2	the	the	DET
bam-12993	46	3	confidence	confidence	NOUN
bam-12993	46	4	level	level	NOUN
bam-12993	46	5	of	of	ADP
bam-12993	46	6	95	95	NUM
bam-12993	46	7	%	%	NOUN
bam-12993	46	8	(	(	PUNCT
bam-12993	46	9	significance	significance	NOUN
bam-12993	46	10	level	level	NOUN
bam-12993	46	11	of	of	ADP
bam-12993	46	12	5	5	NUM
bam-12993	46	13	%	%	NOUN
bam-12993	46	14	)	)	PUNCT
bam-12993	46	15	,	,	PUNCT
bam-12993	46	16	the	the	DET
bam-12993	46	17	power	power	NOUN
bam-12993	46	18	of	of	ADP
bam-12993	46	19	the	the	DET
bam-12993	46	20	study	study	NOUN
bam-12993	46	21	was	be	AUX
bam-12993	46	22	estimated	estimate	VERB
bam-12993	46	23	to	to	PART
bam-12993	46	24	be	be	AUX
bam-12993	46	25	80	80	NUM
bam-12993	46	26	%	%	NOUN
bam-12993	46	27	,	,	PUNCT
bam-12993	46	28	according	accord	VERB
bam-12993	46	29	to	to	ADP
bam-12993	46	30	the	the	DET
bam-12993	46	31	almost	almost	ADV
bam-12993	46	32	similar	similar	ADJ
bam-12993	46	33	study	study	NOUN
bam-12993	46	34	of	of	ADP
bam-12993	46	35	21	21	NUM
bam-12993	46	36	people	people	NOUN
bam-12993	46	37	for	for	ADP
bam-12993	46	38	each	each	DET
bam-12993	46	39	study	study	NOUN
bam-12993	46	40	group	group	NOUN
bam-12993	46	41	.	.	PUNCT
bam-12993	47	1	in	in	ADP
bam-12993	47	2	order	order	NOUN
bam-12993	47	3	to	to	PART
bam-12993	47	4	increase	increase	VERB
bam-12993	47	5	the	the	DET
bam-12993	47	6	power	power	NOUN
bam-12993	47	7	of	of	ADP
bam-12993	47	8	the	the	DET
bam-12993	47	9	study	study	NOUN
bam-12993	47	10	and	and	CCONJ
bam-12993	47	11	also	also	ADV
bam-12993	47	12	to	to	PART
bam-12993	47	13	consider	consider	VERB
bam-12993	47	14	the	the	DET
bam-12993	47	15	possibility	possibility	NOUN
bam-12993	47	16	of	of	ADP
bam-12993	47	17	dropping	drop	VERB
bam-12993	47	18	out	out	ADP
bam-12993	47	19	,	,	PUNCT
bam-12993	47	20	the	the	DET
bam-12993	47	21	minimum	minimum	ADJ
bam-12993	47	22	sample	sample	NOUN
bam-12993	47	23	size	size	NOUN
bam-12993	47	24	required	require	VERB
bam-12993	47	25	for	for	ADP
bam-12993	47	26	the	the	DET
bam-12993	47	27	study	study	NOUN
bam-12993	47	28	group	group	NOUN
bam-12993	47	29	was	be	AUX
bam-12993	47	30	25	25	NUM
bam-12993	47	31	rrms	rrm	NOUN
bam-12993	47	32	patients	patient	NOUN
bam-12993	47	33	and	and	CCONJ
bam-12993	47	34	12	12	NUM
bam-12993	47	35	healthy	healthy	ADJ
bam-12993	47	36	controls	control	NOUN
bam-12993	47	37	.	.	PUNCT
bam-12993	48	1	α=0.05	α=0.05	NOUN
bam-12993	48	2	;	;	PUNCT
bam-12993	48	3	β=0.2	β=0.2	NUM
bam-12993	48	4	;	;	PUNCT
bam-12993	48	5	zα	zα	PROPN
bam-12993	48	6	=	=	SYM
bam-12993	48	7	1.95	1.95	NUM
bam-12993	48	8	;	;	PUNCT
bam-12993	48	9	zβ	zβ	PROPN
bam-12993	48	10	=	=	PUNCT
bam-12993	48	11	0.84	0.84	NUM
bam-12993	48	12	;	;	PUNCT
bam-12993	48	13	mean	mean	VERB
bam-12993	48	14	in	in	ADP
bam-12993	48	15	group	group	NOUN
bam-12993	48	16	1(µ1	1(µ1	NUM
bam-12993	48	17	)	)	PUNCT
bam-12993	48	18	=	=	NOUN
bam-12993	48	19	2.77	2.77	NUM
bam-12993	48	20	;	;	PUNCT
bam-12993	48	21	standard	standard	ADJ
bam-12993	48	22	deviation	deviation	NOUN
bam-12993	48	23	in	in	ADP
bam-12993	48	24	group	group	NOUN
bam-12993	48	25	1(σ1	1(σ1	NUM
bam-12993	48	26	)	)	PUNCT
bam-12993	49	1	=	=	NOUN
bam-12993	49	2	1.45	1.45	NUM
bam-12993	49	3	;	;	PUNCT
bam-12993	49	4	mean	mean	VERB
bam-12993	49	5	in	in	ADP
bam-12993	49	6	group	group	NOUN
bam-12993	49	7	2(µ2	2(µ2	NUM
bam-12993	49	8	)	)	PUNCT
bam-12993	50	1	=	=	NOUN
bam-12993	50	2	4.11	4.11	NUM
bam-12993	50	3	;	;	PUNCT
bam-12993	50	4	standard	standard	ADJ
bam-12993	50	5	deviation	deviation	NOUN
bam-12993	50	6	in	in	ADP
bam-12993	50	7	group	group	NOUN
bam-12993	50	8	2(σ2	2(σ2	NUM
bam-12993	50	9	)	)	PUNCT
bam-12993	50	10	=	=	NOUN
bam-12993	50	11	1.41	1.41	NUM
bam-12993	50	12	;	;	PUNCT
bam-12993	50	13	r=1	r=1	NOUN
bam-12993	50	14	.	.	PUNCT
bam-12993	51	1	in	in	ADP
bam-12993	51	2	this	this	DET
bam-12993	51	3	case	case	NOUN
bam-12993	51	4	/	/	SYM
bam-12993	51	5	control	control	NOUN
bam-12993	51	6	study	study	NOUN
bam-12993	51	7	,	,	PUNCT
bam-12993	51	8	25	25	NUM
bam-12993	51	9	patients	patient	NOUN
bam-12993	51	10	with	with	ADP
bam-12993	51	11	rrms	rrm	NOUN
bam-12993	51	12	(	(	PUNCT
bam-12993	51	13	test	test	NOUN
bam-12993	51	14	group	group	NOUN
bam-12993	51	15	)	)	PUNCT
bam-12993	51	16	and	and	CCONJ
bam-12993	51	17	12	12	NUM
bam-12993	51	18	healthy	healthy	ADJ
bam-12993	51	19	people	people	NOUN
bam-12993	51	20	(	(	PUNCT
bam-12993	51	21	control	control	NOUN
bam-12993	51	22	group	group	NOUN
bam-12993	51	23	)	)	PUNCT
bam-12993	51	24	were	be	AUX
bam-12993	51	25	evaluated	evaluate	VERB
bam-12993	51	26	between	between	ADP
bam-12993	51	27	2021	2021	NUM
bam-12993	51	28	and	and	CCONJ
bam-12993	51	29	2023	2023	NUM
bam-12993	51	30	.	.	PUNCT
bam-12993	52	1	a	a	DET
bam-12993	52	2	written	write	VERB
bam-12993	52	3	consent	consent	NOUN
bam-12993	52	4	was	be	AUX
bam-12993	52	5	obtained	obtain	VERB
bam-12993	52	6	from	from	ADP
bam-12993	52	7	all	all	DET
bam-12993	52	8	the	the	DET
bam-12993	52	9	people	people	NOUN
bam-12993	52	10	participating	participate	VERB
bam-12993	52	11	in	in	ADP
bam-12993	52	12	the	the	DET
bam-12993	52	13	study	study	NOUN
bam-12993	52	14	,	,	PUNCT
bam-12993	52	15	stating	state	VERB
bam-12993	52	16	that	that	SCONJ
bam-12993	52	17	this	this	DET
bam-12993	52	18	study	study	NOUN
bam-12993	52	19	did	do	AUX
bam-12993	52	20	not	not	PART
bam-12993	52	21	impose	impose	VERB
bam-12993	52	22	any	any	DET
bam-12993	52	23	additional	additional	ADJ
bam-12993	52	24	costs	cost	NOUN
bam-12993	52	25	,	,	PUNCT
bam-12993	52	26	threats	threat	NOUN
bam-12993	52	27	,	,	PUNCT
bam-12993	52	28	or	or	CCONJ
bam-12993	52	29	problems	problem	NOUN
bam-12993	52	30	for	for	ADP
bam-12993	52	31	them	they	PRON
bam-12993	52	32	,	,	PUNCT
bam-12993	52	33	and	and	CCONJ
bam-12993	52	34	whenever	whenever	SCONJ
bam-12993	52	35	they	they	PRON
bam-12993	52	36	were	be	AUX
bam-12993	52	37	unable	unable	ADJ
bam-12993	52	38	to	to	PART
bam-12993	52	39	cooperate	cooperate	VERB
bam-12993	52	40	and	and	CCONJ
bam-12993	52	41	continue	continue	VERB
bam-12993	52	42	to	to	PART
bam-12993	52	43	participate	participate	VERB
bam-12993	52	44	,	,	PUNCT
bam-12993	52	45	they	they	PRON
bam-12993	52	46	were	be	AUX
bam-12993	52	47	excluded	exclude	VERB
bam-12993	52	48	from	from	ADP
bam-12993	52	49	the	the	DET
bam-12993	52	50	study	study	NOUN
bam-12993	52	51	,	,	PUNCT
bam-12993	52	52	and	and	CCONJ
bam-12993	52	53	there	there	PRON
bam-12993	52	54	was	be	VERB
bam-12993	52	55	no	no	DET
bam-12993	52	56	negligence	negligence	NOUN
bam-12993	52	57	.	.	PUNCT
bam-12993	53	1	it	it	PRON
bam-12993	53	2	does	do	AUX
bam-12993	53	3	not	not	PART
bam-12993	53	4	take	take	VERB
bam-12993	53	5	place	place	NOUN
bam-12993	53	6	when	when	SCONJ
bam-12993	53	7	handling	handle	VERB
bam-12993	53	8	them	they	PRON
bam-12993	53	9	.	.	PUNCT
bam-12993	54	1	we	we	PRON
bam-12993	54	2	fully	fully	ADV
bam-12993	54	3	explained	explain	VERB
bam-12993	54	4	the	the	DET
bam-12993	54	5	situation	situation	NOUN
bam-12993	54	6	to	to	ADP
bam-12993	54	7	the	the	DET
bam-12993	54	8	patient	patient	NOUN
bam-12993	54	9	’s	’s	PART
bam-12993	54	10	legal	legal	ADJ
bam-12993	54	11	representative	representative	NOUN
bam-12993	54	12	,	,	PUNCT
bam-12993	54	13	child	child	NOUN
bam-12993	54	14	,	,	PUNCT
bam-12993	54	15	or	or	CCONJ
bam-12993	54	16	first	first	ADJ
bam-12993	54	17	-	-	PUNCT
bam-12993	54	18	degree	degree	NOUN
bam-12993	54	19	relative	relative	NOUN
bam-12993	54	20	if	if	SCONJ
bam-12993	54	21	he	he	PRON
bam-12993	54	22	did	do	AUX
bam-12993	54	23	not	not	PART
bam-12993	54	24	understand	understand	VERB
bam-12993	54	25	or	or	CCONJ
bam-12993	54	26	was	be	AUX
bam-12993	54	27	not	not	PART
bam-12993	54	28	sufficiently	sufficiently	ADV
bam-12993	54	29	literate	literate	ADJ
bam-12993	54	30	,	,	PUNCT
bam-12993	54	31	and	and	CCONJ
bam-12993	54	32	obtained	obtain	VERB
bam-12993	54	33	consent	consent	NOUN
bam-12993	54	34	in	in	ADP
bam-12993	54	35	their	their	PRON
bam-12993	54	36	presence	presence	NOUN
bam-12993	54	37	and	and	CCONJ
bam-12993	54	38	with	with	ADP
bam-12993	54	39	their	their	PRON
bam-12993	54	40	approval	approval	NOUN
bam-12993	54	41	.	.	PUNCT
bam-12993	55	1	the	the	DET
bam-12993	55	2	project	project	NOUN
bam-12993	55	3	manager	manager	NOUN
bam-12993	55	4	fully	fully	ADV
bam-12993	55	5	communicated	communicate	VERB
bam-12993	55	6	all	all	DET
bam-12993	55	7	the	the	DET
bam-12993	55	8	study	study	NOUN
bam-12993	55	9	results	result	NOUN
bam-12993	55	10	,	,	PUNCT
bam-12993	55	11	including	include	VERB
bam-12993	55	12	genetic	genetic	ADJ
bam-12993	55	13	test	test	NOUN
bam-12993	55	14	results	result	NOUN
bam-12993	55	15	and	and	CCONJ
bam-12993	55	16	clinical	clinical	ADJ
bam-12993	55	17	and	and	CCONJ
bam-12993	55	18	inflammatory	inflammatory	ADJ
bam-12993	55	19	factor	factor	NOUN
bam-12993	55	20	examination	examination	NOUN
bam-12993	55	21	results	result	NOUN
bam-12993	55	22	,	,	PUNCT
bam-12993	55	23	to	to	ADP
bam-12993	55	24	the	the	DET
bam-12993	55	25	patients	patient	NOUN
bam-12993	55	26	through	through	ADP
bam-12993	55	27	phone	phone	NOUN
bam-12993	55	28	calls	call	NOUN
bam-12993	55	29	or	or	CCONJ
bam-12993	55	30	face	face	NOUN
bam-12993	55	31	-	-	PUNCT
bam-12993	55	32	to	to	ADP
bam-12993	55	33	-	-	PUNCT
bam-12993	55	34	face	face	NOUN
bam-12993	55	35	interactions	interaction	NOUN
bam-12993	55	36	,	,	PUNCT
bam-12993	55	37	significantly	significantly	ADV
bam-12993	55	38	aiding	aid	VERB
bam-12993	55	39	in	in	ADP
bam-12993	55	40	their	their	PRON
bam-12993	55	41	disease	disease	NOUN
bam-12993	55	42	treatment	treatment	NOUN
bam-12993	55	43	process	process	NOUN
bam-12993	55	44	.	.	PUNCT
bam-12993	56	1	the	the	DET
bam-12993	56	2	following	follow	VERB
bam-12993	56	3	clinical	clinical	ADJ
bam-12993	56	4	variables	variable	NOUN
bam-12993	56	5	were	be	AUX
bam-12993	56	6	considered	consider	VERB
bam-12993	56	7	for	for	ADP
bam-12993	56	8	analysis	analysis	NOUN
bam-12993	56	9	at	at	ADP
bam-12993	56	10	sample	sample	NOUN
bam-12993	56	11	collection	collection	NOUN
bam-12993	56	12	:	:	PUNCT
bam-12993	56	13	age	age	NOUN
bam-12993	56	14	of	of	ADP
bam-12993	56	15	onset	onset	NOUN
bam-12993	56	16	(	(	PUNCT
bam-12993	56	17	years	year	NOUN
bam-12993	56	18	)	)	PUNCT
bam-12993	56	19	,	,	PUNCT
bam-12993	56	20	duration	duration	NOUN
bam-12993	56	21	of	of	ADP
bam-12993	56	22	ms	ms	PROPN
bam-12993	56	23	disease	disease	NOUN
bam-12993	56	24	(	(	PUNCT
bam-12993	56	25	months	month	NOUN
bam-12993	56	26	)	)	PUNCT
bam-12993	56	27	,	,	PUNCT
bam-12993	56	28	extended	extend	VERB
bam-12993	56	29	disability	disability	NOUN
bam-12993	56	30	status	status	NOUN
bam-12993	56	31	scale	scale	NOUN
bam-12993	56	32	score	score	NOUN
bam-12993	56	33	(	(	PUNCT
bam-12993	56	34	edss/1	edss/1	PROPN
bam-12993	56	35	-	-	SYM
bam-12993	56	36	3	3	NUM
bam-12993	56	37	)	)	PUNCT
bam-12993	56	38	,	,	PUNCT
bam-12993	56	39	multiple	multiple	ADJ
bam-12993	56	40	sclerosis	sclerosis	NOUN
bam-12993	56	41	severity	severity	NOUN
bam-12993	56	42	score	score	NOUN
bam-12993	56	43	(	(	PUNCT
bam-12993	56	44	msss	msss	NOUN
bam-12993	56	45	)	)	PUNCT
bam-12993	56	46	,	,	PUNCT
bam-12993	56	47	annual	annual	ADJ
bam-12993	56	48	relapse	relapse	NOUN
bam-12993	56	49	the	the	DET
bam-12993	56	50	rate	rate	NOUN
bam-12993	56	51	since	since	SCONJ
bam-12993	56	52	the	the	DET
bam-12993	56	53	onset	onset	NOUN
bam-12993	56	54	of	of	ADP
bam-12993	56	55	the	the	DET
bam-12993	56	56	disease	disease	NOUN
bam-12993	56	57	,	,	PUNCT
bam-12993	56	58	the	the	DET
bam-12993	56	59	number	number	NOUN
bam-12993	56	60	of	of	ADP
bam-12993	56	61	relapses	relapse	NOUN
bam-12993	56	62	two	two	NUM
bam-12993	56	63	years	year	NOUN
bam-12993	56	64	ago	ago	ADV
bam-12993	56	65	and	and	CCONJ
bam-12993	56	66	the	the	DET
bam-12993	56	67	doctors	doctor	NOUN
bam-12993	56	68	at	at	ADP
bam-12993	56	69	the	the	DET
bam-12993	56	70	time	time	NOUN
bam-12993	56	71	of	of	ADP
bam-12993	56	72	the	the	DET
bam-12993	56	73	examination	examination	NOUN
bam-12993	56	74	,	,	PUNCT
bam-12993	56	75	gender	gender	NOUN
bam-12993	56	76	,	,	PUNCT
bam-12993	56	77	disease	disease	NOUN
bam-12993	56	78	and	and	CCONJ
bam-12993	56	79	smoking	smoking	NOUN
bam-12993	56	80	history	history	NOUN
bam-12993	56	81	,	,	PUNCT
bam-12993	56	82	vitamin	vitamin	NOUN
bam-12993	56	83	d	d	NOUN
bam-12993	56	84	consumption	consumption	NOUN
bam-12993	56	85	in	in	ADP
bam-12993	56	86	the	the	DET
bam-12993	56	87	last	last	ADJ
bam-12993	56	88	6	6	NUM
bam-12993	56	89	months	month	NOUN
bam-12993	56	90	,	,	PUNCT
bam-12993	56	91	behavioral	behavioral	ADJ
bam-12993	56	92	tests	test	NOUN
bam-12993	56	93	and	and	CCONJ
bam-12993	56	94	cognitive	cognitive	ADJ
bam-12993	56	95	disorders	disorder	NOUN
bam-12993	56	96	were	be	AUX
bam-12993	56	97	evaluated	evaluate	VERB
bam-12993	56	98	.	.	PUNCT
bam-12993	57	1	the	the	DET
bam-12993	57	2	edss	edss	NOUN
bam-12993	57	3	provides	provide	VERB
bam-12993	57	4	a	a	DET
bam-12993	57	5	total	total	ADJ
bam-12993	57	6	score	score	NOUN
bam-12993	57	7	on	on	ADP
bam-12993	57	8	a	a	DET
bam-12993	57	9	scale	scale	NOUN
bam-12993	57	10	of	of	ADP
bam-12993	57	11	0	0	NUM
bam-12993	57	12	to	to	PART
bam-12993	57	13	10	10	NUM
bam-12993	57	14	.	.	PUNCT
bam-12993	58	1	edss	edss	ADJ
bam-12993	58	2	levels	level	NOUN
bam-12993	58	3	1.0	1.0	NUM
bam-12993	58	4	to	to	PART
bam-12993	58	5	4.5	4.5	NUM
bam-12993	58	6	refer	refer	VERB
bam-12993	58	7	to	to	ADP
bam-12993	58	8	fully	fully	ADV
bam-12993	58	9	ambulatory	ambulatory	ADJ
bam-12993	58	10	patients	patient	NOUN
bam-12993	58	11	and	and	CCONJ
bam-12993	58	12	the	the	DET
bam-12993	58	13	2	2	NUM
bam-12993	58	14	vitamin	vitamin	NOUN
bam-12993	58	15	d	d	NOUN
bam-12993	58	16	receptor	receptor	NOUN
bam-12993	58	17	gene	gene	NOUN
bam-12993	58	18	polymorphisms	polymorphism	NOUN
bam-12993	58	19	in	in	ADP
bam-12993	58	20	patients	patient	NOUN
bam-12993	58	21	with	with	ADP
bam-12993	58	22	relapsing	relapse	VERB
bam-12993	58	23	multiple	multiple	ADJ
bam-12993	58	24	sclerosis	sclerosis	NOUN
bam-12993	58	25	eur	eur	PROPN
bam-12993	58	26	j	j	PROPN
bam-12993	58	27	transl	transl	PROPN
bam-12993	58	28	myol	myol	ADV
bam-12993	58	29	35	35	NUM
bam-12993	58	30	(	(	PUNCT
bam-12993	58	31	1	1	NUM
bam-12993	58	32	)	)	PUNCT
bam-12993	58	33	12993	12993	NUM
bam-12993	58	34	,	,	PUNCT
bam-12993	58	35	2025	2025	NUM
bam-12993	58	36	doi	doi	NOUN
bam-12993	58	37	:	:	PUNCT
bam-12993	58	38	10.4081	10.4081	NUM
bam-12993	58	39	/	/	SYM
bam-12993	58	40	ejtm.2024.12993	ejtm.2024.12993	NOUN
bam-12993	58	41	exact	exact	ADJ
bam-12993	58	42	step	step	NOUN
bam-12993	58	43	count	count	NOUN
bam-12993	58	44	is	be	AUX
bam-12993	58	45	defined	define	VERB
bam-12993	58	46	by	by	ADP
bam-12993	58	47	the	the	DET
bam-12993	58	48	functional	functional	ADJ
bam-12993	58	49	system	system	NOUN
bam-12993	58	50	score(s	score(s	NOUN
bam-12993	58	51	)	)	PUNCT
bam-12993	58	52	.	.	PUNCT
bam-12993	59	1	edss	edss	ADJ
bam-12993	59	2	stages	stage	VERB
bam-12993	59	3	5.0	5.0	NUM
bam-12993	59	4	to	to	PART
bam-12993	59	5	9.5	9.5	NUM
bam-12993	59	6	are	be	AUX
bam-12993	59	7	defined	define	VERB
bam-12993	59	8	by	by	ADP
bam-12993	59	9	movement	movement	NOUN
bam-12993	59	10	disorders	disorder	NOUN
bam-12993	59	11	and	and	CCONJ
bam-12993	59	12	common	common	ADJ
bam-12993	59	13	equivalents	equivalent	NOUN
bam-12993	59	14	are	be	AUX
bam-12993	59	15	provided	provide	VERB
bam-12993	59	16	in	in	ADP
bam-12993	59	17	the	the	DET
bam-12993	59	18	functional	functional	ADJ
bam-12993	59	19	systems	system	NOUN
bam-12993	59	20	scores	score	NOUN
bam-12993	59	21	.	.	PUNCT
bam-12993	60	1	msss	msss	NOUN
bam-12993	60	2	is	be	AUX
bam-12993	60	3	a	a	DET
bam-12993	60	4	useful	useful	ADJ
bam-12993	60	5	measure	measure	NOUN
bam-12993	60	6	of	of	ADP
bam-12993	60	7	ms	ms	NOUN
bam-12993	60	8	severity	severity	NOUN
bam-12993	60	9	that	that	PRON
bam-12993	60	10	includes	include	VERB
bam-12993	60	11	edss	edss	ADV
bam-12993	60	12	and	and	CCONJ
bam-12993	60	13	disease	disease	NOUN
bam-12993	60	14	duration	duration	NOUN
bam-12993	60	15	.	.	PUNCT
bam-12993	61	1	achieving	achieve	VERB
bam-12993	61	2	an	an	DET
bam-12993	61	3	msss	msss	NOUN
bam-12993	61	4	score	score	NOUN
bam-12993	61	5	≥	≥	NOUN
bam-12993	61	6	4.8	4.8	NUM
bam-12993	61	7	indicates	indicate	VERB
bam-12993	61	8	a	a	DET
bam-12993	61	9	severe	severe	ADJ
bam-12993	61	10	phase	phase	NOUN
bam-12993	61	11	of	of	ADP
bam-12993	61	12	the	the	DET
bam-12993	61	13	disease	disease	NOUN
bam-12993	61	14	and	and	CCONJ
bam-12993	61	15	an	an	DET
bam-12993	61	16	msss	msss	NOUN
bam-12993	61	17	<	<	X
bam-12993	61	18	4.8	4.8	NUM
bam-12993	61	19	indicates	indicate	VERB
bam-12993	61	20	a	a	DET
bam-12993	61	21	mild	mild	ADJ
bam-12993	61	22	phase	phase	NOUN
bam-12993	61	23	of	of	ADP
bam-12993	61	24	the	the	DET
bam-12993	61	25	disease	disease	NOUN
bam-12993	61	26	.	.	PUNCT
bam-12993	62	1	for	for	ADP
bam-12993	62	2	each	each	DET
bam-12993	62	3	person	person	NOUN
bam-12993	62	4	participating	participate	VERB
bam-12993	62	5	in	in	ADP
bam-12993	62	6	the	the	DET
bam-12993	62	7	study	study	NOUN
bam-12993	62	8	(	(	PUNCT
bam-12993	62	9	rrms	rrm	NOUN
bam-12993	62	10	patient	patient	ADJ
bam-12993	62	11	and	and	CCONJ
bam-12993	62	12	healthy	healthy	ADJ
bam-12993	62	13	)	)	PUNCT
bam-12993	62	14	,	,	PUNCT
bam-12993	62	15	five	five	NUM
bam-12993	62	16	milliliters	milliliter	NOUN
bam-12993	62	17	of	of	ADP
bam-12993	62	18	peripheral	peripheral	ADJ
bam-12993	62	19	blood	blood	NOUN
bam-12993	62	20	with	with	ADP
bam-12993	62	21	edta	edta	NOUN
bam-12993	62	22	anticoagulant	anticoagulant	NOUN
bam-12993	62	23	were	be	AUX
bam-12993	62	24	taken	take	VERB
bam-12993	62	25	.	.	PUNCT
bam-12993	63	1	all	all	DET
bam-12993	63	2	samples	sample	NOUN
bam-12993	63	3	were	be	AUX
bam-12993	63	4	collected	collect	VERB
bam-12993	63	5	from	from	ADP
bam-12993	63	6	8	8	NUM
bam-12993	63	7	am	am	NOUN
bam-12993	63	8	to	to	ADP
bam-12993	63	9	11	11	NUM
bam-12993	63	10	am	am	NOUN
bam-12993	63	11	.	.	PUNCT
bam-12993	64	1	two	two	NUM
bam-12993	64	2	tubes	tube	NOUN
bam-12993	64	3	of	of	ADP
bam-12993	64	4	cell	cell	NOUN
bam-12993	64	5	preparation	preparation	NOUN
bam-12993	64	6	were	be	AUX
bam-12993	64	7	collected	collect	VERB
bam-12993	64	8	with	with	ADP
bam-12993	64	9	sodium	sodium	NOUN
bam-12993	64	10	citrate	citrate	NOUN
bam-12993	64	11	for	for	ADP
bam-12993	64	12	cell	cell	NOUN
bam-12993	64	13	and	and	CCONJ
bam-12993	64	14	plasma	plasma	NOUN
bam-12993	64	15	separation	separation	NOUN
bam-12993	64	16	.	.	PUNCT
bam-12993	65	1	peripheral	peripheral	ADJ
bam-12993	65	2	blood	blood	NOUN
bam-12993	65	3	mononuclear	mononuclear	ADJ
bam-12993	65	4	cells	cell	NOUN
bam-12993	65	5	were	be	AUX
bam-12993	65	6	isolated	isolate	VERB
bam-12993	65	7	using	use	VERB
bam-12993	65	8	gradient	gradient	ADJ
bam-12993	65	9	centrifugation	centrifugation	NOUN
bam-12993	65	10	(	(	PUNCT
bam-12993	65	11	920	920	NUM
bam-12993	65	12	g	g	NOUN
bam-12993	65	13	,	,	PUNCT
bam-12993	65	14	30	30	NUM
bam-12993	65	15	min	min	NOUN
bam-12993	65	16	)	)	PUNCT
bam-12993	65	17	.	.	PUNCT
bam-12993	66	1	they	they	PRON
bam-12993	66	2	were	be	AUX
bam-12993	66	3	frozen	freeze	VERB
bam-12993	66	4	in	in	ADP
bam-12993	66	5	serum	serum	NOUN
bam-12993	66	6	with	with	ADP
bam-12993	66	7	dmso	dmso	NOUN
bam-12993	66	8	(	(	PUNCT
bam-12993	66	9	10	10	NUM
bam-12993	66	10	%	%	NOUN
bam-12993	66	11	)	)	PUNCT
bam-12993	66	12	and	and	CCONJ
bam-12993	66	13	stored	store	VERB
bam-12993	66	14	in	in	ADP
bam-12993	66	15	liquid	liquid	ADJ
bam-12993	66	16	nitrogen	nitrogen	NOUN
bam-12993	66	17	(	(	PUNCT
bam-12993	66	18	−196	−196	NOUN
bam-12993	66	19	◦	◦	NOUN
bam-12993	66	20	c	c	NOUN
bam-12993	66	21	)	)	PUNCT
bam-12993	66	22	.	.	PUNCT
bam-12993	67	1	serum	serum	NOUN
bam-12993	67	2	was	be	AUX
bam-12993	67	3	separated	separate	VERB
bam-12993	67	4	by	by	ADP
bam-12993	67	5	centrifugation	centrifugation	NOUN
bam-12993	67	6	(	(	PUNCT
bam-12993	67	7	920	920	NUM
bam-12993	67	8	g	g	NOUN
bam-12993	67	9	,	,	PUNCT
bam-12993	67	10	15	15	NUM
bam-12993	67	11	min	min	NOUN
bam-12993	67	12	,	,	PUNCT
bam-12993	67	13	room	room	NOUN
bam-12993	67	14	temperature	temperature	NOUN
bam-12993	67	15	)	)	PUNCT
bam-12993	67	16	in	in	ADP
bam-12993	67	17	serum	serum	NOUN
bam-12993	67	18	separator	separator	NOUN
bam-12993	67	19	tubes	tube	NOUN
bam-12993	67	20	.	.	PUNCT
bam-12993	68	1	after	after	ADP
bam-12993	68	2	centrifugation	centrifugation	NOUN
bam-12993	68	3	,	,	PUNCT
bam-12993	68	4	plasma	plasma	NOUN
bam-12993	68	5	and	and	CCONJ
bam-12993	68	6	serum	serum	NOUN
bam-12993	68	7	samples	sample	NOUN
bam-12993	68	8	were	be	AUX
bam-12993	68	9	divided	divide	VERB
bam-12993	68	10	into	into	ADP
bam-12993	68	11	each	each	DET
bam-12993	68	12	part	part	NOUN
bam-12993	68	13	and	and	CCONJ
bam-12993	68	14	stored	store	VERB
bam-12993	68	15	at	at	ADP
bam-12993	68	16	−80	−80	PROPN
bam-12993	68	17	◦	◦	NOUN
bam-12993	68	18	temperature	temperature	NOUN
bam-12993	68	19	.	.	PUNCT
bam-12993	69	1	dna	dna	NOUN
bam-12993	69	2	of	of	ADP
bam-12993	69	3	blood	blood	NOUN
bam-12993	69	4	samples	sample	NOUN
bam-12993	69	5	was	be	AUX
bam-12993	69	6	extracted	extract	VERB
bam-12993	69	7	using	use	VERB
bam-12993	69	8	a	a	DET
bam-12993	69	9	genomic	genomic	ADJ
bam-12993	69	10	dna	dna	NOUN
bam-12993	69	11	column	column	NOUN
bam-12993	69	12	extraction	extraction	NOUN
bam-12993	69	13	kit	kit	NOUN
bam-12993	69	14	manufactured	manufacture	VERB
bam-12993	69	15	by	by	ADP
bam-12993	69	16	mbst	mbst	PROPN
bam-12993	69	17	company	company	NOUN
bam-12993	69	18	in	in	ADP
bam-12993	69	19	iran	iran	PROPN
bam-12993	69	20	.	.	PUNCT
bam-12993	70	1	the	the	DET
bam-12993	70	2	dna	dna	PROPN
bam-12993	70	3	purification	purification	NOUN
bam-12993	70	4	method	method	NOUN
bam-12993	70	5	in	in	ADP
bam-12993	70	6	this	this	DET
bam-12993	70	7	kit	kit	NOUN
bam-12993	70	8	is	be	AUX
bam-12993	70	9	based	base	VERB
bam-12993	70	10	on	on	ADP
bam-12993	70	11	the	the	DET
bam-12993	70	12	specific	specific	ADJ
bam-12993	70	13	binding	binding	NOUN
bam-12993	70	14	of	of	ADP
bam-12993	70	15	nucleic	nucleic	ADJ
bam-12993	70	16	acids	acid	NOUN
bam-12993	70	17	to	to	ADP
bam-12993	70	18	the	the	DET
bam-12993	70	19	silica	silica	NOUN
bam-12993	70	20	column	column	NOUN
bam-12993	70	21	in	in	ADP
bam-12993	70	22	the	the	DET
bam-12993	70	23	presence	presence	NOUN
bam-12993	70	24	of	of	ADP
bam-12993	70	25	chemotropic	chemotropic	ADJ
bam-12993	70	26	salts	salt	NOUN
bam-12993	70	27	.	.	PUNCT
bam-12993	71	1	the	the	DET
bam-12993	71	2	non	non	ADJ
bam-12993	71	3	-	-	ADJ
bam-12993	71	4	nucleic	nucleic	ADJ
bam-12993	71	5	acid	acid	NOUN
bam-12993	71	6	materials	material	NOUN
bam-12993	71	7	that	that	PRON
bam-12993	71	8	could	could	AUX
bam-12993	71	9	bind	bind	VERB
bam-12993	71	10	to	to	ADP
bam-12993	71	11	the	the	DET
bam-12993	71	12	column	column	NOUN
bam-12993	71	13	membrane	membrane	NOUN
bam-12993	71	14	were	be	AUX
bam-12993	71	15	washed	wash	VERB
bam-12993	71	16	from	from	ADP
bam-12993	71	17	the	the	DET
bam-12993	71	18	column	column	NOUN
bam-12993	71	19	during	during	ADP
bam-12993	71	20	different	different	ADJ
bam-12993	71	21	washing	washing	NOUN
bam-12993	71	22	steps	step	NOUN
bam-12993	71	23	and	and	CCONJ
bam-12993	71	24	by	by	ADP
bam-12993	71	25	centrifugation	centrifugation	NOUN
bam-12993	71	26	.	.	PUNCT
bam-12993	72	1	then	then	ADV
bam-12993	72	2	,	,	PUNCT
bam-12993	72	3	the	the	DET
bam-12993	72	4	dna	dna	PROPN
bam-12993	72	5	attached	attach	VERB
bam-12993	72	6	to	to	ADP
bam-12993	72	7	the	the	DET
bam-12993	72	8	column	column	NOUN
bam-12993	72	9	was	be	AUX
bam-12993	72	10	dissolved	dissolve	VERB
bam-12993	72	11	and	and	CCONJ
bam-12993	72	12	separated	separate	VERB
bam-12993	72	13	by	by	ADP
bam-12993	72	14	adding	add	VERB
bam-12993	72	15	an	an	DET
bam-12993	72	16	elution	elution	NOUN
bam-12993	72	17	buffer	buffer	NOUN
bam-12993	72	18	,	,	PUNCT
bam-12993	72	19	and	and	CCONJ
bam-12993	72	20	after	after	ADP
bam-12993	72	21	checking	check	VERB
bam-12993	72	22	the	the	DET
bam-12993	72	23	purity	purity	NOUN
bam-12993	72	24	and	and	CCONJ
bam-12993	72	25	quality	quality	NOUN
bam-12993	72	26	,	,	PUNCT
bam-12993	72	27	it	it	PRON
bam-12993	72	28	was	be	AUX
bam-12993	72	29	frozen	freeze	VERB
bam-12993	72	30	until	until	SCONJ
bam-12993	72	31	used	use	VERB
bam-12993	72	32	for	for	ADP
bam-12993	72	33	the	the	DET
bam-12993	72	34	next	next	ADJ
bam-12993	72	35	steps	step	NOUN
bam-12993	72	36	.	.	PUNCT
bam-12993	73	1	in	in	ADP
bam-12993	73	2	the	the	DET
bam-12993	73	3	next	next	ADJ
bam-12993	73	4	step	step	NOUN
bam-12993	73	5	,	,	PUNCT
bam-12993	73	6	a	a	DET
bam-12993	73	7	polymerase	polymerase	NOUN
bam-12993	73	8	chain	chain	NOUN
bam-12993	73	9	reaction	reaction	NOUN
bam-12993	73	10	(	(	PUNCT
bam-12993	73	11	pcr	pcr	PROPN
bam-12993	73	12	)	)	PUNCT
bam-12993	73	13	was	be	AUX
bam-12993	73	14	performed	perform	VERB
bam-12993	73	15	using	use	VERB
bam-12993	73	16	two	two	NUM
bam-12993	73	17	specific	specific	ADJ
bam-12993	73	18	and	and	CCONJ
bam-12993	73	19	appropriate	appropriate	ADJ
bam-12993	73	20	oligonucleotide	oligonucleotide	NOUN
bam-12993	73	21	primers	primer	NOUN
bam-12993	73	22	.	.	PUNCT
bam-12993	74	1	we	we	PRON
bam-12993	74	2	designed	design	VERB
bam-12993	74	3	the	the	DET
bam-12993	74	4	back	back	VERB
bam-12993	74	5	-	-	PUNCT
bam-12993	74	6	and	and	CCONJ
bam-12993	74	7	-	-	PUNCT
bam-12993	74	8	forth	forth	NOUN
bam-12993	74	9	primers	primer	NOUN
bam-12993	74	10	using	use	VERB
bam-12993	74	11	beacon	beacon	NOUN
bam-12993	74	12	software	software	NOUN
bam-12993	74	13	,	,	PUNCT
bam-12993	74	14	confirmed	confirm	VERB
bam-12993	74	15	their	their	PRON
bam-12993	74	16	correct	correct	ADJ
bam-12993	74	17	connection	connection	NOUN
bam-12993	74	18	to	to	ADP
bam-12993	74	19	their	their	PRON
bam-12993	74	20	own	own	ADJ
bam-12993	74	21	sequences	sequence	NOUN
bam-12993	74	22	in	in	ADP
bam-12993	74	23	the	the	DET
bam-12993	74	24	ncbi	ncbi	PROPN
bam-12993	74	25	nucleotide	nucleotide	PROPN
bam-12993	74	26	database	database	NOUN
bam-12993	74	27	,	,	PUNCT
bam-12993	74	28	and	and	CCONJ
bam-12993	74	29	ordered	order	VERB
bam-12993	74	30	the	the	DET
bam-12993	74	31	synthesis	synthesis	NOUN
bam-12993	74	32	from	from	ADP
bam-12993	74	33	tekapo	tekapo	ADJ
bam-12993	74	34	bio	bio	PROPN
bam-12993	74	35	company	company	PROPN
bam-12993	74	36	.	.	PUNCT
bam-12993	75	1	the	the	DET
bam-12993	75	2	primers	primer	NOUN
bam-12993	75	3	were	be	AUX
bam-12993	75	4	lyophilized	lyophilize	VERB
bam-12993	75	5	from	from	ADP
bam-12993	75	6	the	the	DET
bam-12993	75	7	delivery	delivery	NOUN
bam-12993	75	8	company	company	NOUN
bam-12993	75	9	and	and	CCONJ
bam-12993	75	10	according	accord	VERB
bam-12993	75	11	to	to	ADP
bam-12993	75	12	the	the	DET
bam-12993	75	13	manufacturer	manufacturer	NOUN
bam-12993	75	14	’s	’s	PART
bam-12993	75	15	protocol	protocol	NOUN
bam-12993	75	16	,	,	PUNCT
bam-12993	75	17	they	they	PRON
bam-12993	75	18	were	be	AUX
bam-12993	75	19	diluted	dilute	VERB
bam-12993	75	20	with	with	ADP
bam-12993	75	21	dnase	dnase	NOUN
bam-12993	75	22	/	/	SYM
bam-12993	75	23	rnase	rnase	NOUN
bam-12993	75	24	-	-	PUNCT
bam-12993	75	25	free	free	ADJ
bam-12993	75	26	distilled	distil	VERB
bam-12993	75	27	water	water	NOUN
bam-12993	75	28	to	to	ADP
bam-12993	75	29	a	a	DET
bam-12993	75	30	concentration	concentration	NOUN
bam-12993	75	31	of	of	ADP
bam-12993	75	32	100	100	NUM
bam-12993	75	33	pmol	pmol	NOUN
bam-12993	75	34	/	/	SYM
bam-12993	75	35	μl	μl	NOUN
bam-12993	75	36	.	.	PUNCT
bam-12993	76	1	amplification	amplification	NOUN
bam-12993	76	2	of	of	ADP
bam-12993	76	3	taq	taq	PROPN
bam-12993	76	4	dna	dna	PROPN
bam-12993	76	5	polymerase	polymerase	NOUN
bam-12993	76	6	and	and	CCONJ
bam-12993	76	7	dntps	dntps	NOUN
bam-12993	76	8	was	be	AUX
bam-12993	76	9	done	do	VERB
bam-12993	76	10	by	by	ADP
bam-12993	76	11	abi	abi	PROPN
bam-12993	76	12	thermocycler	thermocycler	PROPN
bam-12993	76	13	(	(	PUNCT
bam-12993	76	14	veriti	veriti	NOUN
bam-12993	76	15	96	96	NUM
bam-12993	76	16	well	well	INTJ
bam-12993	76	17	thwrmal	thwrmal	ADJ
bam-12993	76	18	cycle	cycle	NOUN
bam-12993	76	19	device	device	NOUN
bam-12993	76	20	)	)	PUNCT
bam-12993	76	21	(	(	PUNCT
bam-12993	76	22	applied	apply	VERB
bam-12993	76	23	biosystem	biosystem	NOUN
bam-12993	76	24	,	,	PUNCT
bam-12993	76	25	abi	abi	PROPN
bam-12993	76	26	,	,	PUNCT
bam-12993	76	27	company	company	NOUN
bam-12993	76	28	,	,	PUNCT
bam-12993	76	29	usa	usa	PROPN
bam-12993	76	30	)	)	PUNCT
bam-12993	76	31	in	in	ADP
bam-12993	76	32	three	three	NUM
bam-12993	76	33	successive	successive	ADJ
bam-12993	76	34	temperature	temperature	NOUN
bam-12993	76	35	steps	step	NOUN
bam-12993	76	36	.	.	PUNCT
bam-12993	77	1	this	this	DET
bam-12993	77	2	operation	operation	NOUN
bam-12993	77	3	was	be	AUX
bam-12993	77	4	done	do	VERB
bam-12993	77	5	for	for	ADP
bam-12993	77	6	each	each	PRON
bam-12993	77	7	of	of	ADP
bam-12993	77	8	the	the	DET
bam-12993	77	9	enzymes	enzyme	NOUN
bam-12993	77	10	separately	separately	ADV
bam-12993	77	11	,	,	PUNCT
bam-12993	77	12	and	and	CCONJ
bam-12993	77	13	the	the	DET
bam-12993	77	14	used	use	VERB
bam-12993	77	15	items	item	NOUN
bam-12993	77	16	were	be	AUX
bam-12993	77	17	optimized	optimize	VERB
bam-12993	77	18	,	,	PUNCT
bam-12993	77	19	and	and	CCONJ
bam-12993	77	20	then	then	ADV
bam-12993	77	21	four	four	NUM
bam-12993	77	22	pcr	pcr	ADJ
bam-12993	77	23	variants	variant	NOUN
bam-12993	77	24	were	be	AUX
bam-12993	77	25	placed	place	VERB
bam-12993	77	26	for	for	ADP
bam-12993	77	27	each	each	DET
bam-12993	77	28	sample	sample	NOUN
bam-12993	77	29	.	.	PUNCT
bam-12993	78	1	to	to	PART
bam-12993	78	2	check	check	VERB
bam-12993	78	3	the	the	DET
bam-12993	78	4	size	size	NOUN
bam-12993	78	5	of	of	ADP
bam-12993	78	6	the	the	DET
bam-12993	78	7	amplified	amplify	VERB
bam-12993	78	8	fragments	fragment	NOUN
bam-12993	78	9	and	and	CCONJ
bam-12993	78	10	the	the	DET
bam-12993	78	11	specificity	specificity	NOUN
bam-12993	78	12	of	of	ADP
bam-12993	78	13	the	the	DET
bam-12993	78	14	products	product	NOUN
bam-12993	78	15	,	,	PUNCT
bam-12993	78	16	their	their	PRON
bam-12993	78	17	electrophoresis	electrophoresis	NOUN
bam-12993	78	18	was	be	AUX
bam-12993	78	19	performed	perform	VERB
bam-12993	78	20	on	on	ADP
bam-12993	78	21	agarose	agarose	NOUN
bam-12993	78	22	gel	gel	NOUN
bam-12993	78	23	,	,	PUNCT
bam-12993	78	24	and	and	CCONJ
bam-12993	78	25	after	after	ADP
bam-12993	78	26	the	the	DET
bam-12993	78	27	completion	completion	NOUN
bam-12993	78	28	of	of	ADP
bam-12993	78	29	the	the	DET
bam-12993	78	30	pcr	pcr	ADJ
bam-12993	78	31	reaction	reaction	NOUN
bam-12993	78	32	,	,	PUNCT
bam-12993	78	33	the	the	DET
bam-12993	78	34	products	product	NOUN
bam-12993	78	35	were	be	AUX
bam-12993	78	36	electrophoresed	electrophorese	VERB
bam-12993	78	37	on	on	ADP
bam-12993	78	38	2	2	NUM
bam-12993	78	39	%	%	NOUN
bam-12993	78	40	agarose	agarose	X
bam-12993	78	41	gel	gel	NOUN
bam-12993	78	42	.	.	PUNCT
bam-12993	79	1	then	then	ADV
bam-12993	79	2	,	,	PUNCT
bam-12993	79	3	the	the	DET
bam-12993	79	4	pcr	pcr	NOUN
bam-12993	79	5	-	-	PUNCT
bam-12993	79	6	rflp	rflp	PROPN
bam-12993	79	7	(	(	PUNCT
bam-12993	79	8	restriction	restriction	NOUN
bam-12993	79	9	fragment	fragment	NOUN
bam-12993	79	10	length	length	NOUN
bam-12993	79	11	polymorphism	polymorphism	NOUN
bam-12993	79	12	)	)	PUNCT
bam-12993	79	13	technique	technique	NOUN
bam-12993	79	14	,	,	PUNCT
bam-12993	79	15	which	which	PRON
bam-12993	79	16	is	be	AUX
bam-12993	79	17	one	one	NUM
bam-12993	79	18	of	of	ADP
bam-12993	79	19	the	the	DET
bam-12993	79	20	standard	standard	ADJ
bam-12993	79	21	methods	method	NOUN
bam-12993	79	22	for	for	ADP
bam-12993	79	23	identifying	identify	VERB
bam-12993	79	24	polymorphisms	polymorphism	NOUN
bam-12993	79	25	,	,	PUNCT
bam-12993	79	26	was	be	AUX
bam-12993	79	27	used	use	VERB
bam-12993	79	28	.	.	PUNCT
bam-12993	80	1	to	to	PART
bam-12993	80	2	achieve	achieve	VERB
bam-12993	80	3	this	this	PRON
bam-12993	80	4	,	,	PUNCT
bam-12993	80	5	we	we	PRON
bam-12993	80	6	mixed	mix	VERB
bam-12993	80	7	the	the	DET
bam-12993	80	8	pcr	pcr	ADJ
bam-12993	80	9	product	product	NOUN
bam-12993	80	10	with	with	ADP
bam-12993	80	11	restriction	restriction	NOUN
bam-12993	80	12	enzymes	enzyme	NOUN
bam-12993	80	13	as	as	ADP
bam-12993	80	14	per	per	ADP
bam-12993	80	15	the	the	DET
bam-12993	80	16	manufacturer	manufacturer	NOUN
bam-12993	80	17	’s	’s	PART
bam-12993	80	18	instructions	instruction	NOUN
bam-12993	80	19	,	,	PUNCT
bam-12993	80	20	and	and	CCONJ
bam-12993	80	21	selected	select	VERB
bam-12993	80	22	the	the	DET
bam-12993	80	23	optimal	optimal	ADJ
bam-12993	80	24	cutting	cutting	NOUN
bam-12993	80	25	temperature	temperature	NOUN
bam-12993	80	26	based	base	VERB
bam-12993	80	27	on	on	ADP
bam-12993	80	28	the	the	DET
bam-12993	80	29	enzyme	enzyme	NOUN
bam-12993	80	30	’s	’s	PART
bam-12993	80	31	cutting	cutting	NOUN
bam-12993	80	32	time	time	NOUN
bam-12993	80	33	specified	specify	VERB
bam-12993	80	34	in	in	ADP
bam-12993	80	35	the	the	DET
bam-12993	80	36	recipe	recipe	NOUN
bam-12993	80	37	.	.	PUNCT
bam-12993	81	1	after	after	ADP
bam-12993	81	2	the	the	DET
bam-12993	81	3	incubation	incubation	NOUN
bam-12993	81	4	time	time	NOUN
bam-12993	81	5	of	of	ADP
bam-12993	81	6	the	the	DET
bam-12993	81	7	product	product	NOUN
bam-12993	81	8	,	,	PUNCT
bam-12993	81	9	electrophoresis	electrophoresis	NOUN
bam-12993	81	10	was	be	AUX
bam-12993	81	11	performed	perform	VERB
bam-12993	81	12	on	on	ADP
bam-12993	81	13	a	a	DET
bam-12993	81	14	2	2	NUM
bam-12993	81	15	%	%	NOUN
bam-12993	81	16	agarose	agarose	NOUN
bam-12993	81	17	gel	gel	NOUN
bam-12993	81	18	,	,	PUNCT
bam-12993	81	19	and	and	CCONJ
bam-12993	81	20	by	by	ADP
bam-12993	81	21	using	use	VERB
bam-12993	81	22	the	the	DET
bam-12993	81	23	pattern	pattern	NOUN
bam-12993	81	24	obtained	obtain	VERB
bam-12993	81	25	from	from	ADP
bam-12993	81	26	restriction	restriction	NOUN
bam-12993	81	27	enzyme	enzyme	NOUN
bam-12993	81	28	cleavage	cleavage	NOUN
bam-12993	81	29	,	,	PUNCT
bam-12993	81	30	the	the	DET
bam-12993	81	31	different	different	ADJ
bam-12993	81	32	polymorphisms	polymorphism	NOUN
bam-12993	81	33	of	of	ADP
bam-12993	81	34	the	the	DET
bam-12993	81	35	vitamin	vitamin	NOUN
bam-12993	81	36	d	d	NOUN
bam-12993	81	37	receptor	receptor	NOUN
bam-12993	81	38	gene	gene	NOUN
bam-12993	81	39	studied	study	VERB
bam-12993	81	40	in	in	ADP
bam-12993	81	41	each	each	DET
bam-12993	81	42	participant	participant	NOUN
bam-12993	81	43	were	be	AUX
bam-12993	81	44	separated	separate	VERB
bam-12993	81	45	and	and	CCONJ
bam-12993	81	46	the	the	DET
bam-12993	81	47	gels	gel	NOUN
bam-12993	81	48	electrophoresed	electrophorese	VERB
bam-12993	81	49	with	with	ADP
bam-12993	81	50	the	the	DET
bam-12993	81	51	gel	gel	NOUN
bam-12993	81	52	machine	machine	NOUN
bam-12993	81	53	.	.	PUNCT
bam-12993	82	1	figures	figure	NOUN
bam-12993	82	2	1	1	NUM
bam-12993	82	3	to	to	PART
bam-12993	82	4	4	4	NUM
bam-12993	82	5	display	display	VERB
bam-12993	82	6	the	the	DET
bam-12993	82	7	genotype	genotype	NOUN
bam-12993	82	8	of	of	ADP
bam-12993	82	9	vdr	vdr	NOUN
bam-12993	82	10	gene	gene	NOUN
bam-12993	82	11	polymorphisms	polymorphism	NOUN
bam-12993	82	12	based	base	VERB
bam-12993	82	13	on	on	ADP
bam-12993	82	14	pcr	pcr	NOUN
bam-12993	82	15	-	-	PUNCT
bam-12993	82	16	rflp	rflp	NOUN
bam-12993	82	17	.	.	PUNCT
bam-12993	83	1	table	table	NOUN
bam-12993	83	2	1	1	NUM
bam-12993	83	3	summarizes	summarize	NOUN
bam-12993	83	4	the	the	DET
bam-12993	83	5	visualization	visualization	NOUN
bam-12993	83	6	of	of	ADP
bam-12993	83	7	rflp	rflp	NOUN
bam-12993	83	8	bands	band	NOUN
bam-12993	83	9	using	use	VERB
bam-12993	83	10	3	3	NUM
bam-12993	83	11	%	%	NOUN
bam-12993	83	12	agarose	agarose	NOUN
bam-12993	83	13	gel	gel	NOUN
bam-12993	83	14	electrophoresis	electrophoresis	NOUN
bam-12993	83	15	.	.	PUNCT
bam-12993	84	1	table	table	NOUN
bam-12993	84	2	1	1	NUM
bam-12993	84	3	summarizes	summarize	NOUN
bam-12993	84	4	the	the	DET
bam-12993	84	5	snp	snp	ADJ
bam-12993	84	6	primer	primer	NOUN
bam-12993	84	7	sequences	sequence	NOUN
bam-12993	84	8	and	and	CCONJ
bam-12993	84	9	amplicon	amplicon	NOUN
bam-12993	84	10	sizes	size	NOUN
bam-12993	84	11	.	.	PUNCT
bam-12993	85	1	statistical	statistical	ADJ
bam-12993	85	2	analysis	analysis	NOUN
bam-12993	85	3	was	be	AUX
bam-12993	85	4	performed	perform	VERB
bam-12993	85	5	using	use	VERB
bam-12993	85	6	spss	spss	PROPN
bam-12993	85	7	software	software	NOUN
bam-12993	85	8	version	version	NOUN
bam-12993	85	9	23	23	NUM
bam-12993	85	10	.	.	PUNCT
bam-12993	86	1	differences	difference	NOUN
bam-12993	86	2	with	with	ADP
bam-12993	86	3	a	a	DET
bam-12993	86	4	p	p	NOUN
bam-12993	86	5	value	value	NOUN
bam-12993	86	6	<	<	NOUN
bam-12993	86	7	0.05	0.05	NUM
bam-12993	86	8	were	be	AUX
bam-12993	86	9	considered	consider	VERB
bam-12993	86	10	significant	significant	ADJ
bam-12993	86	11	.	.	PUNCT
bam-12993	87	1	to	to	PART
bam-12993	87	2	check	check	VERB
bam-12993	87	3	the	the	DET
bam-12993	87	4	normality	normality	NOUN
bam-12993	87	5	of	of	ADP
bam-12993	87	6	the	the	DET
bam-12993	87	7	data	datum	NOUN
bam-12993	87	8	,	,	PUNCT
bam-12993	87	9	the	the	DET
bam-12993	87	10	kolmogorov	kolmogorov	ADJ
bam-12993	87	11	-	-	PUNCT
bam-12993	87	12	smirnov	smirnov	ADJ
bam-12993	87	13	test	test	NOUN
bam-12993	87	14	was	be	AUX
bam-12993	87	15	used	use	VERB
bam-12993	87	16	.	.	PUNCT
bam-12993	88	1	two	two	NUM
bam-12993	88	2	study	study	NOUN
bam-12993	88	3	groups	group	NOUN
bam-12993	88	4	were	be	AUX
bam-12993	88	5	examined	examine	VERB
bam-12993	88	6	for	for	ADP
bam-12993	88	7	demographic	demographic	ADJ
bam-12993	88	8	variables	variable	NOUN
bam-12993	88	9	.	.	PUNCT
bam-12993	89	1	the	the	DET
bam-12993	89	2	mann	mann	PROPN
bam-12993	89	3	-	-	PUNCT
bam-12993	89	4	whitney	whitney	PROPN
bam-12993	89	5	u	u	PROPN
bam-12993	89	6	test	test	NOUN
bam-12993	89	7	was	be	AUX
bam-12993	89	8	used	use	VERB
bam-12993	89	9	to	to	PART
bam-12993	89	10	evaluate	evaluate	VERB
bam-12993	89	11	the	the	DET
bam-12993	89	12	differences	difference	NOUN
bam-12993	89	13	between	between	ADP
bam-12993	89	14	case	case	NOUN
bam-12993	89	15	and	and	CCONJ
bam-12993	89	16	control	control	NOUN
bam-12993	89	17	groups	group	NOUN
bam-12993	89	18	.	.	PUNCT
bam-12993	90	1	spearman	spearman	NOUN
bam-12993	90	2	’s	’s	PART
bam-12993	90	3	rank	rank	NOUN
bam-12993	90	4	correlation	correlation	NOUN
bam-12993	90	5	coefficient	coefficient	NOUN
bam-12993	90	6	was	be	AUX
bam-12993	90	7	used	use	VERB
bam-12993	90	8	to	to	PART
bam-12993	90	9	determine	determine	VERB
bam-12993	90	10	continuous	continuous	ADJ
bam-12993	90	11	correlation	correlation	NOUN
bam-12993	90	12	.	.	PUNCT
bam-12993	91	1	to	to	PART
bam-12993	91	2	measure	measure	VERB
bam-12993	91	3	the	the	DET
bam-12993	91	4	relationship	relationship	NOUN
bam-12993	91	5	between	between	ADP
bam-12993	91	6	the	the	DET
bam-12993	91	7	factors	factor	NOUN
bam-12993	91	8	and	and	CCONJ
bam-12993	91	9	ms	ms	NOUN
bam-12993	91	10	risk	risk	NOUN
bam-12993	91	11	,	,	PUNCT
bam-12993	91	12	odds	odd	VERB
bam-12993	91	13	ratio	ratio	NOUN
bam-12993	91	14	and	and	CCONJ
bam-12993	91	15	95	95	NUM
bam-12993	91	16	%	%	NOUN
bam-12993	91	17	confidence	confidence	NOUN
bam-12993	91	18	limits	limit	NOUN
bam-12993	91	19	were	be	AUX
bam-12993	91	20	calculated	calculate	VERB
bam-12993	91	21	.	.	PUNCT
bam-12993	92	1	the	the	DET
bam-12993	92	2	relationship	relationship	NOUN
bam-12993	92	3	between	between	ADP
bam-12993	92	4	ms	ms	PROPN
bam-12993	92	5	patients	patient	NOUN
bam-12993	92	6	and	and	CCONJ
bam-12993	92	7	clinical	clinical	ADJ
bam-12993	92	8	factors	factor	NOUN
bam-12993	92	9	was	be	AUX
bam-12993	92	10	evaluated	evaluate	VERB
bam-12993	92	11	by	by	ADP
bam-12993	92	12	the	the	DET
bam-12993	92	13	chi	chi	ADJ
bam-12993	92	14	-	-	PUNCT
bam-12993	92	15	square	square	NOUN
bam-12993	92	16	test	test	NOUN
bam-12993	92	17	and	and	CCONJ
bam-12993	92	18	fisher	fisher	PROPN
bam-12993	92	19	’s	’s	PART
bam-12993	92	20	exact	exact	ADJ
bam-12993	92	21	test	test	NOUN
bam-12993	92	22	.	.	PUNCT
bam-12993	93	1	an	an	DET
bam-12993	93	2	odds	odd	NOUN
bam-12993	93	3	ratio	ratio	NOUN
bam-12993	93	4	and	and	CCONJ
bam-12993	93	5	95	95	NUM
bam-12993	93	6	%	%	NOUN
bam-12993	93	7	confidence	confidence	NOUN
bam-12993	93	8	limits	limit	NOUN
bam-12993	93	9	are	be	AUX
bam-12993	93	10	calculated	calculate	VERB
bam-12993	93	11	.	.	PUNCT
bam-12993	94	1	the	the	DET
bam-12993	94	2	snp	snp	PROPN
bam-12993	94	3	analyzer	analyzer	PROPN
bam-12993	94	4	software	software	NOUN
bam-12993	94	5	was	be	AUX
bam-12993	94	6	used	use	VERB
bam-12993	94	7	to	to	PART
bam-12993	94	8	analyze	analyze	VERB
bam-12993	94	9	the	the	DET
bam-12993	94	10	allele	allele	NOUN
bam-12993	94	11	frequency	frequency	NOUN
bam-12993	94	12	of	of	ADP
bam-12993	94	13	each	each	DET
bam-12993	94	14	3	3	NUM
bam-12993	94	15	figure	figure	NOUN
bam-12993	94	16	1	1	NUM
bam-12993	94	17	.	.	PUNCT
bam-12993	95	1	foki	foki	NOUN
bam-12993	95	2	:	:	PUNCT
bam-12993	95	3	lane	lane	NOUN
bam-12993	95	4	1	1	NUM
bam-12993	95	5	:	:	PUNCT
bam-12993	95	6	ff	ff	NUM
bam-12993	95	7	,	,	PUNCT
bam-12993	95	8	lane	lane	NOUN
bam-12993	95	9	2	2	NUM
bam-12993	95	10	:	:	PUNCT
bam-12993	95	11	ff	ff	NOUN
bam-12993	95	12	,	,	PUNCT
bam-12993	95	13	and	and	CCONJ
bam-12993	95	14	lane	lane	NOUN
bam-12993	95	15	3	3	NUM
bam-12993	95	16	:	:	PUNCT
bam-12993	95	17	ff	ff	NOUN
bam-12993	95	18	.	.	PUNCT
bam-12993	95	19	figure	figure	NOUN
bam-12993	95	20	2	2	NUM
bam-12993	95	21	.	.	X
bam-12993	95	22	bsmi	bsmi	PROPN
bam-12993	95	23	:	:	PUNCT
bam-12993	95	24	line	line	NOUN
bam-12993	95	25	1	1	NUM
bam-12993	95	26	:	:	PUNCT
bam-12993	95	27	bb	bb	NUM
bam-12993	95	28	,	,	PUNCT
bam-12993	95	29	lines	line	NOUN
bam-12993	95	30	2	2	NUM
bam-12993	95	31	,	,	PUNCT
bam-12993	95	32	4	4	NUM
bam-12993	95	33	:	:	PUNCT
bam-12993	95	34	bb	bb	NOUN
bam-12993	95	35	,	,	PUNCT
bam-12993	95	36	and	and	CCONJ
bam-12993	95	37	line	line	NOUN
bam-12993	95	38	3	3	NUM
bam-12993	95	39	:	:	PUNCT
bam-12993	95	40	bb	bb	NOUN
bam-12993	95	41	.	.	PUNCT
bam-12993	95	42	vitamin	vitamin	NOUN
bam-12993	95	43	d	d	NOUN
bam-12993	95	44	receptor	receptor	NOUN
bam-12993	95	45	gene	gene	NOUN
bam-12993	95	46	polymorphisms	polymorphism	NOUN
bam-12993	95	47	in	in	ADP
bam-12993	95	48	patients	patient	NOUN
bam-12993	95	49	with	with	ADP
bam-12993	95	50	relapsing	relapse	VERB
bam-12993	95	51	multiple	multiple	ADJ
bam-12993	95	52	sclerosis	sclerosis	NOUN
bam-12993	95	53	eur	eur	PROPN
bam-12993	95	54	j	j	PROPN
bam-12993	95	55	transl	transl	PROPN
bam-12993	95	56	myol	myol	ADV
bam-12993	95	57	35	35	NUM
bam-12993	95	58	(	(	PUNCT
bam-12993	95	59	1	1	NUM
bam-12993	95	60	)	)	PUNCT
bam-12993	95	61	12993	12993	NUM
bam-12993	95	62	,	,	PUNCT
bam-12993	95	63	2025	2025	NUM
bam-12993	95	64	doi	doi	NOUN
bam-12993	95	65	:	:	PUNCT
bam-12993	95	66	10.4081	10.4081	NUM
bam-12993	95	67	/	/	SYM
bam-12993	95	68	ejtm.2024.12993	ejtm.2024.12993	NOUN
bam-12993	95	69	polymorphism	polymorphism	NOUN
bam-12993	95	70	in	in	ADP
bam-12993	95	71	healthy	healthy	ADJ
bam-12993	95	72	and	and	CCONJ
bam-12993	95	73	rrms	rrm	VERB
bam-12993	95	74	individuals	individual	NOUN
bam-12993	95	75	and	and	CCONJ
bam-12993	95	76	compare	compare	VERB
bam-12993	95	77	the	the	DET
bam-12993	95	78	values	value	NOUN
bam-12993	95	79	.	.	PUNCT
bam-12993	96	1	prism	prism	NOUN
bam-12993	96	2	version	version	NOUN
bam-12993	96	3	5	5	NUM
bam-12993	96	4	software	software	NOUN
bam-12993	96	5	was	be	AUX
bam-12993	96	6	used	use	VERB
bam-12993	96	7	to	to	PART
bam-12993	96	8	draw	draw	VERB
bam-12993	96	9	diagrams	diagram	NOUN
bam-12993	96	10	.	.	PUNCT
bam-12993	97	1	findings	finding	VERB
bam-12993	97	2	the	the	DET
bam-12993	97	3	mean	mean	ADJ
bam-12993	97	4	and	and	CCONJ
bam-12993	97	5	standard	standard	ADJ
bam-12993	97	6	deviation	deviation	NOUN
bam-12993	97	7	of	of	ADP
bam-12993	97	8	the	the	DET
bam-12993	97	9	age	age	NOUN
bam-12993	97	10	of	of	ADP
bam-12993	97	11	the	the	DET
bam-12993	97	12	participants	participant	NOUN
bam-12993	97	13	in	in	ADP
bam-12993	97	14	this	this	DET
bam-12993	97	15	study	study	NOUN
bam-12993	97	16	in	in	ADP
bam-12993	97	17	the	the	DET
bam-12993	97	18	test	test	NOUN
bam-12993	97	19	and	and	CCONJ
bam-12993	97	20	control	control	NOUN
bam-12993	97	21	groups	group	NOUN
bam-12993	97	22	were	be	AUX
bam-12993	97	23	32.16±5.87	32.16±5.87	NUM
bam-12993	97	24	years	year	NOUN
bam-12993	97	25	and	and	CCONJ
bam-12993	97	26	31.58±8.14	31.58±8.14	NUM
bam-12993	97	27	years	year	NOUN
bam-12993	97	28	,	,	PUNCT
bam-12993	97	29	respectively	respectively	ADV
bam-12993	97	30	.	.	PUNCT
bam-12993	98	1	the	the	DET
bam-12993	98	2	independent	independent	ADJ
bam-12993	98	3	t	t	PROPN
bam-12993	98	4	-	-	PUNCT
bam-12993	98	5	test	test	NOUN
bam-12993	98	6	did	do	AUX
bam-12993	98	7	not	not	PART
bam-12993	98	8	demonstrate	demonstrate	VERB
bam-12993	98	9	a	a	DET
bam-12993	98	10	statistically	statistically	ADV
bam-12993	98	11	significant	significant	ADJ
bam-12993	98	12	difference	difference	NOUN
bam-12993	98	13	in	in	ADP
bam-12993	98	14	the	the	DET
bam-12993	98	15	mean	mean	ADJ
bam-12993	98	16	age	age	NOUN
bam-12993	98	17	of	of	ADP
bam-12993	98	18	the	the	DET
bam-12993	98	19	two	two	NUM
bam-12993	98	20	groups	group	NOUN
bam-12993	98	21	,	,	PUNCT
bam-12993	98	22	and	and	CCONJ
bam-12993	98	23	both	both	DET
bam-12993	98	24	groups	group	NOUN
bam-12993	98	25	were	be	AUX
bam-12993	98	26	similar	similar	ADJ
bam-12993	98	27	in	in	ADP
bam-12993	98	28	age	age	NOUN
bam-12993	98	29	(	(	PUNCT
bam-12993	98	30	p=0.829	p=0.829	NOUN
bam-12993	98	31	)	)	PUNCT
bam-12993	98	32	.	.	PUNCT
bam-12993	99	1	72	72	NUM
bam-12993	99	2	%	%	NOUN
bam-12993	99	3	of	of	ADP
bam-12993	99	4	the	the	DET
bam-12993	99	5	test	test	NOUN
bam-12993	99	6	group	group	NOUN
bam-12993	99	7	and	and	CCONJ
bam-12993	99	8	41.6	41.6	NUM
bam-12993	99	9	%	%	NOUN
bam-12993	99	10	of	of	ADP
bam-12993	99	11	the	the	DET
bam-12993	99	12	control	control	NOUN
bam-12993	99	13	group	group	NOUN
bam-12993	99	14	were	be	AUX
bam-12993	99	15	women	woman	NOUN
bam-12993	99	16	(	(	PUNCT
bam-12993	99	17	p=0.364	p=0.364	X
bam-12993	99	18	)	)	PUNCT
bam-12993	99	19	.	.	PUNCT
bam-12993	100	1	the	the	DET
bam-12993	100	2	mean	mean	ADJ
bam-12993	100	3	and	and	CCONJ
bam-12993	100	4	standard	standard	ADJ
bam-12993	100	5	deviation	deviation	NOUN
bam-12993	100	6	of	of	ADP
bam-12993	100	7	the	the	DET
bam-12993	100	8	duration	duration	NOUN
bam-12993	100	9	of	of	ADP
bam-12993	100	10	disease	disease	NOUN
bam-12993	100	11	in	in	ADP
bam-12993	100	12	the	the	DET
bam-12993	100	13	patients	patient	NOUN
bam-12993	100	14	participating	participate	VERB
bam-12993	100	15	in	in	ADP
bam-12993	100	16	this	this	DET
bam-12993	100	17	study	study	NOUN
bam-12993	100	18	in	in	ADP
bam-12993	100	19	the	the	DET
bam-12993	100	20	test	test	NOUN
bam-12993	100	21	group	group	NOUN
bam-12993	100	22	was	be	AUX
bam-12993	100	23	45.44±41.74	45.44±41.74	NUM
bam-12993	100	24	months	month	NOUN
bam-12993	100	25	.	.	PUNCT
bam-12993	101	1	the	the	DET
bam-12993	101	2	mean	mean	ADJ
bam-12993	101	3	and	and	CCONJ
bam-12993	101	4	standard	standard	ADJ
bam-12993	101	5	deviation	deviation	NOUN
bam-12993	101	6	of	of	ADP
bam-12993	101	7	the	the	DET
bam-12993	101	8	age	age	NOUN
bam-12993	101	9	of	of	ADP
bam-12993	101	10	disease	disease	NOUN
bam-12993	101	11	onset	onset	VERB
bam-12993	101	12	in	in	ADP
bam-12993	101	13	the	the	DET
bam-12993	101	14	patients	patient	NOUN
bam-12993	101	15	participating	participate	VERB
bam-12993	101	16	in	in	ADP
bam-12993	101	17	this	this	DET
bam-12993	101	18	study	study	NOUN
bam-12993	101	19	in	in	ADP
bam-12993	101	20	the	the	DET
bam-12993	101	21	test	test	NOUN
bam-12993	101	22	group	group	NOUN
bam-12993	101	23	was	be	AUX
bam-12993	101	24	28.52±5.07	28.52±5.07	NUM
bam-12993	101	25	years	year	NOUN
bam-12993	101	26	.	.	PUNCT
bam-12993	102	1	28	28	NUM
bam-12993	102	2	%	%	NOUN
bam-12993	102	3	of	of	ADP
bam-12993	102	4	newly	newly	ADV
bam-12993	102	5	admitted	admit	VERB
bam-12993	102	6	patients	patient	NOUN
bam-12993	102	7	were	be	AUX
bam-12993	102	8	in	in	ADP
bam-12993	102	9	the	the	DET
bam-12993	102	10	relapse	relapse	NOUN
bam-12993	102	11	phase	phase	NOUN
bam-12993	102	12	while	while	SCONJ
bam-12993	102	13	taking	take	VERB
bam-12993	102	14	no	no	DET
bam-12993	102	15	medication	medication	NOUN
bam-12993	102	16	,	,	PUNCT
bam-12993	102	17	and	and	CCONJ
bam-12993	102	18	72	72	NUM
bam-12993	102	19	%	%	NOUN
bam-12993	102	20	of	of	ADP
bam-12993	102	21	the	the	DET
bam-12993	102	22	patients	patient	NOUN
bam-12993	102	23	were	be	AUX
bam-12993	102	24	only	only	ADV
bam-12993	102	25	treated	treat	VERB
bam-12993	102	26	with	with	ADP
bam-12993	102	27	intron	intron	ADJ
bam-12993	102	28	beta	beta	NOUN
bam-12993	102	29	and	and	CCONJ
bam-12993	102	30	with	with	ADP
bam-12993	102	31	a	a	DET
bam-12993	102	32	gap	gap	NOUN
bam-12993	102	33	of	of	ADP
bam-12993	102	34	at	at	ADV
bam-12993	102	35	least	least	ADV
bam-12993	102	36	3	3	NUM
bam-12993	102	37	months	month	NOUN
bam-12993	102	38	from	from	ADP
bam-12993	102	39	the	the	DET
bam-12993	102	40	relapse	relapse	NOUN
bam-12993	102	41	phase	phase	NOUN
bam-12993	102	42	.	.	PUNCT
bam-12993	103	1	the	the	DET
bam-12993	103	2	average	average	ADJ
bam-12993	103	3	and	and	CCONJ
bam-12993	103	4	deviation	deviation	NOUN
bam-12993	103	5	of	of	ADP
bam-12993	103	6	the	the	DET
bam-12993	103	7	time	time	NOUN
bam-12993	103	8	since	since	SCONJ
bam-12993	103	9	the	the	DET
bam-12993	103	10	last	last	ADJ
bam-12993	103	11	attack	attack	NOUN
bam-12993	103	12	in	in	ADP
bam-12993	103	13	the	the	DET
bam-12993	103	14	patients	patient	NOUN
bam-12993	103	15	participating	participate	VERB
bam-12993	103	16	in	in	ADP
bam-12993	103	17	this	this	DET
bam-12993	103	18	study	study	NOUN
bam-12993	103	19	in	in	ADP
bam-12993	103	20	the	the	DET
bam-12993	103	21	test	test	NOUN
bam-12993	103	22	group	group	NOUN
bam-12993	103	23	was	be	AUX
bam-12993	103	24	3.60±2.44	3.60±2.44	NUM
bam-12993	103	25	months	month	NOUN
bam-12993	103	26	.	.	PUNCT
bam-12993	104	1	in	in	ADP
bam-12993	104	2	the	the	DET
bam-12993	104	3	test	test	NOUN
bam-12993	104	4	group	group	NOUN
bam-12993	104	5	,	,	PUNCT
bam-12993	104	6	88	88	NUM
bam-12993	104	7	%	%	NOUN
bam-12993	104	8	of	of	ADP
bam-12993	104	9	the	the	DET
bam-12993	104	10	participants	participant	NOUN
bam-12993	104	11	had	have	VERB
bam-12993	104	12	a	a	DET
bam-12993	104	13	deficiency	deficiency	NOUN
bam-12993	104	14	of	of	ADP
bam-12993	104	15	25	25	NUM
bam-12993	104	16	-	-	PUNCT
bam-12993	104	17	hydroxyvitamin	hydroxyvitamin	NOUN
bam-12993	104	18	d	d	NOUN
bam-12993	104	19	level	level	NOUN
bam-12993	104	20	,	,	PUNCT
bam-12993	104	21	and	and	CCONJ
bam-12993	104	22	in	in	ADP
bam-12993	104	23	the	the	DET
bam-12993	104	24	control	control	NOUN
bam-12993	104	25	group	group	NOUN
bam-12993	104	26	,	,	PUNCT
bam-12993	104	27	66.7	66.7	NUM
bam-12993	104	28	%	%	NOUN
bam-12993	104	29	of	of	ADP
bam-12993	104	30	the	the	DET
bam-12993	104	31	participants	participant	NOUN
bam-12993	104	32	had	have	VERB
bam-12993	104	33	insufficient	insufficient	ADJ
bam-12993	104	34	vitamin	vitamin	NOUN
bam-12993	104	35	d.	d.	NOUN
bam-12993	104	36	according	accord	VERB
bam-12993	104	37	to	to	ADP
bam-12993	104	38	the	the	DET
bam-12993	104	39	results	result	NOUN
bam-12993	104	40	of	of	ADP
bam-12993	104	41	the	the	DET
bam-12993	104	42	spearman	spearman	NOUN
bam-12993	104	43	test	test	NOUN
bam-12993	104	44	,	,	PUNCT
bam-12993	104	45	the	the	DET
bam-12993	104	46	two	two	NUM
bam-12993	104	47	groups	group	NOUN
bam-12993	104	48	had	have	VERB
bam-12993	104	49	a	a	DET
bam-12993	104	50	statistically	statistically	ADV
bam-12993	104	51	significant	significant	ADJ
bam-12993	104	52	difference	difference	NOUN
bam-12993	104	53	in	in	ADP
bam-12993	104	54	terms	term	NOUN
bam-12993	104	55	of	of	ADP
bam-12993	104	56	the	the	DET
bam-12993	104	57	level	level	NOUN
bam-12993	104	58	of	of	ADP
bam-12993	104	59	25	25	NUM
bam-12993	104	60	hydroxy	hydroxy	ADJ
bam-12993	104	61	vitamin	vitamin	NOUN
bam-12993	104	62	d	d	NOUN
bam-12993	104	63	(	(	PUNCT
bam-12993	104	64	p<0.001	p<0.001	PROPN
bam-12993	104	65	)	)	PUNCT
bam-12993	104	66	.	.	PUNCT
bam-12993	105	1	according	accord	VERB
bam-12993	105	2	to	to	ADP
bam-12993	105	3	table	table	NOUN
bam-12993	105	4	2	2	NUM
bam-12993	105	5	,	,	PUNCT
bam-12993	105	6	4	4	NUM
bam-12993	105	7	figure	figure	NOUN
bam-12993	105	8	3	3	NUM
bam-12993	105	9	.	.	PUNCT
bam-12993	105	10	apai	apai	NOUN
bam-12993	105	11	:	:	PUNCT
bam-12993	105	12	lane	lane	NOUN
bam-12993	105	13	1	1	NUM
bam-12993	105	14	,	,	PUNCT
bam-12993	105	15	2	2	NUM
bam-12993	105	16	:	:	PUNCT
bam-12993	105	17	aa	aa	NOUN
bam-12993	105	18	,	,	PUNCT
bam-12993	105	19	lane	lane	NOUN
bam-12993	105	20	3	3	NUM
bam-12993	105	21	,	,	PUNCT
bam-12993	105	22	4	4	NUM
bam-12993	105	23	:	:	PUNCT
bam-12993	105	24	aa	aa	NOUN
bam-12993	105	25	,	,	PUNCT
bam-12993	105	26	and	and	CCONJ
bam-12993	105	27	lane	lane	NOUN
bam-12993	105	28	5	5	NUM
bam-12993	105	29	,	,	PUNCT
bam-12993	105	30	6	6	NUM
bam-12993	105	31	:	:	PUNCT
bam-12993	105	32	aa	aa	PROPN
bam-12993	105	33	.	.	PUNCT
bam-12993	105	34	figure	figure	NOUN
bam-12993	105	35	4	4	NUM
bam-12993	105	36	.	.	PUNCT
bam-12993	105	37	taqi	taqi	ADJ
bam-12993	105	38	:	:	PUNCT
bam-12993	105	39	lane	lane	NOUN
bam-12993	105	40	1	1	NUM
bam-12993	105	41	:	:	PUNCT
bam-12993	105	42	tt	tt	PROPN
bam-12993	105	43	,	,	PUNCT
bam-12993	105	44	lane	lane	NOUN
bam-12993	105	45	2	2	NUM
bam-12993	105	46	:	:	PUNCT
bam-12993	105	47	tt	tt	PROPN
bam-12993	105	48	,	,	PUNCT
bam-12993	105	49	and	and	CCONJ
bam-12993	105	50	lane	lane	NOUN
bam-12993	105	51	3	3	NUM
bam-12993	105	52	:	:	PUNCT
bam-12993	105	53	tt	tt	PROPN
bam-12993	105	54	.	.	PROPN
bam-12993	105	55	table	table	PROPN
bam-12993	106	1	1	1	NUM
bam-12993	106	2	.	.	PUNCT
bam-12993	106	3	rflp	rflp	PROPN
bam-12993	106	4	bands	band	NOUN
bam-12993	106	5	with	with	ADP
bam-12993	106	6	3	3	NUM
bam-12993	106	7	%	%	NOUN
bam-12993	106	8	agarose	agarose	NOUN
bam-12993	106	9	gel	gel	NOUN
bam-12993	106	10	electrophoresis	electrophoresis	NOUN
bam-12993	106	11	.	.	PUNCT
bam-12993	107	1	snp	snp	ADJ
bam-12993	107	2	size	size	NOUN
bam-12993	107	3	(	(	PUNCT
bam-12993	107	4	bp	bp	PROPN
bam-12993	107	5	)	)	PUNCT
bam-12993	107	6	the	the	DET
bam-12993	107	7	number	number	NOUN
bam-12993	107	8	genotype	genotype	NOUN
bam-12993	107	9	of	of	ADP
bam-12993	107	10	bands	band	NOUN
bam-12993	107	11	foki	foki	VERB
bam-12993	107	12	265	265	NUM
bam-12993	107	13	1	1	NUM
bam-12993	107	14	ff	ff	PROPN
bam-12993	107	15	265	265	NUM
bam-12993	107	16	،	،	NOUN
bam-12993	107	17	196	196	NUM
bam-12993	107	18	،	،	NOUN
bam-12993	107	19	69	69	NUM
bam-12993	107	20	3	3	NUM
bam-12993	107	21	ff	ff	PROPN
bam-12993	107	22	196	196	NUM
bam-12993	107	23	،	،	NOUN
bam-12993	107	24	69	69	NUM
bam-12993	107	25	2	2	NUM
bam-12993	107	26	ff	ff	NOUN
bam-12993	107	27	bsmi	bsmi	NOUN
bam-12993	107	28	358	358	NUM
bam-12993	107	29	1	1	NUM
bam-12993	107	30	bb	bb	NUM
bam-12993	107	31	358	358	NUM
bam-12993	107	32	،	،	NOUN
bam-12993	107	33	192،166	192،166	NOUN
bam-12993	107	34	3	3	NUM
bam-12993	107	35	bb	bb	NOUN
bam-12993	107	36	192	192	NUM
bam-12993	107	37	،	،	NOUN
bam-12993	107	38	166	166	NUM
bam-12993	107	39	2	2	NUM
bam-12993	107	40	bb	bb	NUM
bam-12993	107	41	apai	apai	NOUN
bam-12993	107	42	740	740	NUM
bam-12993	107	43	1	1	NUM
bam-12993	107	44	aa	aa	NOUN
bam-12993	107	45	740،530	740،530	PROPN
bam-12993	107	46	،	،	NOUN
bam-12993	107	47	210	210	NUM
bam-12993	107	48	3	3	NUM
bam-12993	107	49	aa	aa	NOUN
bam-12993	107	50	530	530	NUM
bam-12993	107	51	،	،	NOUN
bam-12993	107	52	210	210	NUM
bam-12993	107	53	2	2	NUM
bam-12993	107	54	aa	aa	NOUN
bam-12993	107	55	taqi	taqi	NOUN
bam-12993	107	56	495	495	NUM
bam-12993	107	57	،	،	NOUN
bam-12993	107	58	245	245	NUM
bam-12993	107	59	2	2	NUM
bam-12993	107	60	tt	tt	PROPN
bam-12993	107	61	495	495	NUM
bam-12993	107	62	،	،	NOUN
bam-12993	107	63	290	290	NUM
bam-12993	107	64	،	،	NOUN
bam-12993	107	65	245	245	NUM
bam-12993	107	66	،	،	NOUN
bam-12993	107	67	205	205	NUM
bam-12993	107	68	4	4	NUM
bam-12993	107	69	tt	tt	PROPN
bam-12993	107	70	290	290	NUM
bam-12993	107	71	،	،	NOUN
bam-12993	107	72	245	245	NUM
bam-12993	107	73	،	،	NOUN
bam-12993	107	74	205	205	NUM
bam-12993	107	75	3	3	NUM
bam-12993	107	76	tt	tt	PROPN
bam-12993	107	77	table	table	NOUN
bam-12993	107	78	2	2	NUM
bam-12993	107	79	.	.	NUM
bam-12993	107	80	polymorphisms	polymorphism	NOUN
bam-12993	107	81	and	and	CCONJ
bam-12993	107	82	haplotypes	haplotype	NOUN
bam-12993	107	83	of	of	ADP
bam-12993	107	84	the	the	DET
bam-12993	107	85	vdr	vdr	NOUN
bam-12993	107	86	gene	gene	NOUN
bam-12993	107	87	.	.	PUNCT
bam-12993	108	1	snp	snp	ADJ
bam-12993	108	2	primers	primer	NOUN
bam-12993	108	3	sequences	sequence	NOUN
bam-12993	108	4	amplicon	amplicon	NOUN
bam-12993	108	5	(	(	PUNCT
bam-12993	108	6	bp	bp	PROPN
bam-12993	108	7	)	)	PUNCT
bam-12993	108	8	foki	foki	PROPN
bam-12993	108	9	f	f	PROPN
bam-12993	108	10	5′-agc	5′-agc	NOUN
bam-12993	108	11	tgg	tgg	PROPN
bam-12993	108	12	ccc	ccc	PROPN
bam-12993	108	13	tgg	tgg	PROPN
bam-12993	108	14	cac	cac	PROPN
bam-12993	108	15	tga	tga	PROPN
bam-12993	108	16	ctc	ctc	PROPN
bam-12993	108	17	tgc	tgc	PROPN
bam-12993	108	18	tct-3′	tct-3′	PROPN
bam-12993	108	19	265	265	NUM
bam-12993	108	20	r	r	NOUN
bam-12993	108	21	5′-atg	5′-atg	NUM
bam-12993	108	22	gaa	gaa	NOUN
bam-12993	108	23	aca	aca	PROPN
bam-12993	108	24	cct	cct	PROPN
bam-12993	108	25	tgc	tgc	PROPN
bam-12993	108	26	ttc	ttc	PROPN
bam-12993	108	27	ttc	ttc	PROPN
bam-12993	108	28	tcc	tcc	PROPN
bam-12993	108	29	ctc-3′	ctc-3′	PROPN
bam-12993	108	30	bsmi	bsmi	PROPN
bam-12993	108	31	f	f	PROPN
bam-12993	108	32	5′-ggg	5′-ggg	PROPN
bam-12993	108	33	aga	aga	NOUN
bam-12993	108	34	cgt	cgt	PROPN
bam-12993	108	35	agc	agc	PROPN
bam-12993	108	36	aaa	aaa	PROPN
bam-12993	108	37	agg-3′	agg-3′	PROPN
bam-12993	108	38	358	358	NUM
bam-12993	108	39	r	r	NOUN
bam-12993	108	40	5′-aga	5′-aga	NUM
bam-12993	108	41	ggt	ggt	PROPN
bam-12993	108	42	caa	caa	PROPN
bam-12993	108	43	ggg	ggg	PROPN
bam-12993	108	44	tca	tca	PROPN
bam-12993	108	45	ctg-3′	ctg-3′	PROPN
bam-12993	108	46	apai	apai	NOUN
bam-12993	108	47	f	f	PROPN
bam-12993	109	1	5′-cag	5′-cag	NUM
bam-12993	109	2	agc	agc	PROPN
bam-12993	109	3	atg	atg	PROPN
bam-12993	109	4	gac	gac	PROPN
bam-12993	109	5	agg	agg	PROPN
bam-12993	109	6	gag	gag	PROPN
bam-12993	109	7	caa-3′	caa-3′	PROPN
bam-12993	109	8	740	740	NUM
bam-12993	109	9	r	r	NOUN
bam-12993	109	10	5′-gca	5′-gca	NUM
bam-12993	109	11	act	act	NOUN
bam-12993	109	12	cct	cct	PROPN
bam-12993	109	13	cat	cat	PROPN
bam-12993	109	14	ggc	ggc	PROPN
bam-12993	109	15	tga	tga	PROPN
bam-12993	109	16	ggt	ggt	PROPN
bam-12993	109	17	ctc-3′	ctc-3′	VERB
bam-12993	109	18	taqi	taqi	ADJ
bam-12993	109	19	f	f	NOUN
bam-12993	109	20	5′-cag	5′-cag	NUM
bam-12993	109	21	agc	agc	PROPN
bam-12993	109	22	atg	atg	PROPN
bam-12993	109	23	gac	gac	PROPN
bam-12993	109	24	agg	agg	PROPN
bam-12993	109	25	gag	gag	PROPN
bam-12993	109	26	caa-3′	caa-3′	PROPN
bam-12993	109	27	495	495	NUM
bam-12993	109	28	,	,	PUNCT
bam-12993	109	29	245	245	NUM
bam-12993	109	30	r	r	NOUN
bam-12993	109	31	5′-gca	5′-gca	NUM
bam-12993	109	32	act	act	NOUN
bam-12993	109	33	cct	cct	PROPN
bam-12993	109	34	cat	cat	PROPN
bam-12993	109	35	ggc	ggc	PROPN
bam-12993	109	36	tga	tga	PROPN
bam-12993	109	37	ggt	ggt	PROPN
bam-12993	109	38	ctc-3′	ctc-3′	VERB
bam-12993	109	39	vitamin	vitamin	NOUN
bam-12993	109	40	d	d	NOUN
bam-12993	109	41	receptor	receptor	NOUN
bam-12993	109	42	gene	gene	NOUN
bam-12993	109	43	polymorphisms	polymorphism	NOUN
bam-12993	109	44	in	in	ADP
bam-12993	109	45	patients	patient	NOUN
bam-12993	109	46	with	with	ADP
bam-12993	109	47	relapsing	relapse	VERB
bam-12993	109	48	multiple	multiple	ADJ
bam-12993	109	49	sclerosis	sclerosis	NOUN
bam-12993	109	50	eur	eur	PROPN
bam-12993	109	51	j	j	PROPN
bam-12993	109	52	transl	transl	PROPN
bam-12993	109	53	myol	myol	ADV
bam-12993	109	54	35	35	NUM
bam-12993	109	55	(	(	PUNCT
bam-12993	109	56	1	1	NUM
bam-12993	109	57	)	)	PUNCT
bam-12993	109	58	12993	12993	NUM
bam-12993	109	59	,	,	PUNCT
bam-12993	109	60	2025	2025	NUM
bam-12993	109	61	doi	doi	NOUN
bam-12993	109	62	:	:	PUNCT
bam-12993	109	63	10.4081	10.4081	NUM
bam-12993	109	64	/	/	SYM
bam-12993	109	65	ejtm.2024.12993	ejtm.2024.12993	PRON
bam-12993	109	66	the	the	DET
bam-12993	109	67	mean	mean	ADJ
bam-12993	109	68	and	and	CCONJ
bam-12993	109	69	standard	standard	ADJ
bam-12993	109	70	deviation	deviation	NOUN
bam-12993	109	71	of	of	ADP
bam-12993	109	72	25	25	NUM
bam-12993	109	73	hydroxy	hydroxy	ADJ
bam-12993	109	74	vitamin	vitamin	NOUN
bam-12993	109	75	d	d	NOUN
bam-12993	109	76	levels	level	NOUN
bam-12993	109	77	of	of	ADP
bam-12993	109	78	the	the	DET
bam-12993	109	79	patients	patient	NOUN
bam-12993	109	80	participating	participate	VERB
bam-12993	109	81	in	in	ADP
bam-12993	109	82	this	this	DET
bam-12993	109	83	study	study	NOUN
bam-12993	109	84	in	in	ADP
bam-12993	109	85	the	the	DET
bam-12993	109	86	control	control	NOUN
bam-12993	109	87	and	and	CCONJ
bam-12993	109	88	control	control	NOUN
bam-12993	109	89	groups	group	NOUN
bam-12993	109	90	were	be	AUX
bam-12993	109	91	16.20±4.01	16.20±4.01	NUM
bam-12993	109	92	ng	ng	PROPN
bam-12993	109	93	/	/	SYM
bam-12993	109	94	ml	ml	PROPN
bam-12993	109	95	and	and	CCONJ
bam-12993	109	96	25.50±4.87	25.50±4.87	NUM
bam-12993	109	97	ng	ng	PROPN
bam-12993	109	98	/	/	SYM
bam-12993	109	99	ml	ml	PROPN
bam-12993	109	100	,	,	PUNCT
bam-12993	109	101	respectively	respectively	ADV
bam-12993	109	102	.	.	PUNCT
bam-12993	110	1	according	accord	VERB
bam-12993	110	2	to	to	ADP
bam-12993	110	3	the	the	DET
bam-12993	110	4	mann	mann	PROPN
bam-12993	110	5	-	-	PUNCT
bam-12993	110	6	whitney	whitney	PROPN
bam-12993	110	7	statistical	statistical	ADJ
bam-12993	110	8	test	test	NOUN
bam-12993	110	9	,	,	PUNCT
bam-12993	110	10	there	there	PRON
bam-12993	110	11	was	be	VERB
bam-12993	110	12	a	a	DET
bam-12993	110	13	statistically	statistically	ADV
bam-12993	110	14	significant	significant	ADJ
bam-12993	110	15	difference	difference	NOUN
bam-12993	110	16	in	in	ADP
bam-12993	110	17	terms	term	NOUN
bam-12993	110	18	of	of	ADP
bam-12993	110	19	the	the	DET
bam-12993	110	20	level	level	NOUN
bam-12993	110	21	of	of	ADP
bam-12993	110	22	25	25	NUM
bam-12993	110	23	hydroxy	hydroxy	ADJ
bam-12993	110	24	vitamin	vitamin	NOUN
bam-12993	110	25	d	d	NOUN
bam-12993	110	26	between	between	ADP
bam-12993	110	27	the	the	DET
bam-12993	110	28	test	test	NOUN
bam-12993	110	29	and	and	CCONJ
bam-12993	110	30	control	control	NOUN
bam-12993	110	31	groups	group	NOUN
bam-12993	110	32	(	(	PUNCT
bam-12993	110	33	p<0.001	p<0.001	PROPN
bam-12993	110	34	)	)	PUNCT
bam-12993	110	35	,	,	PUNCT
bam-12993	110	36	so	so	CCONJ
bam-12993	110	37	in	in	ADP
bam-12993	110	38	the	the	DET
bam-12993	110	39	test	test	NOUN
bam-12993	110	40	group	group	NOUN
bam-12993	110	41	,	,	PUNCT
bam-12993	110	42	vitamin	vitamin	NOUN
bam-12993	110	43	d	d	NOUN
bam-12993	110	44	deficiency	deficiency	NOUN
bam-12993	110	45	was	be	AUX
bam-12993	110	46	observed	observe	VERB
bam-12993	110	47	,	,	PUNCT
bam-12993	110	48	and	and	CCONJ
bam-12993	110	49	in	in	ADP
bam-12993	110	50	the	the	DET
bam-12993	110	51	control	control	NOUN
bam-12993	110	52	group	group	NOUN
bam-12993	110	53	,	,	PUNCT
bam-12993	110	54	insufficient	insufficient	ADJ
bam-12993	110	55	vitamin	vitamin	NOUN
bam-12993	110	56	d	d	NOUN
bam-12993	110	57	in	in	ADP
bam-12993	110	58	the	the	DET
bam-12993	110	59	company	company	NOUN
bam-12993	110	60	.	.	PUNCT
bam-12993	111	1	there	there	PRON
bam-12993	111	2	was	be	VERB
bam-12993	111	3	the	the	DET
bam-12993	111	4	mean	mean	ADJ
bam-12993	111	5	serum	serum	NOUN
bam-12993	111	6	level	level	NOUN
bam-12993	111	7	of	of	ADP
bam-12993	111	8	25	25	NUM
bam-12993	111	9	-	-	PUNCT
bam-12993	111	10	hydroxyvitamin	hydroxyvitamin	NOUN
bam-12993	111	11	d	d	NOUN
bam-12993	111	12	in	in	ADP
bam-12993	111	13	patients	patient	NOUN
bam-12993	111	14	with	with	ADP
bam-12993	111	15	the	the	DET
bam-12993	111	16	disease	disease	NOUN
bam-12993	111	17	was	be	AUX
bam-12993	111	18	significantly	significantly	ADV
bam-12993	111	19	lower	low	ADJ
bam-12993	111	20	than	than	ADP
bam-12993	111	21	that	that	PRON
bam-12993	111	22	of	of	ADP
bam-12993	111	23	healthy	healthy	ADJ
bam-12993	111	24	subjects	subject	NOUN
bam-12993	111	25	(	(	PUNCT
bam-12993	111	26	p<0.001	p<0.001	X
bam-12993	111	27	)	)	PUNCT
bam-12993	111	28	(	(	PUNCT
bam-12993	111	29	table	table	NOUN
bam-12993	111	30	3	3	NUM
bam-12993	111	31	)	)	PUNCT
bam-12993	111	32	.	.	PUNCT
bam-12993	112	1	according	accord	VERB
bam-12993	112	2	to	to	ADP
bam-12993	112	3	table	table	NOUN
bam-12993	112	4	4	4	NUM
bam-12993	112	5	,	,	PUNCT
bam-12993	112	6	in	in	ADP
bam-12993	112	7	the	the	DET
bam-12993	112	8	present	present	ADJ
bam-12993	112	9	study	study	NOUN
bam-12993	112	10	,	,	PUNCT
bam-12993	112	11	the	the	DET
bam-12993	112	12	value	value	NOUN
bam-12993	112	13	of	of	ADP
bam-12993	112	14	spearman	spearman	NOUN
bam-12993	112	15	’s	’s	PART
bam-12993	112	16	correlation	correlation	NOUN
bam-12993	112	17	coefficient	coefficient	NOUN
bam-12993	112	18	was	be	AUX
bam-12993	112	19	-0.435	-0.435	VERB
bam-12993	112	20	.	.	PUNCT
bam-12993	113	1	because	because	SCONJ
bam-12993	113	2	the	the	DET
bam-12993	113	3	p	p	NOUN
bam-12993	113	4	-	-	PUNCT
bam-12993	113	5	value	value	NOUN
bam-12993	113	6	in	in	ADP
bam-12993	113	7	this	this	DET
bam-12993	113	8	study	study	NOUN
bam-12993	113	9	was	be	AUX
bam-12993	113	10	calculated	calculate	VERB
bam-12993	113	11	as	as	ADP
bam-12993	113	12	0.030	0.030	NUM
bam-12993	113	13	and	and	CCONJ
bam-12993	113	14	this	this	DET
bam-12993	113	15	value	value	NOUN
bam-12993	113	16	is	be	AUX
bam-12993	113	17	smaller	small	ADJ
bam-12993	113	18	than	than	ADP
bam-12993	113	19	0.05	0.05	NUM
bam-12993	113	20	,	,	PUNCT
bam-12993	113	21	then	then	ADV
bam-12993	113	22	this	this	DET
bam-12993	113	23	correlation	correlation	NOUN
bam-12993	113	24	coefficient	coefficient	NOUN
bam-12993	113	25	is	be	AUX
bam-12993	113	26	significant	significant	ADJ
bam-12993	113	27	at	at	ADP
bam-12993	113	28	the	the	DET
bam-12993	113	29	0.05	0.05	NUM
bam-12993	113	30	level	level	NOUN
bam-12993	113	31	.	.	PUNCT
bam-12993	114	1	so	so	ADV
bam-12993	114	2	,	,	PUNCT
bam-12993	114	3	it	it	PRON
bam-12993	114	4	can	can	AUX
bam-12993	114	5	be	be	AUX
bam-12993	114	6	concluded	conclude	VERB
bam-12993	114	7	that	that	SCONJ
bam-12993	114	8	there	there	PRON
bam-12993	114	9	is	be	VERB
bam-12993	114	10	a	a	DET
bam-12993	114	11	statistically	statistically	ADV
bam-12993	114	12	significant	significant	ADJ
bam-12993	114	13	relationship	relationship	NOUN
bam-12993	114	14	between	between	ADP
bam-12993	114	15	the	the	DET
bam-12993	114	16	edss	edss	ADJ
bam-12993	114	17	scale	scale	NOUN
bam-12993	114	18	scores	score	NOUN
bam-12993	114	19	and	and	CCONJ
bam-12993	114	20	the	the	DET
bam-12993	114	21	level	level	NOUN
bam-12993	114	22	of	of	ADP
bam-12993	114	23	25	25	NUM
bam-12993	114	24	hydroxy	hydroxy	ADJ
bam-12993	114	25	vitamin	vitamin	NOUN
bam-12993	114	26	d	d	NOUN
bam-12993	114	27	in	in	ADP
bam-12993	114	28	ms	ms	PROPN
bam-12993	114	29	patients	patient	NOUN
bam-12993	114	30	participating	participate	VERB
bam-12993	114	31	in	in	ADP
bam-12993	114	32	the	the	DET
bam-12993	114	33	study	study	NOUN
bam-12993	114	34	.	.	PUNCT
bam-12993	115	1	the	the	DET
bam-12993	115	2	negative	negative	ADJ
bam-12993	115	3	sign	sign	NOUN
bam-12993	115	4	of	of	ADP
bam-12993	115	5	the	the	DET
bam-12993	115	6	correlation	correlation	NOUN
bam-12993	115	7	coefficient	coefficient	NOUN
bam-12993	115	8	indicates	indicate	VERB
bam-12993	115	9	that	that	SCONJ
bam-12993	115	10	the	the	DET
bam-12993	115	11	relationship	relationship	NOUN
bam-12993	115	12	is	be	AUX
bam-12993	115	13	not	not	PART
bam-12993	115	14	aligned	align	VERB
bam-12993	115	15	.	.	PUNCT
bam-12993	116	1	this	this	PRON
bam-12993	116	2	means	mean	VERB
bam-12993	116	3	that	that	SCONJ
bam-12993	116	4	ms	ms	PROPN
bam-12993	116	5	patients	patient	NOUN
bam-12993	116	6	with	with	ADP
bam-12993	116	7	lower	low	ADJ
bam-12993	116	8	levels	level	NOUN
bam-12993	116	9	of	of	ADP
bam-12993	116	10	25	25	NUM
bam-12993	116	11	-	-	PUNCT
bam-12993	116	12	hydroxyvitamin	hydroxyvitamin	NOUN
bam-12993	116	13	d	d	NOUN
bam-12993	116	14	had	have	VERB
bam-12993	116	15	higher	high	ADJ
bam-12993	116	16	scores	score	NOUN
bam-12993	116	17	and	and	CCONJ
bam-12993	116	18	patients	patient	NOUN
bam-12993	116	19	with	with	ADP
bam-12993	116	20	higher	high	ADJ
bam-12993	116	21	levels	level	NOUN
bam-12993	116	22	of	of	ADP
bam-12993	116	23	25	25	NUM
bam-12993	116	24	-	-	PUNCT
bam-12993	116	25	hydroxyvitamin	hydroxyvitamin	NOUN
bam-12993	116	26	d	d	NOUN
bam-12993	116	27	had	have	VERB
bam-12993	116	28	lower	low	ADJ
bam-12993	116	29	scores	score	NOUN
bam-12993	116	30	.	.	PUNCT
bam-12993	117	1	as	as	SCONJ
bam-12993	117	2	seen	see	VERB
bam-12993	117	3	in	in	ADP
bam-12993	117	4	table	table	NOUN
bam-12993	117	5	4	4	NUM
bam-12993	117	6	,	,	PUNCT
bam-12993	117	7	there	there	PRON
bam-12993	117	8	was	be	VERB
bam-12993	117	9	.	.	PUNCT
bam-12993	118	1	a	a	DET
bam-12993	118	2	significant	significant	ADJ
bam-12993	118	3	negative	negative	ADJ
bam-12993	118	4	trend	trend	NOUN
bam-12993	118	5	between	between	ADP
bam-12993	118	6	serum	serum	NOUN
bam-12993	118	7	levels	level	NOUN
bam-12993	118	8	of	of	ADP
bam-12993	118	9	25	25	NUM
bam-12993	118	10	hydroxy	hydroxy	ADJ
bam-12993	118	11	vitamin	vitamin	NOUN
bam-12993	118	12	d	d	NOUN
bam-12993	118	13	and	and	CCONJ
bam-12993	118	14	edss	edss	ADJ
bam-12993	118	15	score	score	NOUN
bam-12993	118	16	(	(	PUNCT
bam-12993	118	17	p<0.001	p<0.001	PROPN
bam-12993	118	18	)	)	PUNCT
bam-12993	118	19	.	.	PUNCT
bam-12993	119	1	according	accord	VERB
bam-12993	119	2	to	to	ADP
bam-12993	119	3	table	table	NOUN
bam-12993	119	4	5	5	NUM
bam-12993	119	5	,	,	PUNCT
bam-12993	119	6	in	in	ADP
bam-12993	119	7	univariate	univariate	ADJ
bam-12993	119	8	conditional	conditional	ADJ
bam-12993	119	9	logistic	logistic	ADJ
bam-12993	119	10	regression	regression	NOUN
bam-12993	119	11	analysis	analysis	NOUN
bam-12993	119	12	,	,	PUNCT
bam-12993	119	13	the	the	DET
bam-12993	119	14	odds	odd	NOUN
bam-12993	119	15	ratio	ratio	NOUN
bam-12993	119	16	(	(	PUNCT
bam-12993	119	17	or	or	CCONJ
bam-12993	119	18	)	)	PUNCT
bam-12993	119	19	was	be	AUX
bam-12993	119	20	1.55	1.55	NUM
bam-12993	119	21	(	(	PUNCT
bam-12993	119	22	95	95	NUM
bam-12993	119	23	%	%	NOUN
bam-12993	119	24	ci	ci	NOUN
bam-12993	119	25	,	,	PUNCT
bam-12993	119	26	1.187–2.040	1.187–2.040	NUM
bam-12993	119	27	;	;	PUNCT
bam-12993	119	28	p<0.001	p<0.001	X
bam-12993	119	29	)	)	PUNCT
bam-12993	119	30	,	,	PUNCT
bam-12993	119	31	indicating	indicate	VERB
bam-12993	119	32	that	that	SCONJ
bam-12993	119	33	low	low	ADJ
bam-12993	119	34	levels	level	NOUN
bam-12993	119	35	of	of	ADP
bam-12993	119	36	25hydroxyvitamin	25hydroxyvitamin	NUM
bam-12993	119	37	d	d	NOUN
bam-12993	119	38	can	can	AUX
bam-12993	119	39	1.55	1.55	NUM
bam-12993	119	40	to	to	PART
bam-12993	119	41	increase	increase	VERB
bam-12993	119	42	the	the	DET
bam-12993	119	43	odds	odd	NOUN
bam-12993	119	44	of	of	ADP
bam-12993	119	45	ms	ms	NOUN
bam-12993	119	46	disease	disease	NOUN
bam-12993	119	47	,	,	PUNCT
bam-12993	119	48	this	this	DET
bam-12993	119	49	relationship	relationship	NOUN
bam-12993	119	50	was	be	AUX
bam-12993	119	51	statistically	statistically	ADV
bam-12993	119	52	significant	significant	ADJ
bam-12993	119	53	,	,	PUNCT
bam-12993	119	54	and	and	CCONJ
bam-12993	119	55	a	a	DET
bam-12993	119	56	strong	strong	ADJ
bam-12993	119	57	relationship	relationship	NOUN
bam-12993	119	58	was	be	AUX
bam-12993	119	59	observed	observe	VERB
bam-12993	119	60	(	(	PUNCT
bam-12993	119	61	p<0.001	p<0.001	PROPN
bam-12993	119	62	)	)	PUNCT
bam-12993	119	63	.	.	PUNCT
bam-12993	120	1	according	accord	VERB
bam-12993	120	2	to	to	ADP
bam-12993	120	3	table	table	NOUN
bam-12993	120	4	6	6	NUM
bam-12993	120	5	,	,	PUNCT
bam-12993	120	6	the	the	DET
bam-12993	120	7	mean	mean	ADJ
bam-12993	120	8	and	and	CCONJ
bam-12993	120	9	standard	standard	ADJ
bam-12993	120	10	deviation	deviation	NOUN
bam-12993	120	11	of	of	ADP
bam-12993	120	12	25	25	NUM
bam-12993	120	13	hydroxy	hydroxy	ADJ
bam-12993	120	14	vitamin	vitamin	NOUN
bam-12993	120	15	d	d	NOUN
bam-12993	120	16	levels	level	NOUN
bam-12993	120	17	in	in	ADP
bam-12993	120	18	patients	patient	NOUN
bam-12993	120	19	participating	participate	VERB
bam-12993	120	20	in	in	ADP
bam-12993	120	21	this	this	DET
bam-12993	120	22	study	study	NOUN
bam-12993	120	23	in	in	ADP
bam-12993	120	24	the	the	DET
bam-12993	120	25	mild	mild	ADJ
bam-12993	120	26	and	and	CCONJ
bam-12993	120	27	severe	severe	ADJ
bam-12993	120	28	groups	group	NOUN
bam-12993	120	29	were	be	AUX
bam-12993	120	30	18.42±3.64	18.42±3.64	NUM
bam-12993	120	31	ng	ng	PROPN
bam-12993	120	32	/	/	SYM
bam-12993	120	33	ml	ml	PROPN
bam-12993	120	34	and	and	CCONJ
bam-12993	120	35	15.33±3.89	15.33±3.89	PRON
bam-12993	120	36	ng	ng	PROPN
bam-12993	120	37	/	/	SYM
bam-12993	120	38	ml	ml	PROPN
bam-12993	120	39	,	,	PUNCT
bam-12993	120	40	respectively	respectively	ADV
bam-12993	120	41	.	.	PUNCT
bam-12993	121	1	according	accord	VERB
bam-12993	121	2	to	to	ADP
bam-12993	121	3	the	the	DET
bam-12993	121	4	mann	mann	PROPN
bam-12993	121	5	-	-	PUNCT
bam-12993	121	6	whitney	whitney	PROPN
bam-12993	121	7	statistical	statistical	ADJ
bam-12993	121	8	test	test	NOUN
bam-12993	121	9	,	,	PUNCT
bam-12993	121	10	a	a	DET
bam-12993	121	11	statistically	statistically	ADV
bam-12993	121	12	significant	significant	ADJ
bam-12993	121	13	difference	difference	NOUN
bam-12993	121	14	was	be	AUX
bam-12993	121	15	observed	observe	VERB
bam-12993	121	16	in	in	ADP
bam-12993	121	17	terms	term	NOUN
bam-12993	121	18	of	of	ADP
bam-12993	121	19	the	the	DET
bam-12993	121	20	level	level	NOUN
bam-12993	121	21	of	of	ADP
bam-12993	121	22	25	25	NUM
bam-12993	121	23	-	-	PUNCT
bam-12993	121	24	hydroxyvitamin	hydroxyvitamin	NOUN
bam-12993	121	25	d	d	NOUN
bam-12993	121	26	between	between	ADP
bam-12993	121	27	the	the	DET
bam-12993	121	28	two	two	NUM
bam-12993	121	29	mild	mild	ADJ
bam-12993	121	30	and	and	CCONJ
bam-12993	121	31	severe	severe	ADJ
bam-12993	121	32	groups	group	NOUN
bam-12993	121	33	5	5	NUM
bam-12993	121	34	table	table	NOUN
bam-12993	121	35	3	3	NUM
bam-12993	121	36	.	.	PUNCT
bam-12993	122	1	mean	mean	ADJ
bam-12993	122	2	values	value	NOUN
bam-12993	122	3	of	of	ADP
bam-12993	122	4	25	25	NUM
bam-12993	122	5	hydroxy	hydroxy	ADJ
bam-12993	122	6	vitamin	vitamin	NOUN
bam-12993	122	7	d	d	NOUN
bam-12993	122	8	levels	level	NOUN
bam-12993	122	9	in	in	ADP
bam-12993	122	10	patients	patient	NOUN
bam-12993	122	11	with	with	ADP
bam-12993	122	12	relapsing	relapse	VERB
bam-12993	122	13	-	-	PUNCT
bam-12993	122	14	remitting	remit	VERB
bam-12993	122	15	ms	ms	NOUN
bam-12993	122	16	in	in	ADP
bam-12993	122	17	both	both	CCONJ
bam-12993	122	18	experimental	experimental	ADJ
bam-12993	122	19	and	and	CCONJ
bam-12993	122	20	control	control	NOUN
bam-12993	122	21	groups	group	NOUN
bam-12993	122	22	.	.	PUNCT
bam-12993	123	1	groups	group	NOUN
bam-12993	123	2	test	test	VERB
bam-12993	123	3	(	(	PUNCT
bam-12993	123	4	n=25	n=25	NOUN
bam-12993	123	5	)	)	PUNCT
bam-12993	123	6	witness	witness	NOUN
bam-12993	123	7	(	(	PUNCT
bam-12993	123	8	n=12	n=12	NOUN
bam-12993	123	9	)	)	PUNCT
bam-12993	123	10	p	p	ADJ
bam-12993	123	11	-	-	PUNCT
bam-12993	123	12	value	value	NOUN
bam-12993	123	13	number	number	NOUN
bam-12993	123	14	(	(	PUNCT
bam-12993	123	15	percent	percent	NOUN
bam-12993	123	16	)	)	PUNCT
bam-12993	123	17	number	number	NOUN
bam-12993	123	18	(	(	PUNCT
bam-12993	123	19	percent	percent	NOUN
bam-12993	123	20	)	)	PUNCT
bam-12993	123	21	25	25	NUM
bam-12993	123	22	hydroxy	hydroxy	NOUN
bam-12993	123	23	vitamin	vitamin	NOUN
bam-12993	123	24	d	d	NOUN
bam-12993	123	25	level	level	NOUN
bam-12993	123	26	(	(	PUNCT
bam-12993	123	27	ng	ng	NOUN
bam-12993	123	28	/	/	SYM
bam-12993	123	29	ml	ml	NOUN
bam-12993	123	30	)	)	PUNCT
bam-12993	123	31	1	1	NUM
bam-12993	123	32	(	(	PUNCT
bam-12993	123	33	3/8	3/8	NUM
bam-12993	123	34	)	)	PUNCT
bam-12993	123	35	spearman	spearman	NOUN
bam-12993	123	36	correlation	correlation	NOUN
bam-12993	123	37	>	>	NOUN
bam-12993	123	38	0.001	0.001	NUM
bam-12993	123	39	22	22	NUM
bam-12993	123	40	(	(	PUNCT
bam-12993	123	41	88	88	NUM
bam-12993	123	42	)	)	PUNCT
bam-12993	123	43	8	8	NUM
bam-12993	123	44	(	(	PUNCT
bam-12993	123	45	7/66	7/66	NUM
bam-12993	123	46	)	)	PUNCT
bam-12993	123	47	shortage	shortage	NOUN
bam-12993	123	48	3	3	NUM
bam-12993	123	49	(	(	PUNCT
bam-12993	123	50	12	12	NUM
bam-12993	123	51	)	)	PUNCT
bam-12993	123	52	3	3	NUM
bam-12993	123	53	(	(	PUNCT
bam-12993	123	54	25	25	NUM
bam-12993	123	55	%	%	NOUN
bam-12993	123	56	)	)	PUNCT
bam-12993	123	57	insufficient	insufficient	ADJ
bam-12993	123	58	vitamin	vitamin	NOUN
bam-12993	123	59	d	d	NOUN
bam-12993	123	60	0	0	NUM
bam-12993	123	61	87/4	87/4	NUM
bam-12993	123	62	±	±	NUM
bam-12993	123	63	50/25	50/25	NUM
bam-12993	123	64	mann	mann	PROPN
bam-12993	123	65	-	-	PUNCT
bam-12993	123	66	whitney	whitney	PROPN
bam-12993	123	67	test	test	PROPN
bam-12993	123	68	>	>	NOUN
bam-12993	123	69	0.001	0.001	NUM
bam-12993	123	70	table	table	NOUN
bam-12993	123	71	4	4	NUM
bam-12993	123	72	.	.	PUNCT
bam-12993	123	73	correlation	correlation	NOUN
bam-12993	123	74	between	between	ADP
bam-12993	123	75	serum	serum	NOUN
bam-12993	123	76	levels	level	NOUN
bam-12993	123	77	of	of	ADP
bam-12993	123	78	25	25	NUM
bam-12993	123	79	hydroxy	hydroxy	ADJ
bam-12993	123	80	vitamin	vitamin	NOUN
bam-12993	123	81	d	d	NOUN
bam-12993	123	82	and	and	CCONJ
bam-12993	123	83	extended	extended	ADJ
bam-12993	123	84	disability	disability	NOUN
bam-12993	123	85	status	status	NOUN
bam-12993	123	86	scale	scale	NOUN
bam-12993	123	87	(	(	PUNCT
bam-12993	123	88	edss	edss	ADV
bam-12993	123	89	)	)	PUNCT
bam-12993	123	90	score	score	NOUN
bam-12993	123	91	.	.	PUNCT
bam-12993	124	1	vitamin	vitamin	NOUN
bam-12993	124	2	d	d	NOUN
bam-12993	124	3	serum	serum	NOUN
bam-12993	124	4	level	level	NOUN
bam-12993	124	5	edss	edss	NOUN
bam-12993	124	6	spearman	spearman	NOUN
bam-12993	124	7	’s	’s	PART
bam-12993	124	8	statistical	statistical	ADJ
bam-12993	124	9	test	test	NOUN
bam-12993	124	10	vitamin	vitamin	NOUN
bam-12993	124	11	d	d	X
bam-12993	124	12	serum	serum	NOUN
bam-12993	124	13	level	level	NOUN
bam-12993	124	14	correlation	correlation	NOUN
bam-12993	124	15	1/100	1/100	NUM
bam-12993	124	16	-0/435	-0/435	PUNCT
bam-12993	124	17	p	p	NOUN
bam-12993	124	18	-	-	PUNCT
bam-12993	124	19	value	value	NOUN
bam-12993	124	20	0/030	0/030	NUM
bam-12993	124	21	number	number	NOUN
bam-12993	124	22	25	25	NUM
bam-12993	124	23	25	25	NUM
bam-12993	124	24	spearman	spearman	NOUN
bam-12993	124	25	’s	’s	PART
bam-12993	124	26	statistical	statistical	ADJ
bam-12993	124	27	test	test	NOUN
bam-12993	124	28	edss	edss	ADJ
bam-12993	124	29	correlation	correlation	NOUN
bam-12993	124	30	-0/435	-0/435	PUNCT
bam-12993	124	31	1/000	1/000	NUM
bam-12993	124	32	p	p	NOUN
bam-12993	124	33	-	-	PUNCT
bam-12993	124	34	value	value	NOUN
bam-12993	124	35	0/030	0/030	NUM
bam-12993	124	36	number	number	NOUN
bam-12993	124	37	25	25	NUM
bam-12993	124	38	25	25	NUM
bam-12993	124	39	table	table	NOUN
bam-12993	124	40	5	5	NUM
bam-12993	124	41	.	.	PUNCT
bam-12993	124	42	odds	odd	NOUN
bam-12993	124	43	ratio	ratio	NOUN
bam-12993	124	44	of	of	ADP
bam-12993	124	45	ms	ms	NOUN
bam-12993	124	46	disease	disease	NOUN
bam-12993	124	47	with	with	ADP
bam-12993	124	48	25	25	NUM
bam-12993	124	49	hydroxy	hydroxy	ADJ
bam-12993	124	50	vitamin	vitamin	NOUN
bam-12993	124	51	d	d	NOUN
bam-12993	124	52	levels	level	NOUN
bam-12993	124	53	.	.	PUNCT
bam-12993	125	1	b	b	X
bam-12993	125	2	s.e	s.e	PROPN
bam-12993	125	3	.	.	PROPN
bam-12993	125	4	wald	wald	PROPN
bam-12993	125	5	df	df	PROPN
bam-12993	125	6	sig	sig	PROPN
bam-12993	125	7	.	.	PUNCT
bam-12993	126	1	exp	exp	PROPN
bam-12993	126	2	(	(	PUNCT
bam-12993	126	3	b	b	NOUN
bam-12993	126	4	)	)	PUNCT
bam-12993	126	5	95	95	NUM
bam-12993	126	6	%	%	NOUN
bam-12993	126	7	c.i	c.i	NOUN
bam-12993	126	8	.	.	PROPN
bam-12993	126	9	for	for	ADP
bam-12993	126	10	exp(b	exp(b	PROPN
bam-12993	126	11	)	)	PUNCT
bam-12993	126	12	lower	low	ADJ
bam-12993	126	13	upper	upper	ADJ
bam-12993	126	14	vitamin	vitamin	NOUN
bam-12993	126	15	d	d	ADP
bam-12993	126	16	442.0	442.0	NUM
bam-12993	126	17	0.138	0.138	NUM
bam-12993	126	18	10.23	10.23	NUM
bam-12993	126	19	1	1	NUM
bam-12993	126	20	0.001	0.001	NUM
bam-12993	126	21	1.55	1.55	NUM
bam-12993	126	22	1.187	1.187	NUM
bam-12993	126	23	2.040	2.040	NUM
bam-12993	126	24	constant	constant	ADJ
bam-12993	126	25	-9.76	-9.76	NUM
bam-12993	126	26	2.93	2.93	NUM
bam-12993	126	27	11.07	11.07	NUM
bam-12993	126	28	1	1	NUM
bam-12993	126	29	0.001	0.001	NUM
bam-12993	126	30	0	0	NUM
bam-12993	126	31	vitamin	vitamin	NOUN
bam-12993	126	32	d	d	NOUN
bam-12993	126	33	receptor	receptor	NOUN
bam-12993	126	34	gene	gene	NOUN
bam-12993	126	35	polymorphisms	polymorphism	NOUN
bam-12993	126	36	in	in	ADP
bam-12993	126	37	patients	patient	NOUN
bam-12993	126	38	with	with	ADP
bam-12993	126	39	relapsing	relapse	VERB
bam-12993	126	40	multiple	multiple	ADJ
bam-12993	126	41	sclerosis	sclerosis	NOUN
bam-12993	126	42	eur	eur	PROPN
bam-12993	126	43	j	j	PROPN
bam-12993	126	44	transl	transl	PROPN
bam-12993	126	45	myol	myol	ADV
bam-12993	126	46	35	35	NUM
bam-12993	126	47	(	(	PUNCT
bam-12993	126	48	1	1	NUM
bam-12993	126	49	)	)	PUNCT
bam-12993	126	50	12993	12993	NUM
bam-12993	126	51	,	,	PUNCT
bam-12993	126	52	2025	2025	NUM
bam-12993	126	53	doi	doi	NOUN
bam-12993	126	54	:	:	PUNCT
bam-12993	126	55	10.4081	10.4081	NUM
bam-12993	126	56	/	/	SYM
bam-12993	126	57	ejtm.2024.12993	ejtm.2024.12993	NOUN
bam-12993	126	58	(	(	PUNCT
bam-12993	126	59	p<0.001	p<0.001	PROPN
bam-12993	126	60	)	)	PUNCT
bam-12993	126	61	,	,	PUNCT
bam-12993	126	62	so	so	CCONJ
bam-12993	126	63	the	the	DET
bam-12993	126	64	level	level	NOUN
bam-12993	126	65	of	of	ADP
bam-12993	126	66	vitamin	vitamin	NOUN
bam-12993	126	67	d	d	NOUN
bam-12993	126	68	in	in	ADP
bam-12993	126	69	the	the	DET
bam-12993	126	70	severe	severe	ADJ
bam-12993	126	71	group	group	NOUN
bam-12993	126	72	was	be	AUX
bam-12993	126	73	significantly	significantly	ADV
bam-12993	126	74	lower	low	ADJ
bam-12993	126	75	than	than	ADP
bam-12993	126	76	the	the	DET
bam-12993	126	77	mild	mild	ADJ
bam-12993	126	78	group	group	NOUN
bam-12993	126	79	.	.	PUNCT
bam-12993	127	1	according	accord	VERB
bam-12993	127	2	to	to	ADP
bam-12993	127	3	table	table	NOUN
bam-12993	127	4	7	7	NUM
bam-12993	127	5	,	,	PUNCT
bam-12993	127	6	the	the	DET
bam-12993	127	7	foki	foki	ADJ
bam-12993	127	8	genotype	genotype	NOUN
bam-12993	127	9	distribution	distribution	NOUN
bam-12993	127	10	in	in	ADP
bam-12993	127	11	rrms	rrm	NOUN
bam-12993	127	12	patients	patient	NOUN
bam-12993	127	13	was	be	AUX
bam-12993	127	14	as	as	SCONJ
bam-12993	127	15	follows	follow	VERB
bam-12993	127	16	:	:	PUNCT
bam-12993	127	17	ff	ff	INTJ
bam-12993	127	18	(	(	PUNCT
bam-12993	127	19	wild	wild	ADJ
bam-12993	127	20	)	)	PUNCT
bam-12993	127	21	=	=	SYM
bam-12993	127	22	72	72	NUM
bam-12993	127	23	%	%	NOUN
bam-12993	127	24	,	,	PUNCT
bam-12993	127	25	ff	ff	INTJ
bam-12993	127	26	(	(	PUNCT
bam-12993	127	27	heterozygous	heterozygous	ADJ
bam-12993	127	28	)	)	PUNCT
bam-12993	127	29	=	=	SYM
bam-12993	127	30	28	28	NUM
bam-12993	127	31	%	%	NOUN
bam-12993	127	32	and	and	CCONJ
bam-12993	127	33	ff	ff	INTJ
bam-12993	127	34	(	(	PUNCT
bam-12993	127	35	mutant	mutant	NOUN
bam-12993	127	36	)	)	PUNCT
bam-12993	127	37	=	=	SYM
bam-12993	127	38	0	0	NUM
bam-12993	127	39	%	%	NOUN
bam-12993	127	40	;	;	PUNCT
bam-12993	127	41	in	in	ADP
bam-12993	127	42	the	the	DET
bam-12993	127	43	control	control	NOUN
bam-12993	127	44	group	group	NOUN
bam-12993	127	45	:	:	PUNCT
bam-12993	127	46	ff=25	ff=25	ADJ
bam-12993	127	47	%	%	NOUN
bam-12993	127	48	,	,	PUNCT
bam-12993	127	49	ff=41.7	ff=41.7	PROPN
bam-12993	127	50	%	%	NOUN
bam-12993	127	51	,	,	PUNCT
bam-12993	127	52	and	and	CCONJ
bam-12993	127	53	ff=33.3	ff=33.3	NOUN
bam-12993	127	54	%	%	NOUN
bam-12993	127	55	.	.	PUNCT
bam-12993	128	1	the	the	DET
bam-12993	128	2	statistically	statistically	ADV
bam-12993	128	3	significant	significant	ADJ
bam-12993	128	4	difference	difference	NOUN
bam-12993	128	5	was	be	AUX
bam-12993	128	6	observed	observe	VERB
bam-12993	128	7	between	between	ADP
bam-12993	128	8	the	the	DET
bam-12993	128	9	percentage	percentage	NOUN
bam-12993	128	10	of	of	ADP
bam-12993	128	11	genotypes	genotype	NOUN
bam-12993	128	12	in	in	ADP
bam-12993	128	13	both	both	DET
bam-12993	128	14	test	test	NOUN
bam-12993	128	15	and	and	CCONJ
bam-12993	128	16	control	control	NOUN
bam-12993	128	17	groups	group	NOUN
bam-12993	128	18	(	(	PUNCT
bam-12993	128	19	p=0.003	p=0.003	NOUN
bam-12993	128	20	)	)	PUNCT
bam-12993	128	21	.	.	PUNCT
bam-12993	129	1	statistical	statistical	ADJ
bam-12993	129	2	analysis	analysis	NOUN
bam-12993	129	3	of	of	ADP
bam-12993	129	4	foki	foki	ADJ
bam-12993	129	5	polymorphism	polymorphism	NOUN
bam-12993	129	6	showed	show	VERB
bam-12993	129	7	a	a	DET
bam-12993	129	8	significant	significant	ADJ
bam-12993	129	9	increase	increase	NOUN
bam-12993	129	10	in	in	ADP
bam-12993	129	11	risk	risk	NOUN
bam-12993	129	12	in	in	ADP
bam-12993	129	13	patients	patient	NOUN
bam-12993	129	14	with	with	ADP
bam-12993	129	15	ff	ff	NOUN
bam-12993	129	16	genotype	genotype	NOUN
bam-12993	129	17	compared	compare	VERB
bam-12993	129	18	to	to	ADP
bam-12993	129	19	the	the	DET
bam-12993	129	20	control	control	NOUN
bam-12993	129	21	group	group	NOUN
bam-12993	129	22	(	(	PUNCT
bam-12993	129	23	or=7.28	or=7.28	PROPN
bam-12993	129	24	:	:	PUNCT
bam-12993	129	25	95	95	NUM
bam-12993	129	26	%	%	NOUN
bam-12993	129	27	ci	ci	NOUN
bam-12993	129	28	;	;	PUNCT
bam-12993	129	29	1.86	1.86	NUM
bam-12993	129	30	,	,	PUNCT
bam-12993	129	31	28.41	28.41	NUM
bam-12993	129	32	)	)	PUNCT
bam-12993	129	33	.	.	PUNCT
bam-12993	130	1	the	the	DET
bam-12993	130	2	odds	odd	NOUN
bam-12993	130	3	ratio	ratio	NOUN
bam-12993	130	4	was	be	AUX
bam-12993	130	5	7.28	7.28	NUM
bam-12993	130	6	.	.	PUNCT
bam-12993	131	1	the	the	DET
bam-12993	131	2	distribution	distribution	NOUN
bam-12993	131	3	of	of	ADP
bam-12993	131	4	apai	apai	NOUN
bam-12993	131	5	genotype	genotype	NOUN
bam-12993	131	6	in	in	ADP
bam-12993	131	7	rrms	rrm	NOUN
bam-12993	131	8	patients	patient	NOUN
bam-12993	131	9	was	be	AUX
bam-12993	131	10	as	as	SCONJ
bam-12993	131	11	follows	follow	VERB
bam-12993	131	12	:	:	PUNCT
bam-12993	131	13	aa	aa	NOUN
bam-12993	131	14	(	(	PUNCT
bam-12993	131	15	wild	wild	ADJ
bam-12993	131	16	)	)	PUNCT
bam-12993	131	17	=	=	SYM
bam-12993	131	18	40	40	NUM
bam-12993	131	19	%	%	NOUN
bam-12993	131	20	,	,	PUNCT
bam-12993	131	21	aa	aa	INTJ
bam-12993	131	22	(	(	PUNCT
bam-12993	131	23	heterozygous	heterozygous	ADJ
bam-12993	131	24	)	)	PUNCT
bam-12993	131	25	=	=	NOUN
bam-12993	131	26	56	56	NUM
bam-12993	131	27	%	%	NOUN
bam-12993	131	28	and	and	CCONJ
bam-12993	131	29	aa	aa	NOUN
bam-12993	131	30	(	(	PUNCT
bam-12993	131	31	mutant	mutant	NOUN
bam-12993	131	32	)	)	PUNCT
bam-12993	131	33	=	=	SYM
bam-12993	131	34	4	4	NUM
bam-12993	131	35	%	%	NOUN
bam-12993	131	36	;	;	PUNCT
bam-12993	131	37	in	in	ADP
bam-12993	131	38	the	the	DET
bam-12993	131	39	control	control	NOUN
bam-12993	131	40	group	group	NOUN
bam-12993	131	41	:	:	PUNCT
bam-12993	131	42	aa=50	aa=50	NOUN
bam-12993	131	43	%	%	NOUN
bam-12993	131	44	,	,	PUNCT
bam-12993	131	45	aa=25	aa=25	NOUN
bam-12993	131	46	%	%	NOUN
bam-12993	131	47	,	,	PUNCT
bam-12993	131	48	and	and	CCONJ
bam-12993	131	49	aa=25	aa=25	NUM
bam-12993	131	50	%	%	NOUN
bam-12993	131	51	.	.	PUNCT
bam-12993	132	1	no	no	DET
bam-12993	132	2	statistically	statistically	ADV
bam-12993	132	3	significant	significant	ADJ
bam-12993	132	4	difference	difference	NOUN
bam-12993	132	5	was	be	AUX
bam-12993	132	6	observed	observe	VERB
bam-12993	132	7	between	between	ADP
bam-12993	132	8	the	the	DET
bam-12993	132	9	percentage	percentage	NOUN
bam-12993	132	10	of	of	ADP
bam-12993	132	11	genotypes	genotype	NOUN
bam-12993	132	12	in	in	ADP
bam-12993	132	13	the	the	DET
bam-12993	132	14	two	two	NUM
bam-12993	132	15	test	test	NOUN
bam-12993	132	16	and	and	CCONJ
bam-12993	132	17	control	control	NOUN
bam-12993	132	18	groups	group	NOUN
bam-12993	132	19	(	(	PUNCT
bam-12993	132	20	p=0.075	p=0.075	NOUN
bam-12993	132	21	)	)	PUNCT
bam-12993	132	22	.	.	PUNCT
bam-12993	133	1	statistical	statistical	ADJ
bam-12993	133	2	analysis	analysis	NOUN
bam-12993	133	3	of	of	ADP
bam-12993	133	4	apai	apai	NOUN
bam-12993	133	5	polymorphism	polymorphism	NOUN
bam-12993	133	6	showed	show	VERB
bam-12993	133	7	no	no	DET
bam-12993	133	8	significant	significant	ADJ
bam-12993	133	9	risk	risk	NOUN
bam-12993	133	10	increase	increase	NOUN
bam-12993	133	11	in	in	ADP
bam-12993	133	12	patients	patient	NOUN
bam-12993	133	13	with	with	ADP
bam-12993	133	14	aa	aa	NOUN
bam-12993	133	15	genotype	genotype	NOUN
bam-12993	133	16	compared	compare	VERB
bam-12993	133	17	to	to	ADP
bam-12993	133	18	the	the	DET
bam-12993	133	19	control	control	NOUN
bam-12993	133	20	group	group	NOUN
bam-12993	133	21	(	(	PUNCT
bam-12993	133	22	or=1.28	or=1.28	NOUN
bam-12993	133	23	:	:	PUNCT
bam-12993	133	24	95	95	NUM
bam-12993	133	25	%	%	NOUN
bam-12993	133	26	ci	ci	NOUN
bam-12993	133	27	;	;	PUNCT
bam-12993	133	28	0.45	0.45	NUM
bam-12993	133	29	,	,	PUNCT
bam-12993	133	30	3.62	3.62	NUM
bam-12993	133	31	)	)	PUNCT
bam-12993	133	32	.	.	PUNCT
bam-12993	134	1	the	the	DET
bam-12993	134	2	odds	odd	NOUN
bam-12993	134	3	ratio	ratio	NOUN
bam-12993	134	4	was	be	AUX
bam-12993	134	5	1.28	1.28	NUM
bam-12993	134	6	.	.	PUNCT
bam-12993	135	1	the	the	DET
bam-12993	135	2	distribution	distribution	NOUN
bam-12993	135	3	of	of	ADP
bam-12993	135	4	taqi	taqi	ADJ
bam-12993	135	5	genotype	genotype	NOUN
bam-12993	135	6	in	in	ADP
bam-12993	135	7	rrms	rrm	NOUN
bam-12993	135	8	patients	patient	NOUN
bam-12993	135	9	was	be	AUX
bam-12993	135	10	as	as	SCONJ
bam-12993	135	11	follows	follow	VERB
bam-12993	135	12	:	:	PUNCT
bam-12993	135	13	tt	tt	PROPN
bam-12993	135	14	(	(	PUNCT
bam-12993	135	15	wild	wild	ADJ
bam-12993	135	16	)	)	PUNCT
bam-12993	136	1	=	=	SYM
bam-12993	136	2	48	48	NUM
bam-12993	136	3	%	%	NOUN
bam-12993	136	4	,	,	PUNCT
bam-12993	136	5	tt	tt	PROPN
bam-12993	136	6	(	(	PUNCT
bam-12993	136	7	heterozygous	heterozygous	ADJ
bam-12993	136	8	)	)	PUNCT
bam-12993	136	9	=	=	SYM
bam-12993	136	10	40	40	NUM
bam-12993	136	11	%	%	NOUN
bam-12993	136	12	and	and	CCONJ
bam-12993	136	13	tt	tt	PROPN
bam-12993	136	14	(	(	PUNCT
bam-12993	136	15	mutant	mutant	NOUN
bam-12993	136	16	)	)	PUNCT
bam-12993	136	17	=	=	SYM
bam-12993	136	18	12	12	NUM
bam-12993	136	19	%	%	NOUN
bam-12993	136	20	;	;	PUNCT
bam-12993	136	21	in	in	ADP
bam-12993	136	22	the	the	DET
bam-12993	136	23	control	control	NOUN
bam-12993	136	24	group	group	NOUN
bam-12993	136	25	:	:	PUNCT
bam-12993	136	26	tt=33.3	tt=33.3	PROPN
bam-12993	136	27	%	%	NOUN
bam-12993	136	28	,	,	PUNCT
bam-12993	136	29	tt=33.3	tt=33.3	NOUN
bam-12993	136	30	%	%	NOUN
bam-12993	136	31	and	and	CCONJ
bam-12993	136	32	tt=33.3	tt=33.3	PRON
bam-12993	136	33	%	%	NOUN
bam-12993	136	34	.	.	PUNCT
bam-12993	137	1	no	no	DET
bam-12993	137	2	statistically	statistically	ADV
bam-12993	137	3	significant	significant	ADJ
bam-12993	137	4	difference	difference	NOUN
bam-12993	137	5	was	be	AUX
bam-12993	137	6	observed	observe	VERB
bam-12993	137	7	between	between	ADP
bam-12993	137	8	the	the	DET
bam-12993	137	9	percentage	percentage	NOUN
bam-12993	137	10	of	of	ADP
bam-12993	137	11	genotypes	genotype	NOUN
bam-12993	137	12	in	in	ADP
bam-12993	137	13	the	the	DET
bam-12993	137	14	two	two	NUM
bam-12993	137	15	test	test	NOUN
bam-12993	137	16	and	and	CCONJ
bam-12993	137	17	control	control	NOUN
bam-12993	137	18	groups	group	NOUN
bam-12993	137	19	(	(	PUNCT
bam-12993	137	20	p=0.294	p=0.294	NOUN
bam-12993	137	21	)	)	PUNCT
bam-12993	137	22	.	.	PUNCT
bam-12993	138	1	statistical	statistical	ADJ
bam-12993	138	2	analysis	analysis	NOUN
bam-12993	138	3	of	of	ADP
bam-12993	138	4	taqi	taqi	ADJ
bam-12993	138	5	polymorphism	polymorphism	NOUN
bam-12993	138	6	showed	show	VERB
bam-12993	138	7	no	no	DET
bam-12993	138	8	significant	significant	ADJ
bam-12993	138	9	increased	increase	VERB
bam-12993	138	10	risk	risk	NOUN
bam-12993	138	11	in	in	ADP
bam-12993	138	12	patients	patient	NOUN
bam-12993	138	13	with	with	ADP
bam-12993	138	14	tt	tt	PROPN
bam-12993	138	15	genotype	genotype	NOUN
bam-12993	138	16	compared	compare	VERB
bam-12993	138	17	to	to	ADP
bam-12993	138	18	controls	control	NOUN
bam-12993	138	19	(	(	PUNCT
bam-12993	138	20	or=1.89	or=1.89	NOUN
bam-12993	138	21	:	:	PUNCT
bam-12993	138	22	95	95	NUM
bam-12993	138	23	%	%	NOUN
bam-12993	138	24	ci	ci	NOUN
bam-12993	138	25	;	;	PUNCT
bam-12993	138	26	0.74	0.74	NUM
bam-12993	138	27	,	,	PUNCT
bam-12993	138	28	4.84	4.84	NUM
bam-12993	138	29	)	)	PUNCT
bam-12993	138	30	.	.	PUNCT
bam-12993	139	1	the	the	DET
bam-12993	139	2	odds	odd	NOUN
bam-12993	139	3	ratio	ratio	NOUN
bam-12993	139	4	was	be	AUX
bam-12993	139	5	1.89	1.89	NUM
bam-12993	139	6	.	.	PUNCT
bam-12993	140	1	the	the	DET
bam-12993	140	2	distribution	distribution	NOUN
bam-12993	140	3	of	of	ADP
bam-12993	140	4	bsmi	bsmi	NOUN
bam-12993	140	5	genotype	genotype	NOUN
bam-12993	140	6	in	in	ADP
bam-12993	140	7	rrms	rrm	NOUN
bam-12993	140	8	patients	patient	NOUN
bam-12993	140	9	was	be	AUX
bam-12993	140	10	as	as	SCONJ
bam-12993	140	11	follows	follow	VERB
bam-12993	140	12	:	:	PUNCT
bam-12993	140	13	bb	bb	INTJ
bam-12993	140	14	(	(	PUNCT
bam-12993	140	15	wild)=40	wild)=40	NOUN
bam-12993	140	16	%	%	NOUN
bam-12993	140	17	,	,	PUNCT
bam-12993	140	18	bb	bb	INTJ
bam-12993	140	19	(	(	PUNCT
bam-12993	140	20	heterozygous)=24	heterozygous)=24	ADJ
bam-12993	140	21	%	%	NOUN
bam-12993	140	22	and	and	CCONJ
bam-12993	140	23	bb	bb	INTJ
bam-12993	140	24	(	(	PUNCT
bam-12993	140	25	mutant)=36	mutant)=36	NOUN
bam-12993	140	26	%	%	NOUN
bam-12993	140	27	;	;	PUNCT
bam-12993	140	28	in	in	ADP
bam-12993	140	29	the	the	DET
bam-12993	140	30	control	control	NOUN
bam-12993	140	31	group	group	NOUN
bam-12993	140	32	:	:	PUNCT
bam-12993	140	33	bb=41.7	bb=41.7	NOUN
bam-12993	140	34	%	%	NOUN
bam-12993	140	35	,	,	PUNCT
bam-12993	140	36	bb=25	bb=25	PROPN
bam-12993	140	37	%	%	NOUN
bam-12993	140	38	,	,	PUNCT
bam-12993	140	39	and	and	CCONJ
bam-12993	140	40	bb=33.3	bb=33.3	PROPN
bam-12993	140	41	%	%	NOUN
bam-12993	140	42	.	.	PUNCT
bam-12993	141	1	no	no	DET
bam-12993	141	2	statistically	statistically	ADV
bam-12993	141	3	significant	significant	ADJ
bam-12993	141	4	difference	difference	NOUN
bam-12993	141	5	was	be	AUX
bam-12993	141	6	observed	observe	VERB
bam-12993	141	7	between	between	ADP
bam-12993	141	8	the	the	DET
bam-12993	141	9	percentage	percentage	NOUN
bam-12993	141	10	of	of	ADP
bam-12993	141	11	genotypes	genotype	NOUN
bam-12993	141	12	in	in	ADP
bam-12993	141	13	the	the	DET
bam-12993	141	14	two	two	NUM
bam-12993	141	15	test	test	NOUN
bam-12993	141	16	and	and	CCONJ
bam-12993	141	17	control	control	NOUN
bam-12993	141	18	groups	group	NOUN
bam-12993	141	19	(	(	PUNCT
bam-12993	141	20	p=0.987	p=0.987	X
bam-12993	141	21	)	)	PUNCT
bam-12993	141	22	.	.	PUNCT
bam-12993	142	1	statistical	statistical	ADJ
bam-12993	142	2	analysis	analysis	NOUN
bam-12993	142	3	of	of	ADP
bam-12993	142	4	bsmi	bsmi	NOUN
bam-12993	142	5	polymorphism	polymorphism	NOUN
bam-12993	142	6	showed	show	VERB
bam-12993	142	7	no	no	DET
bam-12993	142	8	significant	significant	ADJ
bam-12993	142	9	increased	increase	VERB
bam-12993	142	10	risk	risk	NOUN
bam-12993	142	11	in	in	ADP
bam-12993	142	12	patients	patient	NOUN
bam-12993	142	13	with	with	ADP
bam-12993	142	14	tt	tt	PROPN
bam-12993	142	15	genotype	genotype	NOUN
bam-12993	142	16	compared	compare	VERB
bam-12993	142	17	to	to	ADP
bam-12993	142	18	the	the	DET
bam-12993	142	19	control	control	NOUN
bam-12993	142	20	group	group	NOUN
bam-12993	142	21	(	(	PUNCT
bam-12993	142	22	or=0.94	or=0.94	ADJ
bam-12993	142	23	:	:	PUNCT
bam-12993	142	24	95	95	NUM
bam-12993	142	25	%	%	NOUN
bam-12993	142	26	ci	ci	NOUN
bam-12993	142	27	;	;	PUNCT
bam-12993	142	28	0.42	0.42	NUM
bam-12993	142	29	,	,	PUNCT
bam-12993	142	30	2.08	2.08	NUM
bam-12993	142	31	)	)	PUNCT
bam-12993	142	32	.	.	PUNCT
bam-12993	143	1	the	the	DET
bam-12993	143	2	odds	odd	NOUN
bam-12993	143	3	ratio	ratio	NOUN
bam-12993	143	4	was	be	AUX
bam-12993	143	5	0.94	0.94	NUM
bam-12993	143	6	.	.	NOUN
bam-12993	143	7	6	6	NUM
bam-12993	143	8	table	table	NOUN
bam-12993	143	9	6	6	NUM
bam-12993	143	10	.	.	PUNCT
bam-12993	143	11	determining	determine	VERB
bam-12993	143	12	the	the	DET
bam-12993	143	13	relationship	relationship	NOUN
bam-12993	143	14	between	between	ADP
bam-12993	143	15	25	25	NUM
bam-12993	143	16	-	-	PUNCT
bam-12993	143	17	hydroxyvitamin	hydroxyvitamin	NOUN
bam-12993	143	18	d	d	NOUN
bam-12993	143	19	levels	level	NOUN
bam-12993	143	20	and	and	CCONJ
bam-12993	143	21	ms	ms	NOUN
bam-12993	143	22	disease	disease	NOUN
bam-12993	143	23	progression	progression	NOUN
bam-12993	143	24	.	.	PUNCT
bam-12993	144	1	groups	group	NOUN
bam-12993	144	2	mild	mild	ADJ
bam-12993	144	3	(	(	PUNCT
bam-12993	144	4	n=7	n=7	PROPN
bam-12993	144	5	)	)	PUNCT
bam-12993	144	6	intense	intense	ADJ
bam-12993	144	7	(	(	PUNCT
bam-12993	144	8	n=18	n=18	ADJ
bam-12993	144	9	)	)	PUNCT
bam-12993	144	10	25	25	NUM
bam-12993	144	11	hydroxy	hydroxy	NOUN
bam-12993	144	12	vitamin	vitamin	NOUN
bam-12993	144	13	d	d	NOUN
bam-12993	144	14	level	level	NOUN
bam-12993	144	15	(	(	PUNCT
bam-12993	144	16	ng	ng	NOUN
bam-12993	144	17	/	/	SYM
bam-12993	144	18	ml	ml	NOUN
bam-12993	144	19	)	)	PUNCT
bam-12993	144	20	standard	standard	ADJ
bam-12993	144	21	deviation	deviation	NOUN
bam-12993	144	22	±	±	NOUN
bam-12993	144	23	mean	mean	NOUN
bam-12993	144	24	18.42	18.42	NUM
bam-12993	144	25	±	±	NUM
bam-12993	144	26	3,64	3,64	NUM
bam-12993	144	27	15.33	15.33	NUM
bam-12993	144	28	±	±	NUM
bam-12993	144	29	3.89	3.89	NUM
bam-12993	144	30	z	z	NOUN
bam-12993	144	31	-2.56	-2.56	NUM
bam-12993	144	32	p	p	ADJ
bam-12993	144	33	-	-	PUNCT
bam-12993	144	34	value	value	NOUN
bam-12993	144	35	0.010	0.010	NUM
bam-12993	144	36	table	table	NOUN
bam-12993	144	37	7	7	NUM
bam-12993	144	38	.	.	X
bam-12993	144	39	relationship	relationship	NOUN
bam-12993	144	40	between	between	ADP
bam-12993	144	41	polymorphisms	polymorphism	NOUN
bam-12993	144	42	and	and	CCONJ
bam-12993	144	43	haplotypes	haplotype	NOUN
bam-12993	144	44	of	of	ADP
bam-12993	144	45	the	the	DET
bam-12993	144	46	vdr	vdr	NOUN
bam-12993	144	47	gene	gene	NOUN
bam-12993	144	48	and	and	CCONJ
bam-12993	144	49	the	the	DET
bam-12993	144	50	odds	odd	NOUN
bam-12993	144	51	ratio	ratio	NOUN
bam-12993	144	52	of	of	ADP
bam-12993	144	53	polymorphisms	polymorphism	NOUN
bam-12993	144	54	.	.	PUNCT
bam-12993	145	1	snps	snps	PROPN
bam-12993	145	2	genotype	genotype	NOUN
bam-12993	145	3	genotypic	genotypic	NOUN
bam-12993	145	4	frequency	frequency	NOUN
bam-12993	145	5	(	(	PUNCT
bam-12993	145	6	%	%	INTJ
bam-12993	145	7	)	)	PUNCT
bam-12993	145	8	significance	significance	NOUN
bam-12993	145	9	odds	odd	NOUN
bam-12993	145	10	ratio	ratio	NOUN
bam-12993	145	11	(	(	PUNCT
bam-12993	145	12	95	95	NUM
bam-12993	145	13	%	%	NOUN
bam-12993	145	14	ci	ci	NOUN
bam-12993	145	15	)	)	PUNCT
bam-12993	145	16	rrms	rrm	NOUN
bam-12993	145	17	(	(	PUNCT
bam-12993	145	18	n=25	n=25	NOUN
bam-12993	145	19	)	)	PUNCT
bam-12993	145	20	control	control	NOUN
bam-12993	145	21	(	(	PUNCT
bam-12993	145	22	n=12	n=12	NOUN
bam-12993	145	23	)	)	PUNCT
bam-12993	145	24	foki	foki	ADJ
bam-12993	145	25	rs2228570	rs2228570	NOUN
bam-12993	145	26	ff	ff	NOUN
bam-12993	145	27	18	18	NUM
bam-12993	145	28	(	(	PUNCT
bam-12993	145	29	72	72	NUM
bam-12993	145	30	)	)	PUNCT
bam-12993	145	31	3	3	NUM
bam-12993	145	32	(	(	PUNCT
bam-12993	145	33	25	25	NUM
bam-12993	145	34	)	)	PUNCT
bam-12993	145	35	χ2=	χ2=	NOUN
bam-12993	145	36	11.96	11.96	NUM
bam-12993	145	37	7.28	7.28	NUM
bam-12993	145	38	(	(	PUNCT
bam-12993	145	39	1.86	1.86	NUM
bam-12993	145	40	,	,	PUNCT
bam-12993	145	41	28.41	28.41	NUM
bam-12993	145	42	)	)	PUNCT
bam-12993	145	43	ff	ff	NOUN
bam-12993	145	44	7	7	NUM
bam-12993	145	45	(	(	PUNCT
bam-12993	145	46	28	28	NUM
bam-12993	145	47	)	)	PUNCT
bam-12993	145	48	5	5	NUM
bam-12993	145	49	(	(	PUNCT
bam-12993	145	50	41.7	41.7	NUM
bam-12993	145	51	)	)	PUNCT
bam-12993	145	52	p=	p=	NOUN
bam-12993	145	53	0.003	0.003	NUM
bam-12993	145	54	ff	ff	NOUN
bam-12993	145	55	0	0	NUM
bam-12993	145	56	4(33.3	4(33.3	NUM
bam-12993	145	57	)	)	PUNCT
bam-12993	145	58	apai	apai	NOUN
bam-12993	145	59	rs7975232	rs7975232	NOUN
bam-12993	145	60	aa	aa	NOUN
bam-12993	145	61	10	10	NUM
bam-12993	145	62	(	(	PUNCT
bam-12993	145	63	40	40	NUM
bam-12993	145	64	)	)	PUNCT
bam-12993	145	65	6	6	NUM
bam-12993	145	66	(	(	PUNCT
bam-12993	145	67	50	50	NUM
bam-12993	145	68	)	)	PUNCT
bam-12993	145	69	χ2=5.19	χ2=5.19	NOUN
bam-12993	145	70	1.28	1.28	NUM
bam-12993	145	71	(	(	PUNCT
bam-12993	145	72	0.45	0.45	NUM
bam-12993	145	73	,	,	PUNCT
bam-12993	145	74	3.62	3.62	NUM
bam-12993	145	75	)	)	PUNCT
bam-12993	145	76	aa	aa	NOUN
bam-12993	145	77	14	14	NUM
bam-12993	145	78	(	(	PUNCT
bam-12993	145	79	56	56	NUM
bam-12993	145	80	)	)	PUNCT
bam-12993	145	81	3	3	NUM
bam-12993	145	82	(	(	PUNCT
bam-12993	145	83	25	25	NUM
bam-12993	145	84	)	)	PUNCT
bam-12993	145	85	p=0.075	p=0.075	VERB
bam-12993	145	86	aa	aa	NOUN
bam-12993	145	87	1	1	NUM
bam-12993	145	88	(	(	PUNCT
bam-12993	145	89	4	4	NUM
bam-12993	145	90	)	)	PUNCT
bam-12993	145	91	3	3	NUM
bam-12993	145	92	(	(	PUNCT
bam-12993	145	93	25	25	NUM
bam-12993	145	94	)	)	PUNCT
bam-12993	145	95	taqi	taqi	NOUN
bam-12993	145	96	rs731236	rs731236	PROPN
bam-12993	145	97	tt	tt	PROPN
bam-12993	145	98	12	12	NUM
bam-12993	145	99	(	(	PUNCT
bam-12993	145	100	48	48	NUM
bam-12993	145	101	)	)	PUNCT
bam-12993	145	102	4	4	NUM
bam-12993	145	103	(	(	PUNCT
bam-12993	145	104	33.3	33.3	NUM
bam-12993	145	105	)	)	PUNCT
bam-12993	145	106	χ2=2.44	χ2=2.44	NOUN
bam-12993	145	107	1.89	1.89	NUM
bam-12993	145	108	(	(	PUNCT
bam-12993	145	109	0.74	0.74	NUM
bam-12993	145	110	,	,	PUNCT
bam-12993	145	111	4.84	4.84	NUM
bam-12993	145	112	)	)	PUNCT
bam-12993	145	113	tt	tt	PROPN
bam-12993	145	114	10	10	NUM
bam-12993	145	115	(	(	PUNCT
bam-12993	145	116	40	40	NUM
bam-12993	145	117	)	)	PUNCT
bam-12993	145	118	4	4	NUM
bam-12993	145	119	(	(	PUNCT
bam-12993	145	120	33.3	33.3	NUM
bam-12993	145	121	)	)	PUNCT
bam-12993	145	122	p=0.294	p=0.294	NOUN
bam-12993	145	123	tt	tt	PROPN
bam-12993	145	124	3	3	NUM
bam-12993	145	125	(	(	PUNCT
bam-12993	145	126	12	12	NUM
bam-12993	145	127	)	)	PUNCT
bam-12993	145	128	4	4	NUM
bam-12993	145	129	(	(	PUNCT
bam-12993	145	130	33.3	33.3	NUM
bam-12993	145	131	)	)	PUNCT
bam-12993	145	132	bsmi	bsmi	NOUN
bam-12993	145	133	rs1544410	rs1544410	PROPN
bam-12993	146	1	bb	bb	NUM
bam-12993	146	2	10	10	NUM
bam-12993	146	3	(	(	PUNCT
bam-12993	146	4	40	40	NUM
bam-12993	146	5	)	)	SYM
bam-12993	146	6	5	5	NUM
bam-12993	146	7	(	(	PUNCT
bam-12993	146	8	41.7	41.7	NUM
bam-12993	146	9	)	)	PUNCT
bam-12993	146	10	χ2=0.025	χ2=0.025	X
bam-12993	146	11	0.94	0.94	NUM
bam-12993	146	12	(	(	PUNCT
bam-12993	146	13	0.42	0.42	NUM
bam-12993	146	14	,	,	PUNCT
bam-12993	146	15	2.08	2.08	NUM
bam-12993	146	16	)	)	PUNCT
bam-12993	146	17	bb	bb	NOUN
bam-12993	146	18	6	6	NUM
bam-12993	146	19	(	(	PUNCT
bam-12993	146	20	24	24	NUM
bam-12993	146	21	)	)	PUNCT
bam-12993	146	22	3	3	NUM
bam-12993	146	23	(	(	PUNCT
bam-12993	146	24	25	25	NUM
bam-12993	146	25	)	)	PUNCT
bam-12993	146	26	p=0.987	p=0.987	NOUN
bam-12993	146	27	bb	bb	X
bam-12993	146	28	9	9	NUM
bam-12993	146	29	(	(	PUNCT
bam-12993	146	30	36	36	NUM
bam-12993	146	31	)	)	PUNCT
bam-12993	146	32	4	4	NUM
bam-12993	146	33	(	(	PUNCT
bam-12993	146	34	33.3	33.3	NUM
bam-12993	146	35	)	)	PUNCT
bam-12993	146	36	χ2	χ2	PROPN
bam-12993	146	37	chi	chi	ADJ
bam-12993	146	38	-	-	PUNCT
bam-12993	146	39	square	square	NOUN
bam-12993	146	40	test	test	NOUN
bam-12993	146	41	;	;	PUNCT
bam-12993	146	42	p	p	X
bam-12993	146	43	,	,	PUNCT
bam-12993	146	44	p	p	NOUN
bam-12993	146	45	-	-	PUNCT
bam-12993	146	46	value	value	NOUN
bam-12993	146	47	;	;	PUNCT
bam-12993	146	48	significant	significant	ADJ
bam-12993	146	49	at	at	ADP
bam-12993	146	50	p	p	NOUN
bam-12993	146	51	≤0.05	≤0.05	NOUN
bam-12993	146	52	.	.	PUNCT
bam-12993	147	1	vitamin	vitamin	NOUN
bam-12993	147	2	d	d	NOUN
bam-12993	147	3	receptor	receptor	NOUN
bam-12993	147	4	gene	gene	NOUN
bam-12993	147	5	polymorphisms	polymorphism	NOUN
bam-12993	147	6	in	in	ADP
bam-12993	147	7	patients	patient	NOUN
bam-12993	147	8	with	with	ADP
bam-12993	147	9	relapsing	relapse	VERB
bam-12993	147	10	multiple	multiple	ADJ
bam-12993	147	11	sclerosis	sclerosis	NOUN
bam-12993	147	12	eur	eur	PROPN
bam-12993	147	13	j	j	PROPN
bam-12993	147	14	transl	transl	PROPN
bam-12993	147	15	myol	myol	ADV
bam-12993	147	16	35	35	NUM
bam-12993	147	17	(	(	PUNCT
bam-12993	147	18	1	1	NUM
bam-12993	147	19	)	)	PUNCT
bam-12993	147	20	12993	12993	NUM
bam-12993	147	21	,	,	PUNCT
bam-12993	147	22	2025	2025	NUM
bam-12993	147	23	doi	doi	NOUN
bam-12993	147	24	:	:	PUNCT
bam-12993	147	25	10.4081	10.4081	NUM
bam-12993	147	26	/	/	SYM
bam-12993	147	27	ejtm.2024.12993	ejtm.2024.12993	NOUN
bam-12993	147	28	discussion	discussion	NOUN
bam-12993	147	29	in	in	ADP
bam-12993	147	30	the	the	DET
bam-12993	147	31	present	present	ADJ
bam-12993	147	32	study	study	NOUN
bam-12993	147	33	,	,	PUNCT
bam-12993	147	34	a	a	DET
bam-12993	147	35	statistically	statistically	ADV
bam-12993	147	36	significant	significant	ADJ
bam-12993	147	37	difference	difference	NOUN
bam-12993	147	38	was	be	AUX
bam-12993	147	39	observed	observe	VERB
bam-12993	147	40	between	between	ADP
bam-12993	147	41	the	the	DET
bam-12993	147	42	percentage	percentage	NOUN
bam-12993	147	43	of	of	ADP
bam-12993	147	44	foki	foki	ADJ
bam-12993	147	45	genotypes	genotype	NOUN
bam-12993	147	46	in	in	ADP
bam-12993	147	47	rrms	rrm	NOUN
bam-12993	147	48	patients	patient	NOUN
bam-12993	147	49	and	and	CCONJ
bam-12993	147	50	healthy	healthy	ADJ
bam-12993	147	51	individuals	individual	NOUN
bam-12993	147	52	.	.	PUNCT
bam-12993	148	1	foki	foki	ADJ
bam-12993	148	2	polymorphism	polymorphism	NOUN
bam-12993	148	3	showed	show	VERB
bam-12993	148	4	a	a	DET
bam-12993	148	5	significantly	significantly	ADV
bam-12993	148	6	increased	increase	VERB
bam-12993	148	7	risk	risk	NOUN
bam-12993	148	8	with	with	ADP
bam-12993	148	9	an	an	DET
bam-12993	148	10	odds	odd	NOUN
bam-12993	148	11	ratio	ratio	NOUN
bam-12993	148	12	of	of	ADP
bam-12993	148	13	7.28	7.28	NUM
bam-12993	148	14	in	in	ADP
bam-12993	148	15	patients	patient	NOUN
bam-12993	148	16	with	with	ADP
bam-12993	148	17	the	the	DET
bam-12993	148	18	ff	ff	NOUN
bam-12993	148	19	genotype	genotype	NOUN
bam-12993	148	20	compared	compare	VERB
bam-12993	148	21	to	to	ADP
bam-12993	148	22	healthy	healthy	ADJ
bam-12993	148	23	individuals	individual	NOUN
bam-12993	148	24	.	.	PUNCT
bam-12993	149	1	apai	apai	NOUN
bam-12993	149	2	,	,	PUNCT
bam-12993	149	3	taqi	taqi	NOUN
bam-12993	149	4	,	,	PUNCT
bam-12993	149	5	and	and	CCONJ
bam-12993	149	6	bsmi	bsmi	NOUN
bam-12993	149	7	were	be	AUX
bam-12993	149	8	not	not	PART
bam-12993	149	9	significantly	significantly	ADV
bam-12993	149	10	different	different	ADJ
bam-12993	149	11	between	between	ADP
bam-12993	149	12	the	the	DET
bam-12993	149	13	two	two	NUM
bam-12993	149	14	groups	group	NOUN
bam-12993	149	15	.	.	PUNCT
bam-12993	150	1	in	in	ADP
bam-12993	150	2	previous	previous	ADJ
bam-12993	150	3	studies	study	NOUN
bam-12993	150	4	,	,	PUNCT
bam-12993	150	5	the	the	DET
bam-12993	150	6	association	association	NOUN
bam-12993	150	7	between	between	ADP
bam-12993	150	8	vdr	vdr	NOUN
bam-12993	150	9	gene	gene	NOUN
bam-12993	150	10	polymorphisms	polymorphism	NOUN
bam-12993	150	11	and	and	CCONJ
bam-12993	150	12	ms	ms	NOUN
bam-12993	150	13	was	be	AUX
bam-12993	150	14	investigated	investigate	VERB
bam-12993	150	15	in	in	ADP
bam-12993	150	16	several	several	ADJ
bam-12993	150	17	populations.15	populations.15	NOUN
bam-12993	150	18	-	-	PUNCT
bam-12993	150	19	17	17	NUM
bam-12993	150	20	the	the	DET
bam-12993	150	21	results	result	NOUN
bam-12993	150	22	of	of	ADP
bam-12993	150	23	the	the	DET
bam-12993	150	24	present	present	ADJ
bam-12993	150	25	study	study	NOUN
bam-12993	150	26	are	be	AUX
bam-12993	150	27	consistent	consistent	ADJ
bam-12993	150	28	with	with	ADP
bam-12993	150	29	some	some	DET
bam-12993	150	30	studies	study	NOUN
bam-12993	150	31	conducted	conduct	VERB
bam-12993	150	32	on	on	ADP
bam-12993	150	33	different	different	ADJ
bam-12993	150	34	populations	population	NOUN
bam-12993	150	35	.	.	PUNCT
bam-12993	151	1	a	a	DET
bam-12993	151	2	study	study	NOUN
bam-12993	151	3	in	in	ADP
bam-12993	151	4	iran	iran	PROPN
bam-12993	151	5	found	find	VERB
bam-12993	151	6	a	a	DET
bam-12993	151	7	big	big	ADJ
bam-12993	151	8	difference	difference	NOUN
bam-12993	151	9	in	in	ADP
bam-12993	151	10	the	the	DET
bam-12993	151	11	types	type	NOUN
bam-12993	151	12	of	of	ADP
bam-12993	151	13	genes	gene	NOUN
bam-12993	151	14	found	find	VERB
bam-12993	151	15	in	in	ADP
bam-12993	151	16	ms	ms	ADJ
bam-12993	151	17	patients	patient	NOUN
bam-12993	151	18	and	and	CCONJ
bam-12993	151	19	healthy	healthy	ADJ
bam-12993	151	20	people	people	NOUN
bam-12993	151	21	when	when	SCONJ
bam-12993	151	22	it	it	PRON
bam-12993	151	23	comes	come	VERB
bam-12993	151	24	to	to	ADP
bam-12993	151	25	polymorphism	polymorphism	NOUN
bam-12993	151	26	and	and	CCONJ
bam-12993	151	27	allelic	allelic	ADJ
bam-12993	151	28	frequency	frequency	NOUN
bam-12993	151	29	for	for	ADP
bam-12993	151	30	apai	apai	NOUN
bam-12993	151	31	,	,	PUNCT
bam-12993	151	32	bsmi	bsmi	NOUN
bam-12993	151	33	,	,	PUNCT
bam-12993	151	34	and	and	CCONJ
bam-12993	151	35	taqi.18	taqi.18	SCONJ
bam-12993	151	36	a	a	DET
bam-12993	151	37	japanese	japanese	ADJ
bam-12993	151	38	group	group	NOUN
bam-12993	151	39	found	find	VERB
bam-12993	151	40	an	an	DET
bam-12993	151	41	increased	increase	VERB
bam-12993	151	42	frequency	frequency	NOUN
bam-12993	151	43	of	of	ADP
bam-12993	151	44	the	the	DET
bam-12993	151	45	apai	apai	NOUN
bam-12993	151	46	aa	aa	NOUN
bam-12993	151	47	genotype	genotype	NOUN
bam-12993	151	48	and	and	CCONJ
bam-12993	151	49	a	a	DET
bam-12993	151	50	allele	allele	NOUN
bam-12993	151	51	in	in	ADP
bam-12993	151	52	ms.18	ms.18	PROPN
bam-12993	151	53	sioka	sioka	PROPN
bam-12993	151	54	et	et	PROPN
bam-12993	151	55	al	al	PROPN
bam-12993	151	56	.	.	PROPN
bam-12993	151	57	showed	show	VERB
bam-12993	151	58	no	no	DET
bam-12993	151	59	association	association	NOUN
bam-12993	151	60	between	between	ADP
bam-12993	151	61	apai	apai	NOUN
bam-12993	151	62	,	,	PUNCT
bam-12993	151	63	bsmi	bsmi	NOUN
bam-12993	151	64	,	,	PUNCT
bam-12993	151	65	and	and	CCONJ
bam-12993	151	66	taqi	taqi	ADJ
bam-12993	151	67	polymorphisms	polymorphism	NOUN
bam-12993	151	68	of	of	ADP
bam-12993	151	69	the	the	DET
bam-12993	151	70	vdr	vdr	NOUN
bam-12993	151	71	gene.19	gene.19	VERB
bam-12993	151	72	the	the	DET
bam-12993	151	73	results	result	NOUN
bam-12993	151	74	of	of	ADP
bam-12993	151	75	our	our	PRON
bam-12993	151	76	study	study	NOUN
bam-12993	151	77	are	be	AUX
bam-12993	151	78	consistent	consistent	ADJ
bam-12993	151	79	with	with	ADP
bam-12993	151	80	those	those	PRON
bam-12993	151	81	found	find	VERB
bam-12993	151	82	by	by	ADP
bam-12993	151	83	sioka	sioka	NOUN
bam-12993	151	84	et	et	NOUN
bam-12993	151	85	al.19	al.19	ADV
bam-12993	151	86	previous	previous	ADJ
bam-12993	151	87	epidemiological	epidemiological	ADJ
bam-12993	151	88	and	and	CCONJ
bam-12993	151	89	biological	biological	ADJ
bam-12993	151	90	evidence	evidence	NOUN
bam-12993	151	91	has	have	AUX
bam-12993	151	92	supported	support	VERB
bam-12993	151	93	the	the	DET
bam-12993	151	94	protective	protective	ADJ
bam-12993	151	95	effect	effect	NOUN
bam-12993	151	96	of	of	ADP
bam-12993	151	97	vitamin	vitamin	NOUN
bam-12993	151	98	d	d	NOUN
bam-12993	151	99	on	on	ADP
bam-12993	151	100	the	the	DET
bam-12993	151	101	underlying	underlie	VERB
bam-12993	151	102	disease	disease	NOUN
bam-12993	151	103	course	course	NOUN
bam-12993	151	104	of	of	ADP
bam-12993	151	105	ms.20,21	ms.20,21	VERB
bam-12993	151	106	the	the	DET
bam-12993	151	107	present	present	ADJ
bam-12993	151	108	study	study	NOUN
bam-12993	151	109	’s	’s	PART
bam-12993	151	110	findings	finding	NOUN
bam-12993	151	111	revealed	reveal	VERB
bam-12993	151	112	low	low	ADJ
bam-12993	151	113	serum	serum	NOUN
bam-12993	151	114	levels	level	NOUN
bam-12993	151	115	of	of	ADP
bam-12993	151	116	25	25	NUM
bam-12993	151	117	-	-	PUNCT
bam-12993	151	118	hydroxyvitamin	hydroxyvitamin	NOUN
bam-12993	151	119	d	d	NOUN
bam-12993	151	120	in	in	ADP
bam-12993	151	121	ms	ms	ADJ
bam-12993	151	122	patients	patient	NOUN
bam-12993	151	123	.	.	PUNCT
bam-12993	152	1	patients	patient	NOUN
bam-12993	152	2	with	with	ADP
bam-12993	152	3	ms	ms	PROPN
bam-12993	152	4	had	have	VERB
bam-12993	152	5	a	a	DET
bam-12993	152	6	significantly	significantly	ADV
bam-12993	152	7	lower	low	ADJ
bam-12993	152	8	mean	mean	NOUN
bam-12993	152	9	serum	serum	NOUN
bam-12993	152	10	level	level	NOUN
bam-12993	152	11	of	of	ADP
bam-12993	152	12	25	25	NUM
bam-12993	152	13	-	-	PUNCT
bam-12993	152	14	hydroxyvitamin	hydroxyvitamin	NOUN
bam-12993	152	15	d	d	NOUN
bam-12993	152	16	than	than	ADP
bam-12993	152	17	healthy	healthy	ADJ
bam-12993	152	18	individuals	individual	NOUN
bam-12993	152	19	,	,	PUNCT
bam-12993	152	20	which	which	PRON
bam-12993	152	21	was	be	AUX
bam-12993	152	22	considered	consider	VERB
bam-12993	152	23	statistically	statistically	ADV
bam-12993	152	24	significant	significant	ADJ
bam-12993	152	25	.	.	PUNCT
bam-12993	153	1	the	the	DET
bam-12993	153	2	present	present	ADJ
bam-12993	153	3	study	study	NOUN
bam-12993	153	4	observed	observe	VERB
bam-12993	153	5	a	a	DET
bam-12993	153	6	statistically	statistically	ADV
bam-12993	153	7	significant	significant	ADJ
bam-12993	153	8	relationship	relationship	NOUN
bam-12993	153	9	between	between	ADP
bam-12993	153	10	low	low	ADJ
bam-12993	153	11	serum	serum	NOUN
bam-12993	153	12	levels	level	NOUN
bam-12993	153	13	of	of	ADP
bam-12993	153	14	25	25	NUM
bam-12993	153	15	-	-	PUNCT
bam-12993	153	16	hydroxyvitamin	hydroxyvitamin	NOUN
bam-12993	153	17	d	d	NOUN
bam-12993	153	18	and	and	CCONJ
bam-12993	153	19	the	the	DET
bam-12993	153	20	progression	progression	NOUN
bam-12993	153	21	of	of	ADP
bam-12993	153	22	ms	ms	PROPN
bam-12993	153	23	.	.	PROPN
bam-12993	153	24	fitzgerald	fitzgerald	PROPN
bam-12993	153	25	et	et	PROPN
bam-12993	153	26	al	al	PROPN
bam-12993	153	27	.	.	PROPN
bam-12993	153	28	also	also	ADV
bam-12993	153	29	linked	link	VERB
bam-12993	153	30	low	low	ADJ
bam-12993	153	31	levels	level	NOUN
bam-12993	153	32	of	of	ADP
bam-12993	153	33	25	25	NUM
bam-12993	153	34	-	-	PUNCT
bam-12993	153	35	hydroxyvitamin	hydroxyvitamin	NOUN
bam-12993	153	36	d	d	NOUN
bam-12993	153	37	in	in	ADP
bam-12993	153	38	the	the	DET
bam-12993	153	39	blood	blood	NOUN
bam-12993	153	40	to	to	ADP
bam-12993	153	41	a	a	DET
bam-12993	153	42	higher	high	ADJ
bam-12993	153	43	risk	risk	NOUN
bam-12993	153	44	of	of	ADP
bam-12993	153	45	ms	ms	PROPN
bam-12993	153	46	,	,	PUNCT
bam-12993	153	47	higher	high	ADJ
bam-12993	153	48	disease	disease	NOUN
bam-12993	153	49	activity	activity	NOUN
bam-12993	153	50	,	,	PUNCT
bam-12993	153	51	and	and	CCONJ
bam-12993	153	52	a	a	DET
bam-12993	153	53	faster	fast	ADJ
bam-12993	153	54	rate	rate	NOUN
bam-12993	153	55	of	of	ADP
bam-12993	153	56	progression	progression	NOUN
bam-12993	153	57	in	in	ADP
bam-12993	153	58	early	early	ADJ
bam-12993	153	59	ms	ms	NOUN
bam-12993	153	60	and	and	CCONJ
bam-12993	153	61	clinically	clinically	ADV
bam-12993	153	62	isolated	isolate	VERB
bam-12993	153	63	syndromes	syndrome	NOUN
bam-12993	153	64	,	,	PUNCT
bam-12993	153	65	in	in	ADP
bam-12993	153	66	line	line	NOUN
bam-12993	153	67	with	with	ADP
bam-12993	153	68	the	the	DET
bam-12993	153	69	findings	finding	NOUN
bam-12993	153	70	of	of	ADP
bam-12993	153	71	this	this	DET
bam-12993	153	72	study.22	study.22	NOUN
bam-12993	153	73	similarly	similarly	ADV
bam-12993	153	74	,	,	PUNCT
bam-12993	153	75	the	the	DET
bam-12993	153	76	present	present	ADJ
bam-12993	153	77	study	study	NOUN
bam-12993	153	78	observed	observe	VERB
bam-12993	153	79	a	a	DET
bam-12993	153	80	significant	significant	ADJ
bam-12993	153	81	association	association	NOUN
bam-12993	153	82	between	between	ADP
bam-12993	153	83	low	low	ADJ
bam-12993	153	84	levels	level	NOUN
bam-12993	153	85	of	of	ADP
bam-12993	153	86	25	25	NUM
bam-12993	153	87	-	-	PUNCT
bam-12993	153	88	hydroxyvitamin	hydroxyvitamin	NOUN
bam-12993	153	89	d	d	NOUN
bam-12993	153	90	and	and	CCONJ
bam-12993	153	91	increased	increase	VERB
bam-12993	153	92	disease	disease	NOUN
bam-12993	153	93	activity	activity	NOUN
bam-12993	153	94	,	,	PUNCT
bam-12993	153	95	as	as	SCONJ
bam-12993	153	96	measured	measure	VERB
bam-12993	153	97	by	by	ADP
bam-12993	153	98	the	the	DET
bam-12993	153	99	edss	edss	ADJ
bam-12993	153	100	score	score	NOUN
bam-12993	153	101	.	.	PUNCT
bam-12993	154	1	although	although	SCONJ
bam-12993	154	2	mowry	mowry	PROPN
bam-12993	154	3	et	et	PROPN
bam-12993	154	4	al	al	PROPN
bam-12993	154	5	.	.	PROPN
bam-12993	154	6	reported	report	VERB
bam-12993	154	7	that	that	SCONJ
bam-12993	154	8	vitamin	vitamin	NOUN
bam-12993	154	9	d	d	NOUN
bam-12993	154	10	levels	level	NOUN
bam-12993	154	11	were	be	AUX
bam-12993	154	12	inversely	inversely	ADV
bam-12993	154	13	associated	associate	VERB
bam-12993	154	14	with	with	ADP
bam-12993	154	15	ms	ms	NOUN
bam-12993	154	16	activity	activity	NOUN
bam-12993	154	17	on	on	ADP
bam-12993	154	18	brain	brain	NOUN
bam-12993	154	19	mri.23	mri.23	NOUN
bam-12993	154	20	another	another	DET
bam-12993	154	21	study	study	NOUN
bam-12993	154	22	reported	report	VERB
bam-12993	154	23	that	that	SCONJ
bam-12993	154	24	there	there	PRON
bam-12993	154	25	is	be	VERB
bam-12993	154	26	no	no	DET
bam-12993	154	27	relationship	relationship	NOUN
bam-12993	154	28	between	between	ADP
bam-12993	154	29	25	25	NUM
bam-12993	154	30	-	-	PUNCT
bam-12993	154	31	hydroxyvitamin	hydroxyvitamin	NOUN
bam-12993	154	32	d	d	NOUN
bam-12993	154	33	levels	level	NOUN
bam-12993	154	34	and	and	CCONJ
bam-12993	154	35	disability	disability	NOUN
bam-12993	154	36	scores	score	NOUN
bam-12993	154	37	in	in	ADP
bam-12993	154	38	ms	ms	ADJ
bam-12993	154	39	patients	patient	NOUN
bam-12993	154	40	in	in	ADP
bam-12993	154	41	iran.24	iran.24	NOUN
bam-12993	154	42	however	however	ADV
bam-12993	154	43	,	,	PUNCT
bam-12993	154	44	the	the	DET
bam-12993	154	45	study	study	NOUN
bam-12993	154	46	by	by	ADP
bam-12993	154	47	zhang	zhang	PROPN
bam-12993	154	48	et	et	PROPN
bam-12993	154	49	al	al	PROPN
bam-12993	154	50	.	.	PROPN
bam-12993	155	1	in	in	ADP
bam-12993	155	2	china	china	PROPN
bam-12993	155	3	reported	report	VERB
bam-12993	155	4	the	the	DET
bam-12993	155	5	same	same	ADJ
bam-12993	155	6	findings	finding	NOUN
bam-12993	155	7	as	as	SCONJ
bam-12993	155	8	the	the	DET
bam-12993	155	9	present	present	ADJ
bam-12993	155	10	study.25	study.25	PROPN
bam-12993	155	11	sutherland	sutherland	PROPN
bam-12993	155	12	et	et	PROPN
bam-12993	155	13	al	al	PROPN
bam-12993	155	14	.	.	PROPN
bam-12993	155	15	illustrated	illustrate	VERB
bam-12993	155	16	that	that	SCONJ
bam-12993	155	17	vitamin	vitamin	NOUN
bam-12993	155	18	d	d	NOUN
bam-12993	155	19	deficiency	deficiency	NOUN
bam-12993	155	20	is	be	AUX
bam-12993	155	21	common	common	ADJ
bam-12993	155	22	in	in	ADP
bam-12993	155	23	ms	ms	ADJ
bam-12993	155	24	patients	patient	NOUN
bam-12993	155	25	,	,	PUNCT
bam-12993	155	26	affecting	affect	VERB
bam-12993	155	27	approximately	approximately	ADV
bam-12993	155	28	50	50	NUM
bam-12993	155	29	%	%	NOUN
bam-12993	155	30	of	of	ADP
bam-12993	155	31	ms	ms	NOUN
bam-12993	155	32	patients	patient	NOUN
bam-12993	155	33	in	in	ADP
bam-12993	155	34	europe	europe	PROPN
bam-12993	155	35	and	and	CCONJ
bam-12993	155	36	77	77	NUM
bam-12993	155	37	%	%	NOUN
bam-12993	155	38	in	in	ADP
bam-12993	155	39	african	african	ADJ
bam-12993	155	40	americans.26	americans.26	PROPN
bam-12993	155	41	dong	dong	PROPN
bam-12993	155	42	et	et	PROPN
bam-12993	155	43	al	al	PROPN
bam-12993	155	44	.	.	PROPN
bam-12993	155	45	reported	report	VERB
bam-12993	155	46	that	that	SCONJ
bam-12993	155	47	76	76	NUM
bam-12993	155	48	%	%	NOUN
bam-12993	155	49	of	of	ADP
bam-12993	155	50	kuwaiti	kuwaiti	PROPN
bam-12993	155	51	ms	ms	PROPN
bam-12993	155	52	patients	patient	NOUN
bam-12993	155	53	were	be	AUX
bam-12993	155	54	vitamin	vitamin	NOUN
bam-12993	155	55	d	d	X
bam-12993	155	56	deficient.27	deficient.27	PROPN
bam-12993	155	57	similarly	similarly	ADV
bam-12993	155	58	,	,	PUNCT
bam-12993	155	59	braidy	braidy	VERB
bam-12993	155	60	et	et	PROPN
bam-12993	155	61	al	al	PROPN
bam-12993	155	62	.	.	PROPN
bam-12993	156	1	in	in	ADP
bam-12993	156	2	their	their	PRON
bam-12993	156	3	study	study	NOUN
bam-12993	156	4	showed	show	VERB
bam-12993	156	5	that	that	SCONJ
bam-12993	156	6	,	,	PUNCT
bam-12993	156	7	more	more	ADJ
bam-12993	156	8	than	than	ADP
bam-12993	156	9	half	half	NOUN
bam-12993	156	10	of	of	ADP
bam-12993	156	11	the	the	DET
bam-12993	156	12	ms	ms	PROPN
bam-12993	156	13	patients	patient	NOUN
bam-12993	156	14	had	have	VERB
bam-12993	156	15	vitamin	vitamin	NOUN
bam-12993	156	16	d	d	X
bam-12993	156	17	deficiency.28	deficiency.28	NOUN
bam-12993	156	18	in	in	ADP
bam-12993	156	19	addition	addition	NOUN
bam-12993	156	20	,	,	PUNCT
bam-12993	156	21	the	the	DET
bam-12993	156	22	serum	serum	NOUN
bam-12993	156	23	level	level	NOUN
bam-12993	156	24	of	of	ADP
bam-12993	156	25	25(oh	25(oh	NOUN
bam-12993	156	26	)	)	PUNCT
bam-12993	156	27	d	d	NOUN
bam-12993	156	28	was	be	AUX
bam-12993	156	29	lower	low	ADJ
bam-12993	156	30	in	in	ADP
bam-12993	156	31	ms	ms	ADJ
bam-12993	156	32	patients	patient	NOUN
bam-12993	156	33	compared	compare	VERB
bam-12993	156	34	to	to	ADP
bam-12993	156	35	the	the	DET
bam-12993	156	36	control	control	NOUN
bam-12993	156	37	group	group	NOUN
bam-12993	156	38	.	.	PUNCT
bam-12993	157	1	according	accord	VERB
bam-12993	157	2	to	to	ADP
bam-12993	157	3	beecham	beecham	PROPN
bam-12993	157	4	et	et	PROPN
bam-12993	157	5	al	al	PROPN
bam-12993	157	6	.	.	PROPN
bam-12993	157	7	study	study	PROPN
bam-12993	157	8	serum	serum	NOUN
bam-12993	157	9	vitamin	vitamin	PROPN
bam-12993	157	10	d	d	PROPN
bam-12993	157	11	levels	level	NOUN
bam-12993	157	12	were	be	AUX
bam-12993	157	13	low	low	ADJ
bam-12993	157	14	in	in	ADP
bam-12993	157	15	japanese	japanese	ADJ
bam-12993	157	16	ms	ms	PROPN
bam-12993	157	17	patients.29	patients.29	PROPN
bam-12993	157	18	al	al	PROPN
bam-12993	157	19	-	-	PUNCT
bam-12993	157	20	temaimi	temaimi	PROPN
bam-12993	157	21	et	et	PROPN
bam-12993	157	22	al	al	PROPN
bam-12993	157	23	.	.	PROPN
bam-12993	157	24	found	find	VERB
bam-12993	157	25	that	that	SCONJ
bam-12993	157	26	there	there	PRON
bam-12993	157	27	was	be	VERB
bam-12993	157	28	no	no	DET
bam-12993	157	29	significant	significant	ADJ
bam-12993	157	30	difference	difference	NOUN
bam-12993	157	31	in	in	ADP
bam-12993	157	32	vitamin	vitamin	NOUN
bam-12993	157	33	d	d	NOUN
bam-12993	157	34	levels	level	NOUN
bam-12993	157	35	between	between	ADP
bam-12993	157	36	ms	ms	NOUN
bam-12993	157	37	and	and	CCONJ
bam-12993	157	38	healthy	healthy	ADJ
bam-12993	157	39	subjects	subject	NOUN
bam-12993	157	40	.	.	PUNCT
bam-12993	158	1	in	in	ADP
bam-12993	158	2	this	this	DET
bam-12993	158	3	study	study	NOUN
bam-12993	158	4	,	,	PUNCT
bam-12993	158	5	the	the	DET
bam-12993	158	6	small	small	ADJ
bam-12993	158	7	sample	sample	NOUN
bam-12993	158	8	(	(	PUNCT
bam-12993	158	9	n=50	n=50	ADJ
bam-12993	158	10	)	)	PUNCT
bam-12993	158	11	and	and	CCONJ
bam-12993	158	12	the	the	DET
bam-12993	158	13	high	high	ADJ
bam-12993	158	14	rate	rate	NOUN
bam-12993	158	15	of	of	ADP
bam-12993	158	16	vitamin	vitamin	NOUN
bam-12993	158	17	d	d	NOUN
bam-12993	158	18	deficiency	deficiency	NOUN
bam-12993	158	19	(	(	PUNCT
bam-12993	158	20	82	82	NUM
bam-12993	158	21	%	%	NOUN
bam-12993	158	22	)	)	PUNCT
bam-12993	158	23	in	in	ADP
bam-12993	158	24	the	the	DET
bam-12993	158	25	control	control	NOUN
bam-12993	158	26	group	group	NOUN
bam-12993	158	27	should	should	AUX
bam-12993	158	28	be	be	AUX
bam-12993	158	29	considered.30	considered.30	PROPN
bam-12993	158	30	niino	niino	PROPN
bam-12993	158	31	et	et	PROPN
bam-12993	158	32	al	al	PROPN
bam-12993	158	33	.	.	PROPN
bam-12993	158	34	showed	show	VERB
bam-12993	158	35	that	that	SCONJ
bam-12993	158	36	the	the	DET
bam-12993	158	37	serum	serum	NOUN
bam-12993	158	38	level	level	NOUN
bam-12993	158	39	of	of	ADP
bam-12993	158	40	25(oh	25(oh	NOUN
bam-12993	158	41	)	)	PUNCT
bam-12993	158	42	d	d	NOUN
bam-12993	158	43	was	be	AUX
bam-12993	158	44	higher	high	ADJ
bam-12993	158	45	in	in	ADP
bam-12993	158	46	ms	ms	NOUN
bam-12993	158	47	than	than	ADP
bam-12993	158	48	in	in	ADP
bam-12993	158	49	the	the	DET
bam-12993	158	50	control	control	NOUN
bam-12993	158	51	group	group	NOUN
bam-12993	158	52	(	(	PUNCT
bam-12993	158	53	healthy	healthy	ADJ
bam-12993	158	54	subjects).31	subjects).31	PROPN
bam-12993	158	55	vickaryous	vickaryous	PROPN
bam-12993	158	56	et	et	PROPN
bam-12993	158	57	al	al	PROPN
bam-12993	158	58	.	.	PROPN
bam-12993	158	59	illustrated	illustrate	VERB
bam-12993	158	60	that	that	SCONJ
bam-12993	158	61	population	population	NOUN
bam-12993	158	62	-	-	PUNCT
bam-12993	158	63	based	base	VERB
bam-12993	158	64	prospective	prospective	ADJ
bam-12993	158	65	cohort	cohort	NOUN
bam-12993	158	66	study	study	NOUN
bam-12993	158	67	of	of	ADP
bam-12993	158	68	145	145	NUM
bam-12993	158	69	people	people	NOUN
bam-12993	158	70	with	with	ADP
bam-12993	158	71	rrms	rrm	NOUN
bam-12993	158	72	living	live	VERB
bam-12993	158	73	in	in	ADP
bam-12993	158	74	southern	southern	ADJ
bam-12993	158	75	tasmania	tasmania	PROPN
bam-12993	158	76	and	and	CCONJ
bam-12993	158	77	australia	australia	PROPN
bam-12993	158	78	from	from	ADP
bam-12993	158	79	2002	2002	NUM
bam-12993	158	80	to	to	ADP
bam-12993	158	81	2005	2005	NUM
bam-12993	158	82	found	find	VERB
bam-12993	158	83	that	that	SCONJ
bam-12993	158	84	higher	high	ADJ
bam-12993	158	85	25(oh	25(oh	NOUN
bam-12993	158	86	)	)	PUNCT
bam-12993	158	87	d	d	NOUN
bam-12993	158	88	levels	level	NOUN
bam-12993	158	89	were	be	AUX
bam-12993	158	90	associated	associate	VERB
bam-12993	158	91	with	with	ADP
bam-12993	158	92	a	a	DET
bam-12993	158	93	reduced	reduced	ADJ
bam-12993	158	94	risk	risk	NOUN
bam-12993	158	95	of	of	ADP
bam-12993	158	96	relapse.32	relapse.32	PROPN
bam-12993	158	97	wasnik	wasnik	PROPN
bam-12993	158	98	et	et	PROPN
bam-12993	158	99	al	al	PROPN
bam-12993	158	100	.	.	PROPN
bam-12993	158	101	showed	show	VERB
bam-12993	158	102	that	that	SCONJ
bam-12993	158	103	every	every	DET
bam-12993	158	104	10	10	NUM
bam-12993	158	105	nmol	nmol	NOUN
bam-12993	158	106	/	/	SYM
bam-12993	158	107	l	l	NOUN
bam-12993	158	108	increase	increase	NOUN
bam-12993	158	109	in	in	ADP
bam-12993	158	110	25(oh	25(oh	NOUN
bam-12993	158	111	)	)	PUNCT
bam-12993	158	112	d	d	NOUN
bam-12993	158	113	results	result	VERB
bam-12993	158	114	in	in	ADP
bam-12993	158	115	a	a	DET
bam-12993	158	116	12	12	NUM
bam-12993	158	117	%	%	NOUN
bam-12993	158	118	reduction	reduction	NOUN
bam-12993	158	119	in	in	ADP
bam-12993	158	120	the	the	DET
bam-12993	158	121	risk	risk	NOUN
bam-12993	158	122	of	of	ADP
bam-12993	158	123	recurrence	recurrence	NOUN
bam-12993	158	124	.	.	PUNCT
bam-12993	159	1	the	the	DET
bam-12993	159	2	radiological	radiological	ADJ
bam-12993	159	3	signs	sign	NOUN
bam-12993	159	4	of	of	ADP
bam-12993	159	5	ms	ms	NOUN
bam-12993	159	6	disease	disease	NOUN
bam-12993	159	7	activity	activity	NOUN
bam-12993	159	8	also	also	ADV
bam-12993	159	9	correlate	correlate	VERB
bam-12993	159	10	with	with	ADP
bam-12993	159	11	these	these	DET
bam-12993	159	12	clinical	clinical	ADJ
bam-12993	159	13	findings.4	findings.4	NOUN
bam-12993	159	14	according	accord	VERB
bam-12993	159	15	to	to	ADP
bam-12993	159	16	simpson	simpson	PROPN
bam-12993	159	17	jr	jr	PROPN
bam-12993	159	18	.	.	PROPN
bam-12993	159	19	et	et	PROPN
bam-12993	160	1	al	al	PROPN
bam-12993	160	2	.	.	PROPN
bam-12993	160	3	results	result	VERB
bam-12993	160	4	from	from	ADP
bam-12993	160	5	a	a	DET
bam-12993	160	6	prospective	prospective	ADJ
bam-12993	160	7	cohort	cohort	NOUN
bam-12993	160	8	study	study	NOUN
bam-12993	160	9	of	of	ADP
bam-12993	160	10	1,482	1,482	NUM
bam-12993	160	11	ms	ms	ADJ
bam-12993	160	12	patients	patient	NOUN
bam-12993	160	13	in	in	ADP
bam-12993	160	14	the	the	DET
bam-12993	160	15	beyond	beyond	ADJ
bam-12993	160	16	study	study	NOUN
bam-12993	160	17	who	who	PRON
bam-12993	160	18	were	be	AUX
bam-12993	160	19	administered	administer	VERB
bam-12993	160	20	interferon	interferon	ADJ
bam-12993	160	21	beta	beta	PROPN
bam-12993	160	22	1b	1b	NUM
bam-12993	160	23	found	find	VERB
bam-12993	160	24	that	that	SCONJ
bam-12993	160	25	a	a	DET
bam-12993	160	26	50.0	50.0	NUM
bam-12993	160	27	nmol	nmol	NOUN
bam-12993	160	28	/	/	SYM
bam-12993	160	29	l	l	NOUN
bam-12993	160	30	increase	increase	NOUN
bam-12993	160	31	in	in	ADP
bam-12993	160	32	blood	blood	NOUN
bam-12993	160	33	25(oh)d	25(oh)d	NUM
bam-12993	160	34	levels	level	NOUN
bam-12993	160	35	was	be	AUX
bam-12993	160	36	associated	associate	VERB
bam-12993	160	37	with	with	ADP
bam-12993	160	38	a	a	DET
bam-12993	160	39	31	31	NUM
bam-12993	160	40	%	%	NOUN
bam-12993	160	41	was	be	AUX
bam-12993	160	42	associated	associate	VERB
bam-12993	160	43	with	with	ADP
bam-12993	160	44	a	a	DET
bam-12993	160	45	lower	low	ADJ
bam-12993	160	46	rate	rate	NOUN
bam-12993	160	47	of	of	ADP
bam-12993	160	48	new	new	ADJ
bam-12993	160	49	lesions	lesion	NOUN
bam-12993	160	50	on	on	ADP
bam-12993	160	51	mri	mri	NOUN
bam-12993	160	52	.	.	PUNCT
bam-12993	161	1	patients	patient	NOUN
bam-12993	161	2	with	with	ADP
bam-12993	161	3	25(oh	25(oh	NOUN
bam-12993	161	4	)	)	PUNCT
bam-12993	161	5	d	d	NOUN
bam-12993	161	6	levels	level	NOUN
bam-12993	161	7	above	above	ADP
bam-12993	161	8	100.0	100.0	NUM
bam-12993	161	9	nmol	nmol	NOUN
bam-12993	161	10	/	/	SYM
bam-12993	161	11	l	l	NOUN
bam-12993	161	12	had	have	VERB
bam-12993	161	13	the	the	DET
bam-12993	161	14	lowest	low	ADJ
bam-12993	161	15	rate	rate	NOUN
bam-12993	161	16	of	of	ADP
bam-12993	161	17	new	new	ADJ
bam-12993	161	18	lesions	lesion	NOUN
bam-12993	161	19	on	on	ADP
bam-12993	161	20	mri	mri	NOUN
bam-12993	161	21	.	.	PUNCT
bam-12993	162	1	however	however	ADV
bam-12993	162	2	,	,	PUNCT
bam-12993	162	3	we	we	PRON
bam-12993	162	4	did	do	AUX
bam-12993	162	5	not	not	PART
bam-12993	162	6	observe	observe	VERB
bam-12993	162	7	any	any	DET
bam-12993	162	8	significant	significant	ADJ
bam-12993	162	9	association	association	NOUN
bam-12993	162	10	with	with	ADP
bam-12993	162	11	the	the	DET
bam-12993	162	12	recurrence	recurrence	NOUN
bam-12993	162	13	rate.33	rate.33	NOUN
bam-12993	162	14	the	the	DET
bam-12993	162	15	current	current	ADJ
bam-12993	162	16	study	study	NOUN
bam-12993	162	17	had	have	VERB
bam-12993	162	18	limitations	limitation	NOUN
bam-12993	162	19	such	such	ADJ
bam-12993	162	20	as	as	ADP
bam-12993	162	21	the	the	DET
bam-12993	162	22	small	small	ADJ
bam-12993	162	23	sample	sample	NOUN
bam-12993	162	24	size	size	NOUN
bam-12993	162	25	and	and	CCONJ
bam-12993	162	26	the	the	DET
bam-12993	162	27	need	need	NOUN
bam-12993	162	28	to	to	PART
bam-12993	162	29	select	select	VERB
bam-12993	162	30	more	more	ADJ
bam-12993	162	31	studies	study	NOUN
bam-12993	162	32	with	with	ADP
bam-12993	162	33	a	a	DET
bam-12993	162	34	larger	large	ADJ
bam-12993	162	35	sample	sample	NOUN
bam-12993	162	36	size	size	NOUN
bam-12993	162	37	;	;	PUNCT
bam-12993	162	38	it	it	PRON
bam-12993	162	39	is	be	AUX
bam-12993	162	40	also	also	ADV
bam-12993	162	41	very	very	ADV
bam-12993	162	42	important	important	ADJ
bam-12993	162	43	to	to	PART
bam-12993	162	44	select	select	VERB
bam-12993	162	45	the	the	DET
bam-12993	162	46	sample	sample	NOUN
bam-12993	162	47	size	size	NOUN
bam-12993	162	48	from	from	ADP
bam-12993	162	49	different	different	ADJ
bam-12993	162	50	regions	region	NOUN
bam-12993	162	51	.	.	PUNCT
bam-12993	163	1	conducting	conduct	VERB
bam-12993	163	2	a	a	DET
bam-12993	163	3	study	study	NOUN
bam-12993	163	4	to	to	PART
bam-12993	163	5	investigate	investigate	VERB
bam-12993	163	6	polymorphic	polymorphic	ADJ
bam-12993	163	7	translocation	translocation	NOUN
bam-12993	163	8	of	of	ADP
bam-12993	163	9	the	the	DET
bam-12993	163	10	vdr	vdr	NOUN
bam-12993	163	11	gene	gene	NOUN
bam-12993	163	12	is	be	AUX
bam-12993	163	13	necessary	necessary	ADJ
bam-12993	163	14	to	to	PART
bam-12993	163	15	understand	understand	VERB
bam-12993	163	16	the	the	DET
bam-12993	163	17	function	function	NOUN
bam-12993	163	18	of	of	ADP
bam-12993	163	19	the	the	DET
bam-12993	163	20	vdr	vdr	NOUN
bam-12993	163	21	and	and	CCONJ
bam-12993	163	22	increase	increase	VERB
bam-12993	163	23	the	the	DET
bam-12993	163	24	likelihood	likelihood	NOUN
bam-12993	163	25	of	of	ADP
bam-12993	163	26	detecting	detect	VERB
bam-12993	163	27	alleles	allele	NOUN
bam-12993	163	28	that	that	PRON
bam-12993	163	29	contribute	contribute	VERB
bam-12993	163	30	to	to	ADP
bam-12993	163	31	the	the	DET
bam-12993	163	32	risk	risk	NOUN
bam-12993	163	33	of	of	ADP
bam-12993	163	34	common	common	ADJ
bam-12993	163	35	diseases	disease	NOUN
bam-12993	163	36	,	,	PUNCT
bam-12993	163	37	as	as	ADV
bam-12993	163	38	well	well	ADV
bam-12993	163	39	as	as	ADP
bam-12993	163	40	further	further	ADJ
bam-12993	163	41	research	research	NOUN
bam-12993	163	42	involving	involve	VERB
bam-12993	163	43	more	more	ADJ
bam-12993	163	44	cases	case	NOUN
bam-12993	163	45	to	to	PART
bam-12993	163	46	obtain	obtain	VERB
bam-12993	163	47	results	result	NOUN
bam-12993	163	48	this	this	PRON
bam-12993	163	49	can	can	AUX
bam-12993	163	50	be	be	AUX
bam-12993	163	51	distorted	distort	VERB
bam-12993	163	52	by	by	ADP
bam-12993	163	53	small	small	ADJ
bam-12993	163	54	samples	sample	NOUN
bam-12993	163	55	or	or	CCONJ
bam-12993	163	56	low	low	ADJ
bam-12993	163	57	frequencies	frequency	NOUN
bam-12993	163	58	.	.	PUNCT
bam-12993	164	1	minor	minor	ADJ
bam-12993	164	2	alleles	allele	NOUN
bam-12993	164	3	are	be	AUX
bam-12993	164	4	required	require	VERB
bam-12993	164	5	.	.	PUNCT
bam-12993	165	1	conclusions	conclusion	NOUN
bam-12993	165	2	based	base	VERB
bam-12993	165	3	on	on	ADP
bam-12993	165	4	the	the	DET
bam-12993	165	5	findings	finding	NOUN
bam-12993	165	6	of	of	ADP
bam-12993	165	7	the	the	DET
bam-12993	165	8	present	present	ADJ
bam-12993	165	9	study	study	NOUN
bam-12993	165	10	,	,	PUNCT
bam-12993	165	11	foki	foki	ADJ
bam-12993	165	12	polymorphism	polymorphism	NOUN
bam-12993	165	13	showed	show	VERB
bam-12993	165	14	a	a	DET
bam-12993	165	15	significant	significant	ADJ
bam-12993	165	16	risk	risk	NOUN
bam-12993	165	17	increase	increase	NOUN
bam-12993	165	18	with	with	ADP
bam-12993	165	19	an	an	DET
bam-12993	165	20	odds	odd	NOUN
bam-12993	165	21	ratio	ratio	NOUN
bam-12993	165	22	of	of	ADP
bam-12993	165	23	7.28	7.28	NUM
bam-12993	165	24	in	in	ADP
bam-12993	165	25	rrms	rrm	NOUN
bam-12993	165	26	patients	patient	NOUN
bam-12993	165	27	with	with	ADP
bam-12993	165	28	ff	ff	NOUN
bam-12993	165	29	genotype	genotype	NOUN
bam-12993	165	30	compared	compare	VERB
bam-12993	165	31	to	to	ADP
bam-12993	165	32	healthy	healthy	ADJ
bam-12993	165	33	individuals	individual	NOUN
bam-12993	165	34	(	(	PUNCT
bam-12993	165	35	or=7.28	or=7.28	ADV
bam-12993	165	36	:	:	PUNCT
bam-12993	165	37	95	95	NUM
bam-12993	165	38	%	%	NOUN
bam-12993	165	39	ci	ci	NOUN
bam-12993	165	40	;	;	PUNCT
bam-12993	165	41	1.86	1.86	NUM
bam-12993	165	42	,	,	PUNCT
bam-12993	165	43	28.41	28.41	NUM
bam-12993	165	44	)	)	PUNCT
bam-12993	165	45	.	.	PUNCT
bam-12993	166	1	list	list	NOUN
bam-12993	166	2	of	of	ADP
bam-12993	166	3	abbreviations	abbreviation	NOUN
bam-12993	166	4	vdr	vdr	NOUN
bam-12993	166	5	,	,	PUNCT
bam-12993	166	6	vitamin	vitamin	NOUN
bam-12993	166	7	d	d	NOUN
bam-12993	166	8	receptor	receptor	NOUN
bam-12993	166	9	rrms	rrm	NOUN
bam-12993	166	10	,	,	PUNCT
bam-12993	166	11	relapsing	relapse	VERB
bam-12993	166	12	-	-	PUNCT
bam-12993	166	13	remitting	remit	VERB
bam-12993	166	14	multiple	multiple	ADJ
bam-12993	166	15	sclerosis	sclerosis	NOUN
bam-12993	166	16	ms	ms	NOUN
bam-12993	166	17	,	,	PUNCT
bam-12993	166	18	multiple	multiple	ADJ
bam-12993	166	19	sclerosis	sclerosis	NOUN
bam-12993	166	20	pcr	pcr	NOUN
bam-12993	166	21	,	,	PUNCT
bam-12993	166	22	polymerase	polymerase	NOUN
bam-12993	166	23	chain	chain	NOUN
bam-12993	166	24	reaction	reaction	NOUN
bam-12993	166	25	msss	msss	NOUN
bam-12993	166	26	,	,	PUNCT
bam-12993	166	27	multiple	multiple	ADJ
bam-12993	166	28	sclerosis	sclerosis	NOUN
bam-12993	166	29	severity	severity	NOUN
bam-12993	166	30	score	score	NOUN
bam-12993	166	31	rflp	rflp	PROPN
bam-12993	166	32	,	,	PUNCT
bam-12993	166	33	restriction	restriction	NOUN
bam-12993	166	34	fragment	fragment	NOUN
bam-12993	166	35	length	length	NOUN
bam-12993	166	36	polymorphism	polymorphism	NOUN
bam-12993	166	37	conflict	conflict	NOUN
bam-12993	166	38	of	of	ADP
bam-12993	166	39	interest	interest	NOUN
bam-12993	166	40	the	the	DET
bam-12993	166	41	authors	author	NOUN
bam-12993	166	42	declare	declare	VERB
bam-12993	166	43	no	no	DET
bam-12993	166	44	potential	potential	ADJ
bam-12993	166	45	conflict	conflict	NOUN
bam-12993	166	46	of	of	ADP
bam-12993	166	47	interest	interest	NOUN
bam-12993	166	48	.	.	PUNCT
bam-12993	167	1	ethics	ethic	NOUN
bam-12993	167	2	approval	approval	VERB
bam-12993	167	3	this	this	DET
bam-12993	167	4	research	research	NOUN
bam-12993	167	5	was	be	AUX
bam-12993	167	6	approved	approve	VERB
bam-12993	167	7	by	by	ADP
bam-12993	167	8	the	the	DET
bam-12993	167	9	medical	medical	ADJ
bam-12993	167	10	ethics	ethic	NOUN
bam-12993	167	11	department	department	PROPN
bam-12993	167	12	of	of	ADP
bam-12993	167	13	iran	iran	PROPN
bam-12993	167	14	university	university	PROPN
bam-12993	167	15	of	of	ADP
bam-12993	167	16	medical	medical	ADJ
bam-12993	167	17	sciences	science	NOUN
bam-12993	167	18	with	with	ADP
bam-12993	167	19	no	no	NOUN
bam-12993	167	20	.	.	PUNCT
bam-12993	168	1	ir.iums.fmd.rec.1401.429	ir.iums.fmd.rec.1401.429	PROPN
bam-12993	168	2	informed	informed	ADJ
bam-12993	168	3	consent	consent	NOUN
bam-12993	168	4	and	and	CCONJ
bam-12993	168	5	patient	patient	ADJ
bam-12993	168	6	consent	consent	NOUN
bam-12993	168	7	for	for	ADP
bam-12993	168	8	publication	publication	NOUN
bam-12993	168	9	all	all	DET
bam-12993	168	10	patients	patient	NOUN
bam-12993	168	11	participating	participate	VERB
bam-12993	168	12	in	in	ADP
bam-12993	168	13	this	this	DET
bam-12993	168	14	study	study	NOUN
bam-12993	168	15	signed	sign	VERB
bam-12993	168	16	a	a	DET
bam-12993	168	17	written	write	VERB
bam-12993	168	18	informed	inform	VERB
bam-12993	168	19	consent	consent	NOUN
bam-12993	168	20	form	form	NOUN
bam-12993	168	21	for	for	ADP
bam-12993	168	22	participating	participate	VERB
bam-12993	168	23	in	in	ADP
bam-12993	168	24	this	this	DET
bam-12993	168	25	study	study	NOUN
bam-12993	168	26	.	.	PUNCT
bam-12993	169	1	7	7	NUM
bam-12993	169	2	vitamin	vitamin	NOUN
bam-12993	169	3	d	d	NOUN
bam-12993	169	4	receptor	receptor	NOUN
bam-12993	169	5	gene	gene	NOUN
bam-12993	169	6	polymorphisms	polymorphism	NOUN
bam-12993	169	7	in	in	ADP
bam-12993	169	8	patients	patient	NOUN
bam-12993	169	9	with	with	ADP
bam-12993	169	10	relapsing	relapse	VERB
bam-12993	169	11	multiple	multiple	ADJ
bam-12993	169	12	sclerosis	sclerosis	NOUN
bam-12993	169	13	eur	eur	PROPN
bam-12993	169	14	j	j	PROPN
bam-12993	169	15	transl	transl	PROPN
bam-12993	169	16	myol	myol	ADV
bam-12993	169	17	35	35	NUM
bam-12993	169	18	(	(	PUNCT
bam-12993	169	19	1	1	NUM
bam-12993	169	20	)	)	PUNCT
bam-12993	169	21	12993	12993	NUM
bam-12993	169	22	,	,	PUNCT
bam-12993	169	23	2025	2025	NUM
bam-12993	169	24	doi	doi	NOUN
bam-12993	169	25	:	:	PUNCT
bam-12993	169	26	10.4081	10.4081	NUM
bam-12993	169	27	/	/	SYM
bam-12993	169	28	ejtm.2024.12993	ejtm.2024.12993	NOUN
bam-12993	169	29	availability	availability	NOUN
bam-12993	169	30	of	of	ADP
bam-12993	169	31	data	datum	NOUN
bam-12993	169	32	and	and	CCONJ
bam-12993	169	33	materials	material	NOUN
bam-12993	169	34	all	all	DET
bam-12993	169	35	data	datum	NOUN
bam-12993	169	36	generated	generate	VERB
bam-12993	169	37	or	or	CCONJ
bam-12993	169	38	analyzed	analyze	VERB
bam-12993	169	39	during	during	ADP
bam-12993	169	40	this	this	DET
bam-12993	169	41	study	study	NOUN
bam-12993	169	42	are	be	AUX
bam-12993	169	43	included	include	VERB
bam-12993	169	44	in	in	ADP
bam-12993	169	45	this	this	DET
bam-12993	169	46	published	publish	VERB
bam-12993	169	47	article	article	NOUN
bam-12993	169	48	.	.	PUNCT
bam-12993	170	1	corresponding	correspond	VERB
bam-12993	170	2	author	author	PROPN
bam-12993	170	3	mohammad	mohammad	PROPN
bam-12993	170	4	taghi	taghi	PROPN
bam-12993	170	5	joghataei	joghataei	PROPN
bam-12993	170	6	,	,	PUNCT
bam-12993	170	7	department	department	NOUN
bam-12993	170	8	of	of	ADP
bam-12993	170	9	neuroscience	neuroscience	NOUN
bam-12993	170	10	,	,	PUNCT
bam-12993	170	11	faculty	faculty	NOUN
bam-12993	170	12	of	of	ADP
bam-12993	170	13	advanced	advanced	ADJ
bam-12993	170	14	technologies	technology	NOUN
bam-12993	170	15	in	in	ADP
bam-12993	170	16	medicine	medicine	NOUN
bam-12993	170	17	,	,	PUNCT
bam-12993	170	18	iran	iran	PROPN
bam-12993	170	19	university	university	PROPN
bam-12993	170	20	of	of	ADP
bam-12993	170	21	medical	medical	ADJ
bam-12993	170	22	sciences	sciences	PROPN
bam-12993	170	23	,	,	PUNCT
bam-12993	170	24	tehran	tehran	PROPN
bam-12993	170	25	,	,	PUNCT
bam-12993	170	26	iran	iran	PROPN
bam-12993	170	27	.	.	PUNCT
bam-12993	171	1	orcid	orcid	NOUN
bam-12993	172	1	i	i	PRON
bam-12993	172	2	d	d	NOUN
bam-12993	172	3	:	:	PUNCT
bam-12993	172	4	0000	0000	NUM
bam-12993	172	5	-	-	PUNCT
bam-12993	172	6	0003	0003	NUM
bam-12993	172	7	-	-	PUNCT
bam-12993	172	8	0492	0492	NUM
bam-12993	172	9	-	-	SYM
bam-12993	172	10	8239	8239	NUM
bam-12993	172	11	e	e	NOUN
bam-12993	172	12	-	-	NOUN
bam-12993	172	13	mail	mail	NOUN
bam-12993	172	14	:	:	PUNCT
bam-12993	172	15	m_joghataei@yahoo.com	m_joghataei@yahoo.com	X
bam-12993	173	1	co	co	PROPN
bam-12993	173	2	authors	authors	PROPN
bam-12993	173	3	maryam	maryam	PROPN
bam-12993	173	4	milanifard	milanifard	PROPN
bam-12993	173	5	orcid	orcid	PROPN
bam-12993	173	6	i	i	PROPN
bam-12993	173	7	d	d	NOUN
bam-12993	173	8	:	:	PUNCT
bam-12993	173	9	0000	0000	NUM
bam-12993	173	10	-	-	PUNCT
bam-12993	173	11	0002	0002	NUM
bam-12993	173	12	-	-	PUNCT
bam-12993	173	13	0888	0888	NUM
bam-12993	173	14	-	-	PUNCT
bam-12993	173	15	8847	8847	NUM
bam-12993	173	16	e	e	NOUN
bam-12993	173	17	-	-	NOUN
bam-12993	173	18	mail	mail	NOUN
bam-12993	173	19	:	:	PUNCT
bam-12993	173	20	marayammilani837@yahoo.com	marayammilani837@yahoo.com	X
bam-12993	174	1	soraya	soraya	PROPN
bam-12993	174	2	mehrabi	mehrabi	PROPN
bam-12993	174	3	orcid	orcid	PROPN
bam-12993	175	1	i	i	PRON
bam-12993	175	2	d	d	NOUN
bam-12993	175	3	:	:	PUNCT
bam-12993	175	4	0000	0000	NUM
bam-12993	175	5	-	-	PUNCT
bam-12993	175	6	0001	0001	NUM
bam-12993	175	7	-	-	PUNCT
bam-12993	175	8	8555	8555	NUM
bam-12993	175	9	-	-	PUNCT
bam-12993	175	10	726x	726x	NOUN
bam-12993	175	11	e	e	NOUN
bam-12993	175	12	-	-	NOUN
bam-12993	175	13	mail	mail	NOUN
bam-12993	175	14	:	:	PUNCT
bam-12993	175	15	soraya.mehrabi@gmail.com	soraya.mehrabi@gmail.com	X
bam-12993	175	16	reza	reza	PROPN
bam-12993	175	17	ahadi	ahadi	NOUN
bam-12993	176	1	orcid	orcid	PROPN
bam-12993	177	1	i	i	PRON
bam-12993	177	2	d	d	NOUN
bam-12993	177	3	:	:	PUNCT
bam-12993	177	4	0000	0000	NUM
bam-12993	177	5	-	-	PUNCT
bam-12993	177	6	0002	0002	NUM
bam-12993	177	7	-	-	PUNCT
bam-12993	177	8	3484	3484	NUM
bam-12993	177	9	-	-	SYM
bam-12993	177	10	9606	9606	NUM
bam-12993	177	11	e	e	NOUN
bam-12993	177	12	-	-	NOUN
bam-12993	177	13	mail	mail	NOUN
bam-12993	177	14	:	:	PUNCT
bam-12993	177	15	rezaahadi1353@gmail.com	rezaahadi1353@gmail.com	X
bam-12993	178	1	mohsen	mohsen	PROPN
bam-12993	178	2	nabiuni	nabiuni	PROPN
bam-12993	178	3	orcid	orcid	PROPN
bam-12993	179	1	i	i	PRON
bam-12993	179	2	d	d	NOUN
bam-12993	179	3	:	:	PUNCT
bam-12993	179	4	0000	0000	NUM
bam-12993	179	5	-	-	PUNCT
bam-12993	179	6	0002	0002	NUM
bam-12993	179	7	-	-	PUNCT
bam-12993	179	8	0841	0841	NUM
bam-12993	179	9	-	-	PUNCT
bam-12993	179	10	6612	6612	NUM
bam-12993	179	11	e	e	NOUN
bam-12993	179	12	-	-	NOUN
bam-12993	179	13	mail	mail	NOUN
bam-12993	179	14	:	:	PUNCT
bam-12993	179	15	nabiuni_m@yahoo.com	nabiuni_m@yahoo.com	PROPN
bam-12993	179	16	samaneh	samaneh	PROPN
bam-12993	179	17	azimi	azimi	PROPN
bam-12993	179	18	souteh	souteh	PROPN
bam-12993	179	19	orcid	orcid	PROPN
bam-12993	180	1	i	i	PRON
bam-12993	180	2	d	d	NOUN
bam-12993	180	3	:	:	PUNCT
bam-12993	180	4	0000	0000	NUM
bam-12993	180	5	-	-	PUNCT
bam-12993	180	6	0001	0001	NUM
bam-12993	180	7	-	-	PUNCT
bam-12993	180	8	7703	7703	NUM
bam-12993	180	9	-	-	SYM
bam-12993	180	10	1671	1671	NUM
bam-12993	180	11	e	e	NOUN
bam-12993	180	12	-	-	NOUN
bam-12993	180	13	mail	mail	NOUN
bam-12993	180	14	:	:	PUNCT
bam-12993	180	15	s.azimi.s1991@gmail.com	s.azimi.s1991@gmail.com	X
bam-12993	180	16	references	reference	NOUN
bam-12993	180	17	1	1	NUM
bam-12993	180	18	.	.	PUNCT
bam-12993	181	1	dobson	dobson	PROPN
bam-12993	181	2	r	r	PROPN
bam-12993	181	3	,	,	PUNCT
bam-12993	181	4	giovannoni	giovannoni	NOUN
bam-12993	181	5	g.	g.	PROPN
bam-12993	181	6	multiple	multiple	ADJ
bam-12993	181	7	sclerosis	sclerosis	NOUN
bam-12993	181	8	–	–	PUNCT
bam-12993	181	9	a	a	DET
bam-12993	181	10	review	review	NOUN
bam-12993	181	11	.	.	PUNCT
bam-12993	182	1	eur	eur	PROPN
bam-12993	182	2	j	j	PROPN
bam-12993	182	3	neurol	neurol	PROPN
bam-12993	182	4	2019;26:27	2019;26:27	NUM
bam-12993	182	5	-	-	SYM
bam-12993	182	6	40	40	NUM
bam-12993	182	7	.	.	PUNCT
bam-12993	182	8	2	2	X
bam-12993	182	9	.	.	NUM
bam-12993	182	10	elssayed	elssaye	VERB
bam-12993	182	11	a	a	DET
bam-12993	182	12	,	,	PUNCT
bam-12993	182	13	alrgaiba	alrgaiba	PROPN
bam-12993	182	14	ri	ri	PROPN
bam-12993	182	15	,	,	PUNCT
bam-12993	182	16	alzalbani	alzalbani	PROPN
bam-12993	182	17	mk	mk	PROPN
bam-12993	182	18	,	,	PUNCT
bam-12993	182	19	et	et	PROPN
bam-12993	182	20	al	al	PROPN
bam-12993	182	21	.	.	PROPN
bam-12993	182	22	review	review	NOUN
bam-12993	182	23	on	on	ADP
bam-12993	182	24	diagnosis	diagnosis	NOUN
bam-12993	182	25	and	and	CCONJ
bam-12993	182	26	management	management	NOUN
bam-12993	182	27	approach	approach	NOUN
bam-12993	182	28	of	of	ADP
bam-12993	182	29	multiple	multiple	ADJ
bam-12993	182	30	sclerosis	sclerosis	NOUN
bam-12993	182	31	.	.	PUNCT
bam-12993	183	1	int	int	PROPN
bam-12993	184	1	j	j	PROPN
bam-12993	184	2	pharm	pharm	PROPN
bam-12993	184	3	res	re	NOUN
bam-12993	184	4	allied	ally	VERB
bam-12993	184	5	sci	sci	PROPN
bam-12993	184	6	2023;12:100	2023;12:100	PROPN
bam-12993	184	7	-	-	SYM
bam-12993	184	8	5	5	NUM
bam-12993	184	9	.	.	NOUN
bam-12993	185	1	3	3	NUM
bam-12993	185	2	.	.	X
bam-12993	185	3	filippi	filippi	PROPN
bam-12993	185	4	m	m	PROPN
bam-12993	185	5	,	,	PUNCT
bam-12993	185	6	preziosa	preziosa	PROPN
bam-12993	185	7	p	p	NOUN
bam-12993	185	8	,	,	PUNCT
bam-12993	185	9	barkhof	barkhof	NOUN
bam-12993	185	10	f	f	PROPN
bam-12993	185	11	,	,	PUNCT
bam-12993	185	12	et	et	PROPN
bam-12993	185	13	al	al	PROPN
bam-12993	185	14	.	.	PUNCT
bam-12993	185	15	diagnosis	diagnosis	NOUN
bam-12993	185	16	of	of	ADP
bam-12993	185	17	progressive	progressive	ADJ
bam-12993	185	18	multiple	multiple	ADJ
bam-12993	185	19	sclerosis	sclerosis	NOUN
bam-12993	185	20	from	from	ADP
bam-12993	185	21	the	the	DET
bam-12993	185	22	imaging	imaging	NOUN
bam-12993	185	23	perspective	perspective	NOUN
bam-12993	185	24	:	:	PUNCT
bam-12993	185	25	a	a	DET
bam-12993	185	26	review	review	NOUN
bam-12993	185	27	.	.	PUNCT
bam-12993	186	1	jama	jama	PROPN
bam-12993	186	2	neurol	neurol	PROPN
bam-12993	186	3	2021;78:351	2021;78:351	PROPN
bam-12993	186	4	-	-	SYM
bam-12993	186	5	64	64	NUM
bam-12993	186	6	.	.	PUNCT
bam-12993	187	1	4	4	X
bam-12993	187	2	.	.	X
bam-12993	187	3	wasnik	wasnik	PROPN
bam-12993	187	4	s	s	PROPN
bam-12993	187	5	,	,	PUNCT
bam-12993	187	6	sharma	sharma	PROPN
bam-12993	187	7	i	i	PRON
bam-12993	187	8	,	,	PUNCT
bam-12993	187	9	baylink	baylink	PROPN
bam-12993	187	10	dj	dj	PROPN
bam-12993	187	11	,	,	PUNCT
bam-12993	187	12	tang	tang	X
bam-12993	187	13	x.	x.	NOUN
bam-12993	187	14	vitamin	vitamin	PROPN
bam-12993	187	15	d	d	NOUN
bam-12993	187	16	as	as	ADP
bam-12993	187	17	a	a	DET
bam-12993	187	18	potential	potential	ADJ
bam-12993	187	19	therapy	therapy	NOUN
bam-12993	187	20	for	for	ADP
bam-12993	187	21	multiple	multiple	ADJ
bam-12993	187	22	sclerosis	sclerosis	NOUN
bam-12993	187	23	:	:	PUNCT
bam-12993	187	24	where	where	SCONJ
bam-12993	187	25	are	be	AUX
bam-12993	187	26	we	we	PRON
bam-12993	187	27	?	?	PUNCT
bam-12993	188	1	int	int	PROPN
bam-12993	188	2	j	j	PROPN
bam-12993	188	3	mol	mol	ADP
bam-12993	188	4	sci	sci	PROPN
bam-12993	188	5	2020;21:3102	2020;21:3102	NUM
bam-12993	188	6	.	.	PUNCT
bam-12993	189	1	5	5	NUM
bam-12993	189	2	.	.	PUNCT
bam-12993	189	3	hartl	hartl	PROPN
bam-12993	189	4	c	c	PROPN
bam-12993	189	5	,	,	PUNCT
bam-12993	189	6	obermeier	obermeier	PROPN
bam-12993	189	7	v	v	NOUN
bam-12993	189	8	,	,	PUNCT
bam-12993	189	9	gerdes	gerde	NOUN
bam-12993	189	10	la	la	PROPN
bam-12993	189	11	,	,	PUNCT
bam-12993	189	12	et	et	PROPN
bam-12993	190	1	al	al	PROPN
bam-12993	190	2	.	.	PUNCT
bam-12993	191	1	seasonal	seasonal	ADJ
bam-12993	191	2	variations	variation	NOUN
bam-12993	191	3	of	of	ADP
bam-12993	191	4	25	25	NUM
bam-12993	191	5	-	-	PUNCT
bam-12993	191	6	oh	oh	NUM
bam-12993	191	7	vitamin	vitamin	NOUN
bam-12993	191	8	d	d	NOUN
bam-12993	191	9	serum	serum	NOUN
bam-12993	191	10	levels	level	NOUN
bam-12993	191	11	are	be	AUX
bam-12993	191	12	associated	associate	VERB
bam-12993	191	13	with	with	ADP
bam-12993	191	14	clinical	clinical	ADJ
bam-12993	191	15	disease	disease	NOUN
bam-12993	191	16	activity	activity	NOUN
bam-12993	191	17	in	in	ADP
bam-12993	191	18	multiple	multiple	ADJ
bam-12993	191	19	sclerosis	sclerosis	NOUN
bam-12993	191	20	patients	patient	NOUN
bam-12993	191	21	.	.	PUNCT
bam-12993	192	1	j	j	PROPN
bam-12993	192	2	neurol	neurol	PROPN
bam-12993	192	3	sci	sci	PROPN
bam-12993	192	4	2017;375:160	2017;375:160	PROPN
bam-12993	192	5	-	-	SYM
bam-12993	192	6	4	4	NUM
bam-12993	192	7	.	.	NOUN
bam-12993	192	8	6	6	NUM
bam-12993	192	9	.	.	X
bam-12993	192	10	díez	díez	PROPN
bam-12993	192	11	bc	bc	PROPN
bam-12993	192	12	,	,	PUNCT
bam-12993	192	13	pérez	pérez	NOUN
bam-12993	192	14	-	-	PUNCT
bam-12993	192	15	ramírez	ramírez	NOUN
bam-12993	192	16	c	c	NOUN
bam-12993	192	17	,	,	PUNCT
bam-12993	192	18	del	del	PROPN
bam-12993	192	19	mar	mar	PROPN
bam-12993	192	20	maldonadomontoro	maldonadomontoro	PROPN
bam-12993	192	21	m	m	PROPN
bam-12993	192	22	,	,	PUNCT
bam-12993	192	23	et	et	PROPN
bam-12993	192	24	al	al	PROPN
bam-12993	192	25	.	.	PROPN
bam-12993	192	26	association	association	PROPN
bam-12993	192	27	between	between	ADP
bam-12993	192	28	polymorphisms	polymorphism	NOUN
bam-12993	192	29	in	in	ADP
bam-12993	192	30	the	the	DET
bam-12993	192	31	vitamin	vitamin	NOUN
bam-12993	192	32	d	d	NOUN
bam-12993	192	33	receptor	receptor	NOUN
bam-12993	192	34	and	and	CCONJ
bam-12993	192	35	susceptibility	susceptibility	NOUN
bam-12993	192	36	to	to	ADP
bam-12993	192	37	multiple	multiple	ADJ
bam-12993	192	38	sclerosis	sclerosis	NOUN
bam-12993	192	39	.	.	PUNCT
bam-12993	193	1	pharmacokinetics	pharmacokinetic	NOUN
bam-12993	193	2	genomics	genomic	NOUN
bam-12993	193	3	2021;31:40	2021;31:40	NUM
bam-12993	193	4	-	-	SYM
bam-12993	193	5	7	7	NUM
bam-12993	193	6	.	.	NOUN
bam-12993	193	7	7	7	NUM
bam-12993	193	8	.	.	X
bam-12993	193	9	usategui	usategui	NOUN
bam-12993	193	10	-	-	PUNCT
bam-12993	193	11	martín	martín	NOUN
bam-12993	193	12	r	r	NOUN
bam-12993	193	13	,	,	PUNCT
bam-12993	193	14	de	de	X
bam-12993	193	15	luis	luis	NOUN
bam-12993	193	16	-	-	PUNCT
bam-12993	193	17	román	román	NOUN
bam-12993	193	18	da	da	PROPN
bam-12993	193	19	,	,	PUNCT
bam-12993	193	20	fernándezgómez	fernándezgómez	NOUN
bam-12993	193	21	jm	jm	PROPN
bam-12993	193	22	,	,	PUNCT
bam-12993	193	23	et	et	PROPN
bam-12993	193	24	al	al	PROPN
bam-12993	193	25	.	.	PUNCT
bam-12993	194	1	vitamin	vitamin	NOUN
bam-12993	194	2	d	d	NOUN
bam-12993	194	3	receptor	receptor	NOUN
bam-12993	194	4	(	(	PUNCT
bam-12993	194	5	vdr	vdr	NOUN
bam-12993	194	6	)	)	PUNCT
bam-12993	194	7	gene	gene	NOUN
bam-12993	194	8	polymorphisms	polymorphism	NOUN
bam-12993	194	9	modify	modify	VERB
bam-12993	194	10	the	the	DET
bam-12993	194	11	response	response	NOUN
bam-12993	194	12	to	to	ADP
bam-12993	194	13	vitamin	vitamin	NOUN
bam-12993	194	14	d	d	NOUN
bam-12993	194	15	supplementation	supplementation	NOUN
bam-12993	194	16	:	:	PUNCT
bam-12993	194	17	a	a	DET
bam-12993	194	18	systematic	systematic	ADJ
bam-12993	194	19	review	review	NOUN
bam-12993	194	20	and	and	CCONJ
bam-12993	194	21	meta	meta	ADJ
bam-12993	194	22	-	-	PUNCT
bam-12993	194	23	analysis	analysis	NOUN
bam-12993	194	24	.	.	PUNCT
bam-12993	195	1	nutrients	nutrient	NOUN
bam-12993	195	2	2022;14:360	2022;14:360	NUM
bam-12993	195	3	.	.	PROPN
bam-12993	195	4	8	8	NUM
bam-12993	195	5	.	.	X
bam-12993	196	1	aga	aga	PROPN
bam-12993	196	2	ss	ss	PROPN
bam-12993	196	3	,	,	PUNCT
bam-12993	196	4	banday	banday	PROPN
bam-12993	196	5	mz	mz	PROPN
bam-12993	196	6	,	,	PUNCT
bam-12993	196	7	nissar	nissar	PROPN
bam-12993	196	8	s	s	PROPN
bam-12993	196	9	,	,	PUNCT
bam-12993	196	10	et	et	PROPN
bam-12993	196	11	al	al	PROPN
bam-12993	196	12	.	.	PUNCT
bam-12993	197	1	vitamin	vitamin	NOUN
bam-12993	197	2	d	d	NOUN
bam-12993	197	3	receptor	receptor	NOUN
bam-12993	197	4	polymorphisms	polymorphism	NOUN
bam-12993	197	5	and	and	CCONJ
bam-12993	197	6	diseases	disease	NOUN
bam-12993	197	7	.	.	PUNCT
bam-12993	198	1	in	in	ADP
bam-12993	198	2	:	:	PUNCT
bam-12993	198	3	aga	aga	PROPN
bam-12993	198	4	ss	ss	PROPN
bam-12993	198	5	,	,	PUNCT
bam-12993	198	6	banday	banday	PROPN
bam-12993	198	7	mz	mz	PROPN
bam-12993	198	8	,	,	PUNCT
bam-12993	198	9	nissar	nissar	PROPN
bam-12993	198	10	s	s	PART
bam-12993	198	11	(	(	PUNCT
bam-12993	198	12	eds	ed	NOUN
bam-12993	198	13	.	.	PUNCT
bam-12993	198	14	)	)	PUNCT
bam-12993	198	15	.	.	PUNCT
bam-12993	199	1	genetic	genetic	ADJ
bam-12993	199	2	polymorphism	polymorphism	NOUN
bam-12993	199	3	and	and	CCONJ
bam-12993	199	4	disease	disease	NOUN
bam-12993	199	5	:	:	PUNCT
bam-12993	199	6	crc	crc	NOUN
bam-12993	199	7	press	press	NOUN
bam-12993	199	8	;	;	PUNCT
bam-12993	199	9	2022	2022	NUM
bam-12993	199	10	.	.	PUNCT
bam-12993	200	1	p.	p.	NOUN
bam-12993	200	2	185	185	NUM
bam-12993	200	3	-	-	SYM
bam-12993	200	4	98	98	NUM
bam-12993	200	5	.	.	PUNCT
bam-12993	201	1	9	9	NUM
bam-12993	201	2	.	.	X
bam-12993	201	3	taymans	tayman	NOUN
bam-12993	201	4	se	se	ADV
bam-12993	201	5	,	,	PUNCT
bam-12993	201	6	pack	pack	PROPN
bam-12993	201	7	s	s	PROPN
bam-12993	201	8	,	,	PUNCT
bam-12993	201	9	pak	pak	PROPN
bam-12993	201	10	e	e	NOUN
bam-12993	201	11	,	,	PUNCT
bam-12993	201	12	et	et	PROPN
bam-12993	201	13	al	al	PROPN
bam-12993	201	14	.	.	PUNCT
bam-12993	202	1	the	the	DET
bam-12993	202	2	human	human	ADJ
bam-12993	202	3	vitamin	vitamin	NOUN
bam-12993	202	4	d	d	NOUN
bam-12993	202	5	receptor	receptor	NOUN
bam-12993	202	6	gene	gene	NOUN
bam-12993	202	7	(	(	PUNCT
bam-12993	202	8	vdr	vdr	NOUN
bam-12993	202	9	)	)	PUNCT
bam-12993	202	10	is	be	AUX
bam-12993	202	11	localized	localize	VERB
bam-12993	202	12	to	to	ADP
bam-12993	202	13	region	region	NOUN
bam-12993	202	14	12cen‐q12	12cen‐q12	NUM
bam-12993	202	15	by	by	ADP
bam-12993	202	16	fluorescent	fluorescent	NOUN
bam-12993	202	17	in	in	ADP
bam-12993	202	18	situ	situ	ADJ
bam-12993	202	19	hybridization	hybridization	NOUN
bam-12993	202	20	and	and	CCONJ
bam-12993	202	21	radiation	radiation	NOUN
bam-12993	202	22	hybrid	hybrid	NOUN
bam-12993	202	23	mapping	mapping	NOUN
bam-12993	202	24	:	:	PUNCT
bam-12993	202	25	genetic	genetic	ADJ
bam-12993	202	26	and	and	CCONJ
bam-12993	202	27	physical	physical	ADJ
bam-12993	202	28	vdr	vdr	NOUN
bam-12993	202	29	map	map	NOUN
bam-12993	202	30	.	.	PUNCT
bam-12993	203	1	j	j	PROPN
bam-12993	203	2	bone	bone	NOUN
bam-12993	203	3	mineral	mineral	NOUN
bam-12993	203	4	res	re	VERB
bam-12993	203	5	1999;14:1163	1999;14:1163	NUM
bam-12993	203	6	-	-	SYM
bam-12993	203	7	6	6	NUM
bam-12993	203	8	.	.	NOUN
bam-12993	203	9	10	10	NUM
bam-12993	203	10	.	.	PUNCT
bam-12993	204	1	wöbke	wöbke	PROPN
bam-12993	204	2	tk	tk	PROPN
bam-12993	204	3	,	,	PUNCT
bam-12993	204	4	steinhilber	steinhilber	PROPN
bam-12993	204	5	d.	d.	PROPN
bam-12993	204	6	vitamin	vitamin	PROPN
bam-12993	204	7	d	d	NOUN
bam-12993	204	8	in	in	ADP
bam-12993	204	9	inflammatory	inflammatory	ADJ
bam-12993	204	10	diseases	disease	NOUN
bam-12993	204	11	.	.	PUNCT
bam-12993	205	1	frontiers	frontier	NOUN
bam-12993	205	2	physiol	physiol	PROPN
bam-12993	205	3	2014;5:97223	2014;5:97223	PROPN
bam-12993	205	4	.	.	PUNCT
bam-12993	206	1	11	11	NUM
bam-12993	206	2	.	.	PUNCT
bam-12993	207	1	vanlint	vanlint	ADJ
bam-12993	207	2	s.	s.	PROPN
bam-12993	207	3	vitamin	vitamin	PROPN
bam-12993	207	4	d	d	PROPN
bam-12993	207	5	and	and	CCONJ
bam-12993	207	6	obesity	obesity	NOUN
bam-12993	207	7	.	.	PUNCT
bam-12993	208	1	nutrients	nutrient	NOUN
bam-12993	208	2	2013;5	2013;5	NUM
bam-12993	208	3	:	:	PUNCT
bam-12993	208	4	949	949	NUM
bam-12993	208	5	-	-	SYM
bam-12993	208	6	56	56	NUM
bam-12993	208	7	.	.	NOUN
bam-12993	208	8	12	12	NUM
bam-12993	208	9	.	.	PUNCT
bam-12993	209	1	walsh	walsh	PROPN
bam-12993	209	2	js	js	PROPN
bam-12993	209	3	,	,	PUNCT
bam-12993	209	4	bowles	bowles	PROPN
bam-12993	209	5	s	s	PROPN
bam-12993	209	6	,	,	PUNCT
bam-12993	209	7	evans	evans	PROPN
bam-12993	209	8	al	al	PROPN
bam-12993	209	9	.	.	PUNCT
bam-12993	210	1	vitamin	vitamin	PROPN
bam-12993	210	2	d	d	NOUN
bam-12993	210	3	in	in	ADP
bam-12993	210	4	obesity	obesity	NOUN
bam-12993	210	5	.	.	PUNCT
bam-12993	211	1	curr	curr	PROPN
bam-12993	211	2	opinion	opinion	PROPN
bam-12993	211	3	endocrinol	endocrinol	NOUN
bam-12993	211	4	diabetes	diabetes	NOUN
bam-12993	211	5	obesity	obesity	NOUN
bam-12993	211	6	2017;24	2017;24	NUM
bam-12993	211	7	:	:	PUNCT
bam-12993	211	8	389	389	NUM
bam-12993	211	9	-	-	SYM
bam-12993	211	10	94	94	NUM
bam-12993	211	11	.	.	PUNCT
bam-12993	211	12	13	13	NUM
bam-12993	211	13	.	.	PUNCT
bam-12993	212	1	hwang	hwang	PROPN
bam-12993	212	2	j	j	PROPN
bam-12993	212	3	,	,	PUNCT
bam-12993	212	4	yoo	yoo	PROPN
bam-12993	212	5	ja	ja	PROPN
bam-12993	212	6	,	,	PUNCT
bam-12993	212	7	yoon	yoon	PROPN
bam-12993	212	8	h	h	PROPN
bam-12993	212	9	,	,	PUNCT
bam-12993	212	10	et	et	PROPN
bam-12993	212	11	al	al	PROPN
bam-12993	212	12	.	.	PUNCT
bam-12993	213	1	the	the	DET
bam-12993	213	2	role	role	NOUN
bam-12993	213	3	of	of	ADP
bam-12993	213	4	leptin	leptin	NOUN
bam-12993	213	5	in	in	ADP
bam-12993	213	6	the	the	DET
bam-12993	213	7	association	association	NOUN
bam-12993	213	8	between	between	ADP
bam-12993	213	9	obesity	obesity	NOUN
bam-12993	213	10	and	and	CCONJ
bam-12993	213	11	psoriasis	psoriasis	NOUN
bam-12993	213	12	.	.	PUNCT
bam-12993	214	1	biomol	biomol	NOUN
bam-12993	214	2	ther	ther	PROPN
bam-12993	214	3	(	(	PUNCT
bam-12993	214	4	seoul	seoul	PROPN
bam-12993	214	5	)	)	PUNCT
bam-12993	214	6	2021;29:11	2021;29:11	NUM
bam-12993	214	7	-	-	SYM
bam-12993	214	8	21	21	NUM
bam-12993	214	9	.	.	PUNCT
bam-12993	215	1	14	14	NUM
bam-12993	215	2	.	.	PUNCT
bam-12993	216	1	goodyear	goodyear	PROPN
bam-12993	216	2	md	md	PROPN
bam-12993	216	3	,	,	PUNCT
bam-12993	216	4	krleza	krleza	PROPN
bam-12993	216	5	-	-	PUNCT
bam-12993	216	6	jeric	jeric	PROPN
bam-12993	216	7	k	k	PROPN
bam-12993	216	8	,	,	PUNCT
bam-12993	216	9	lemmens	lemmen	VERB
bam-12993	216	10	t.	t.	PROPN
bam-12993	216	11	the	the	DET
bam-12993	216	12	declaration	declaration	NOUN
bam-12993	216	13	of	of	ADP
bam-12993	216	14	helsinki	helsinki	PROPN
bam-12993	216	15	.	.	PUNCT
bam-12993	217	1	br	br	PROPN
bam-12993	217	2	med	med	PROPN
bam-12993	217	3	j	j	PROPN
bam-12993	217	4	2007;335:624	2007;335:624	PROPN
bam-12993	217	5	-	-	SYM
bam-12993	217	6	5	5	NUM
bam-12993	217	7	.	.	NOUN
bam-12993	217	8	15	15	NUM
bam-12993	217	9	.	.	PUNCT
bam-12993	218	1	chen	chen	PROPN
bam-12993	218	2	xl	xl	PROPN
bam-12993	218	3	,	,	PUNCT
bam-12993	218	4	zhang	zhang	PROPN
bam-12993	218	5	ml	ml	PROPN
bam-12993	218	6	,	,	PUNCT
bam-12993	218	7	zhu	zhu	PROPN
bam-12993	218	8	l	l	NOUN
bam-12993	218	9	,	,	PUNCT
bam-12993	218	10	et	et	PROPN
bam-12993	218	11	al	al	PROPN
bam-12993	218	12	.	.	PUNCT
bam-12993	219	1	vitamin	vitamin	NOUN
bam-12993	219	2	d	d	NOUN
bam-12993	219	3	receptor	receptor	NOUN
bam-12993	219	4	gene	gene	NOUN
bam-12993	219	5	polymorphisms	polymorphism	NOUN
bam-12993	219	6	and	and	CCONJ
bam-12993	219	7	the	the	DET
bam-12993	219	8	risk	risk	NOUN
bam-12993	219	9	of	of	ADP
bam-12993	219	10	multiple	multiple	ADJ
bam-12993	219	11	sclerosis	sclerosis	NOUN
bam-12993	219	12	:	:	PUNCT
bam-12993	219	13	an	an	DET
bam-12993	219	14	updated	update	VERB
bam-12993	219	15	meta	meta	ADJ
bam-12993	219	16	-	-	PUNCT
bam-12993	219	17	analysis	analysis	NOUN
bam-12993	219	18	.	.	PUNCT
bam-12993	220	1	microbial	microbial	ADJ
bam-12993	220	2	pathogenesis	pathogenesis	NOUN
bam-12993	220	3	2017;110:594	2017;110:594	NOUN
bam-12993	220	4	-	-	SYM
bam-12993	220	5	602	602	NUM
bam-12993	220	6	.	.	PUNCT
bam-12993	220	7	16	16	NUM
bam-12993	220	8	.	.	PUNCT
bam-12993	221	1	ben	ben	PROPN
bam-12993	221	2	-	-	PROPN
bam-12993	221	3	selma	selma	PROPN
bam-12993	221	4	w	w	PROPN
bam-12993	221	5	,	,	PUNCT
bam-12993	221	6	ben	ben	PROPN
bam-12993	221	7	-	-	PUNCT
bam-12993	221	8	fredj	fredj	PROPN
bam-12993	221	9	n	n	CCONJ
bam-12993	221	10	,	,	PUNCT
bam-12993	221	11	chebel	chebel	NOUN
bam-12993	221	12	s	s	PROPN
bam-12993	221	13	,	,	PUNCT
bam-12993	221	14	et	et	PROPN
bam-12993	221	15	al	al	PROPN
bam-12993	221	16	.	.	PROPN
bam-12993	221	17	ageand	ageand	PROPN
bam-12993	221	18	gender	gender	NOUN
bam-12993	221	19	-	-	PUNCT
bam-12993	221	20	specific	specific	ADJ
bam-12993	221	21	effects	effect	NOUN
bam-12993	221	22	on	on	ADP
bam-12993	221	23	vdr	vdr	NOUN
bam-12993	221	24	gene	gene	NOUN
bam-12993	221	25	polymorphisms	polymorphism	NOUN
bam-12993	221	26	and	and	CCONJ
bam-12993	221	27	risk	risk	NOUN
bam-12993	221	28	of	of	ADP
bam-12993	221	29	the	the	DET
bam-12993	221	30	development	development	NOUN
bam-12993	221	31	of	of	ADP
bam-12993	221	32	multiple	multiple	ADJ
bam-12993	221	33	sclerosis	sclerosis	NOUN
bam-12993	221	34	in	in	ADP
bam-12993	221	35	tunisians	tunisian	NOUN
bam-12993	221	36	:	:	PUNCT
bam-12993	221	37	a	a	DET
bam-12993	221	38	preliminary	preliminary	ADJ
bam-12993	221	39	study	study	NOUN
bam-12993	221	40	.	.	PUNCT
bam-12993	222	1	int	int	PROPN
bam-12993	222	2	j	j	PROPN
bam-12993	222	3	immunogenet	immunogenet	PROPN
bam-12993	222	4	2015	2015	NUM
bam-12993	222	5	;	;	PUNCT
bam-12993	222	6	42:174	42:174	NUM
bam-12993	222	7	-	-	SYM
bam-12993	222	8	81	81	NUM
bam-12993	222	9	.	.	PUNCT
bam-12993	222	10	17	17	NUM
bam-12993	222	11	.	.	PUNCT
bam-12993	223	1	garcía	garcía	ADJ
bam-12993	223	2	-	-	PUNCT
bam-12993	223	3	martín	martín	NOUN
bam-12993	223	4	e	e	NOUN
bam-12993	223	5	,	,	PUNCT
bam-12993	223	6	agúndez	agúndez	PROPN
bam-12993	223	7	ja	ja	PROPN
bam-12993	223	8	,	,	PUNCT
bam-12993	223	9	martínez	martínez	PROPN
bam-12993	223	10	c	c	NOUN
bam-12993	223	11	,	,	PUNCT
bam-12993	223	12	et	et	PROPN
bam-12993	223	13	al	al	PROPN
bam-12993	223	14	.	.	PUNCT
bam-12993	223	15	vitamin	vitamin	PROPN
bam-12993	223	16	d3	d3	PROPN
bam-12993	223	17	receptor	receptor	NOUN
bam-12993	223	18	(	(	PUNCT
bam-12993	223	19	vdr	vdr	NOUN
bam-12993	223	20	)	)	PUNCT
bam-12993	223	21	gene	gene	NOUN
bam-12993	223	22	rs2228570	rs2228570	NOUN
bam-12993	223	23	(	(	PUNCT
bam-12993	223	24	fok1	fok1	PROPN
bam-12993	223	25	)	)	PUNCT
bam-12993	223	26	and	and	CCONJ
bam-12993	223	27	rs731236	rs731236	PROPN
bam-12993	223	28	(	(	PUNCT
bam-12993	223	29	taq1	taq1	PROPN
bam-12993	223	30	)	)	PUNCT
bam-12993	223	31	variants	variant	NOUN
bam-12993	223	32	are	be	AUX
bam-12993	223	33	not	not	PART
bam-12993	223	34	associated	associate	VERB
bam-12993	223	35	with	with	ADP
bam-12993	223	36	the	the	DET
bam-12993	223	37	risk	risk	NOUN
bam-12993	223	38	for	for	ADP
bam-12993	223	39	multiple	multiple	ADJ
bam-12993	223	40	sclerosis	sclerosis	NOUN
bam-12993	223	41	:	:	PUNCT
bam-12993	223	42	results	result	NOUN
bam-12993	223	43	of	of	ADP
bam-12993	223	44	a	a	DET
bam-12993	223	45	new	new	ADJ
bam-12993	223	46	study	study	NOUN
bam-12993	223	47	and	and	CCONJ
bam-12993	223	48	a	a	DET
bam-12993	223	49	metaanalysis	metaanalysis	NOUN
bam-12993	223	50	.	.	PUNCT
bam-12993	224	1	plos	plos	PROPN
bam-12993	224	2	one	one	NUM
bam-12993	224	3	2013;8	2013;8	NUM
bam-12993	224	4	:	:	PUNCT
bam-12993	224	5	e65487	e65487	PROPN
bam-12993	224	6	.	.	PROPN
bam-12993	224	7	18	18	NUM
bam-12993	224	8	.	.	PUNCT
bam-12993	225	1	abdollahzadeh	abdollahzadeh	NOUN
bam-12993	225	2	r	r	NOUN
bam-12993	225	3	,	,	PUNCT
bam-12993	225	4	fard	fard	NOUN
bam-12993	225	5	ms	ms	NOUN
bam-12993	225	6	,	,	PUNCT
bam-12993	225	7	rahmani	rahmani	X
bam-12993	225	8	f	f	X
bam-12993	225	9	,	,	PUNCT
bam-12993	225	10	et	et	PROPN
bam-12993	225	11	al	al	PROPN
bam-12993	225	12	.	.	PUNCT
bam-12993	225	13	predisposing	predispose	VERB
bam-12993	225	14	role	role	NOUN
bam-12993	225	15	of	of	ADP
bam-12993	225	16	vitamin	vitamin	NOUN
bam-12993	225	17	d	d	NOUN
bam-12993	225	18	receptor	receptor	NOUN
bam-12993	225	19	(	(	PUNCT
bam-12993	225	20	vdr	vdr	NOUN
bam-12993	225	21	)	)	PUNCT
bam-12993	225	22	polymorphisms	polymorphism	NOUN
bam-12993	225	23	in	in	ADP
bam-12993	225	24	the	the	DET
bam-12993	225	25	development	development	NOUN
bam-12993	225	26	of	of	ADP
bam-12993	225	27	multiple	multiple	ADJ
bam-12993	225	28	sclerosis	sclerosis	NOUN
bam-12993	225	29	:	:	PUNCT
bam-12993	225	30	a	a	DET
bam-12993	225	31	case	case	NOUN
bam-12993	225	32	-	-	PUNCT
bam-12993	225	33	control	control	NOUN
bam-12993	225	34	study	study	NOUN
bam-12993	225	35	.	.	PUNCT
bam-12993	226	1	j	j	PROPN
bam-12993	226	2	neurol	neurol	PROPN
bam-12993	226	3	sci	sci	PROPN
bam-12993	226	4	2016;367:148	2016;367:148	PROPN
bam-12993	226	5	-	-	SYM
bam-12993	226	6	51	51	NUM
bam-12993	226	7	.	.	NOUN
bam-12993	226	8	19	19	NUM
bam-12993	226	9	.	.	PUNCT
bam-12993	226	10	sioka	sioka	PROPN
bam-12993	226	11	c	c	PROPN
bam-12993	226	12	,	,	PUNCT
bam-12993	226	13	papakonstantinou	papakonstantinou	PROPN
bam-12993	226	14	s	s	PROPN
bam-12993	226	15	,	,	PUNCT
bam-12993	226	16	markoula	markoula	PROPN
bam-12993	226	17	s	s	PROPN
bam-12993	226	18	,	,	PUNCT
bam-12993	226	19	et	et	PROPN
bam-12993	226	20	al	al	PROPN
bam-12993	226	21	.	.	PUNCT
bam-12993	227	1	vitamin	vitamin	NOUN
bam-12993	227	2	d	d	NOUN
bam-12993	227	3	receptor	receptor	NOUN
bam-12993	227	4	gene	gene	NOUN
bam-12993	227	5	polymorphisms	polymorphism	NOUN
bam-12993	227	6	in	in	ADP
bam-12993	227	7	multiple	multiple	ADJ
bam-12993	227	8	sclerosis	sclerosis	NOUN
bam-12993	227	9	patients	patient	NOUN
bam-12993	227	10	in	in	ADP
bam-12993	227	11	northwest	northwest	PROPN
bam-12993	227	12	greece	greece	PROPN
bam-12993	227	13	.	.	PUNCT
bam-12993	228	1	j	j	PROPN
bam-12993	228	2	negat	negat	PROPN
bam-12993	228	3	results	result	NOUN
bam-12993	228	4	biomed	biome	VERB
bam-12993	228	5	2011;10:3	2011;10:3	NUM
bam-12993	228	6	.	.	PUNCT
bam-12993	229	1	20	20	NUM
bam-12993	229	2	.	.	PUNCT
bam-12993	229	3	ascherio	ascherio	PROPN
bam-12993	229	4	a	a	PROPN
bam-12993	229	5	,	,	PUNCT
bam-12993	229	6	munger	munger	PROPN
bam-12993	229	7	kl	kl	PROPN
bam-12993	229	8	,	,	PUNCT
bam-12993	229	9	lünemann	lünemann	PROPN
bam-12993	229	10	jd	jd	PROPN
bam-12993	229	11	.	.	PUNCT
bam-12993	230	1	the	the	DET
bam-12993	230	2	initiation	initiation	NOUN
bam-12993	230	3	and	and	CCONJ
bam-12993	230	4	prevention	prevention	NOUN
bam-12993	230	5	of	of	ADP
bam-12993	230	6	multiple	multiple	ADJ
bam-12993	230	7	sclerosis	sclerosis	NOUN
bam-12993	230	8	.	.	PUNCT
bam-12993	231	1	nature	nature	PROPN
bam-12993	231	2	rev	rev	VERB
bam-12993	231	3	neurol	neurol	PROPN
bam-12993	231	4	2012;8:602	2012;8:602	PROPN
bam-12993	231	5	-	-	SYM
bam-12993	231	6	12	12	NUM
bam-12993	231	7	.	.	PUNCT
bam-12993	232	1	21	21	NUM
bam-12993	232	2	.	.	PUNCT
bam-12993	233	1	rodríguez	rodríguez	VERB
bam-12993	233	2	murúa	murúa	PROPN
bam-12993	233	3	s	s	PROPN
bam-12993	233	4	,	,	PUNCT
bam-12993	233	5	farez	farez	PROPN
bam-12993	233	6	mf	mf	PROPN
bam-12993	233	7	,	,	PUNCT
bam-12993	233	8	quintana	quintana	PROPN
bam-12993	233	9	fj	fj	PROPN
bam-12993	233	10	.	.	PUNCT
bam-12993	234	1	the	the	DET
bam-12993	234	2	immune	immune	ADJ
bam-12993	234	3	response	response	NOUN
bam-12993	234	4	in	in	ADP
bam-12993	234	5	multiple	multiple	ADJ
bam-12993	234	6	sclerosis	sclerosis	NOUN
bam-12993	234	7	.	.	PUNCT
bam-12993	235	1	annual	annual	ADJ
bam-12993	235	2	review	review	NOUN
bam-12993	235	3	of	of	ADP
bam-12993	235	4	pathology	pathology	NOUN
bam-12993	235	5	:	:	PUNCT
bam-12993	235	6	mechanisms	mechanism	NOUN
bam-12993	235	7	dis	dis	PROPN
bam-12993	235	8	.	.	PUNCT
bam-12993	236	1	2022;17:121	2022;17:121	NUM
bam-12993	236	2	-	-	SYM
bam-12993	236	3	39	39	NUM
bam-12993	236	4	.	.	PUNCT
bam-12993	237	1	22	22	NUM
bam-12993	237	2	.	.	PUNCT
bam-12993	238	1	fitzgerald	fitzgerald	PROPN
bam-12993	238	2	kc	kc	PROPN
bam-12993	238	3	,	,	PUNCT
bam-12993	238	4	munger	munger	PROPN
bam-12993	238	5	kl	kl	PROPN
bam-12993	238	6	,	,	PUNCT
bam-12993	238	7	köchert	köchert	PROPN
bam-12993	238	8	k	k	PROPN
bam-12993	238	9	,	,	PUNCT
bam-12993	238	10	et	et	PROPN
bam-12993	238	11	al	al	PROPN
bam-12993	238	12	.	.	PROPN
bam-12993	238	13	association	association	PROPN
bam-12993	238	14	of	of	ADP
bam-12993	238	15	vitamin	vitamin	NOUN
bam-12993	238	16	d	d	PROPN
bam-12993	238	17	levels	level	NOUN
bam-12993	238	18	with	with	ADP
bam-12993	238	19	multiple	multiple	ADJ
bam-12993	238	20	sclerosis	sclerosis	NOUN
bam-12993	238	21	activity	activity	NOUN
bam-12993	238	22	and	and	CCONJ
bam-12993	238	23	progression	progression	NOUN
bam-12993	238	24	in	in	ADP
bam-12993	238	25	patients	patient	NOUN
bam-12993	238	26	receiving	receive	VERB
bam-12993	238	27	interferon	interferon	PROPN
bam-12993	238	28	beta-1b	beta-1b	PROPN
bam-12993	238	29	.	.	PUNCT
bam-12993	239	1	jama	jama	PROPN
bam-12993	239	2	neurol	neurol	PROPN
bam-12993	239	3	2015;72:1458	2015;72:1458	NUM
bam-12993	239	4	-	-	SYM
bam-12993	239	5	65	65	NUM
bam-12993	239	6	.	.	PUNCT
bam-12993	240	1	23	23	NUM
bam-12993	240	2	.	.	PUNCT
bam-12993	241	1	mowry	mowry	PROPN
bam-12993	241	2	em	em	PRON
bam-12993	241	3	,	,	PUNCT
bam-12993	241	4	waubant	waubant	ADJ
bam-12993	241	5	e	e	NOUN
bam-12993	241	6	,	,	PUNCT
bam-12993	241	7	mcculloch	mcculloch	PROPN
bam-12993	241	8	ce	ce	PROPN
bam-12993	241	9	,	,	PUNCT
bam-12993	241	10	et	et	PROPN
bam-12993	241	11	al	al	PROPN
bam-12993	241	12	.	.	PUNCT
bam-12993	242	1	vitamin	vitamin	PROPN
bam-12993	242	2	d	d	PROPN
bam-12993	242	3	status	status	NOUN
bam-12993	242	4	predicts	predict	VERB
bam-12993	242	5	new	new	ADJ
bam-12993	242	6	brain	brain	NOUN
bam-12993	242	7	magnetic	magnetic	ADJ
bam-12993	242	8	resonance	resonance	NOUN
bam-12993	242	9	imaging	imaging	NOUN
bam-12993	242	10	activity	activity	NOUN
bam-12993	242	11	in	in	ADP
bam-12993	242	12	multiple	multiple	ADJ
bam-12993	242	13	sclerosis	sclerosis	NOUN
bam-12993	242	14	.	.	PUNCT
bam-12993	243	1	ann	ann	PROPN
bam-12993	243	2	neurol	neurol	PROPN
bam-12993	243	3	2012;72:234	2012;72:234	PROPN
bam-12993	243	4	-	-	PUNCT
bam-12993	243	5	40	40	NUM
bam-12993	243	6	.	.	PUNCT
bam-12993	243	7	24	24	NUM
bam-12993	243	8	.	.	PUNCT
bam-12993	243	9	karampoor	karampoor	PROPN
bam-12993	243	10	s	s	PROPN
bam-12993	243	11	,	,	PUNCT
bam-12993	243	12	zahednasab	zahednasab	PROPN
bam-12993	243	13	h	h	PROPN
bam-12993	243	14	,	,	PUNCT
bam-12993	243	15	ramagopalan	ramagopalan	PROPN
bam-12993	243	16	s	s	PROPN
bam-12993	243	17	,	,	PUNCT
bam-12993	243	18	et	et	PROPN
bam-12993	243	19	al	al	PROPN
bam-12993	243	20	.	.	PUNCT
bam-12993	244	1	25hydroxyvitamin	25hydroxyvitamin	NUM
bam-12993	245	1	d	d	NOUN
bam-12993	245	2	levels	level	NOUN
bam-12993	245	3	are	be	AUX
bam-12993	245	4	associated	associate	VERB
bam-12993	245	5	with	with	ADP
bam-12993	245	6	multiple	multiple	ADJ
bam-12993	245	7	8	8	NUM
bam-12993	245	8	vitamin	vitamin	NOUN
bam-12993	245	9	d	d	NOUN
bam-12993	245	10	receptor	receptor	NOUN
bam-12993	245	11	gene	gene	NOUN
bam-12993	245	12	polymorphisms	polymorphism	NOUN
bam-12993	245	13	in	in	ADP
bam-12993	245	14	patients	patient	NOUN
bam-12993	245	15	with	with	ADP
bam-12993	245	16	relapsing	relapse	VERB
bam-12993	245	17	multiple	multiple	ADJ
bam-12993	245	18	sclerosis	sclerosis	NOUN
bam-12993	245	19	eur	eur	PROPN
bam-12993	245	20	j	j	PROPN
bam-12993	245	21	transl	transl	PROPN
bam-12993	245	22	myol	myol	ADV
bam-12993	245	23	35	35	NUM
bam-12993	245	24	(	(	PUNCT
bam-12993	245	25	1	1	NUM
bam-12993	245	26	)	)	PUNCT
bam-12993	245	27	12993	12993	NUM
bam-12993	245	28	,	,	PUNCT
bam-12993	245	29	2025	2025	NUM
bam-12993	245	30	doi	doi	NOUN
bam-12993	245	31	:	:	PUNCT
bam-12993	245	32	10.4081	10.4081	NUM
bam-12993	245	33	/	/	SYM
bam-12993	245	34	ejtm.2024.12993	ejtm.2024.12993	NOUN
bam-12993	245	35	sclerosis	sclerosis	NOUN
bam-12993	245	36	in	in	ADP
bam-12993	245	37	iran	iran	PROPN
bam-12993	245	38	:	:	PUNCT
bam-12993	245	39	a	a	DET
bam-12993	245	40	cross	cross	ADJ
bam-12993	245	41	-	-	ADJ
bam-12993	245	42	sectional	sectional	ADJ
bam-12993	245	43	study	study	NOUN
bam-12993	245	44	.	.	PUNCT
bam-12993	246	1	j	j	PROPN
bam-12993	246	2	neuroimmunol	neuroimmunol	PROPN
bam-12993	246	3	2016;290:47	2016;290:47	NUM
bam-12993	246	4	-	-	SYM
bam-12993	246	5	8	8	NUM
bam-12993	246	6	.	.	X
bam-12993	246	7	25	25	NUM
bam-12993	246	8	.	.	PUNCT
bam-12993	247	1	zhang	zhang	PROPN
bam-12993	247	2	y	y	PROPN
bam-12993	247	3	,	,	PUNCT
bam-12993	247	4	liu	liu	PROPN
bam-12993	247	5	g	g	PROPN
bam-12993	247	6	,	,	PUNCT
bam-12993	247	7	han	han	PROPN
bam-12993	247	8	x	x	PROPN
bam-12993	247	9	,	,	PUNCT
bam-12993	247	10	et	et	PROPN
bam-12993	247	11	al	al	PROPN
bam-12993	247	12	.	.	PUNCT
bam-12993	248	1	the	the	DET
bam-12993	248	2	association	association	NOUN
bam-12993	248	3	of	of	ADP
bam-12993	248	4	serum	serum	NOUN
bam-12993	248	5	25	25	NUM
bam-12993	248	6	-	-	PUNCT
bam-12993	248	7	hydroxyvitamin	hydroxyvitamin	NOUN
bam-12993	248	8	d	d	NOUN
bam-12993	248	9	levels	level	NOUN
bam-12993	248	10	with	with	ADP
bam-12993	248	11	multiple	multiple	ADJ
bam-12993	248	12	sclerosis	sclerosis	NOUN
bam-12993	248	13	severity	severity	NOUN
bam-12993	248	14	and	and	CCONJ
bam-12993	248	15	progression	progression	NOUN
bam-12993	248	16	in	in	ADP
bam-12993	248	17	a	a	DET
bam-12993	248	18	case	case	NOUN
bam-12993	248	19	-	-	PUNCT
bam-12993	248	20	control	control	NOUN
bam-12993	248	21	study	study	NOUN
bam-12993	248	22	from	from	ADP
bam-12993	248	23	china	china	PROPN
bam-12993	248	24	.	.	PUNCT
bam-12993	249	1	j	j	PROPN
bam-12993	249	2	neuroimmunol	neuroimmunol	PROPN
bam-12993	249	3	2016;297:127	2016;297:127	NOUN
bam-12993	249	4	-	-	SYM
bam-12993	249	5	31	31	NUM
bam-12993	249	6	.	.	PUNCT
bam-12993	249	7	26	26	NUM
bam-12993	249	8	.	.	PUNCT
bam-12993	250	1	sutherland	sutherland	PROPN
bam-12993	250	2	jp	jp	PROPN
bam-12993	250	3	,	,	PUNCT
bam-12993	250	4	zhou	zhou	PROPN
bam-12993	250	5	a	a	PRON
bam-12993	250	6	,	,	PUNCT
bam-12993	250	7	leach	leach	NOUN
bam-12993	250	8	mj	mj	PROPN
bam-12993	250	9	,	,	PUNCT
bam-12993	250	10	hyppönen	hyppönen	PROPN
bam-12993	250	11	e.	e.	PROPN
bam-12993	250	12	differences	difference	NOUN
bam-12993	250	13	and	and	CCONJ
bam-12993	250	14	determinants	determinant	NOUN
bam-12993	250	15	of	of	ADP
bam-12993	250	16	vitamin	vitamin	NOUN
bam-12993	250	17	d	d	NOUN
bam-12993	250	18	deficiency	deficiency	NOUN
bam-12993	250	19	among	among	ADP
bam-12993	250	20	uk	uk	PROPN
bam-12993	250	21	biobank	biobank	ADJ
bam-12993	250	22	participants	participant	NOUN
bam-12993	250	23	:	:	PUNCT
bam-12993	250	24	a	a	DET
bam-12993	250	25	cross	cross	ADJ
bam-12993	250	26	-	-	ADJ
bam-12993	250	27	ethnic	ethnic	ADJ
bam-12993	250	28	and	and	CCONJ
bam-12993	250	29	socioeconomic	socioeconomic	ADJ
bam-12993	250	30	study	study	NOUN
bam-12993	250	31	.	.	PUNCT
bam-12993	251	1	clin	clin	PROPN
bam-12993	251	2	nutr	nutr	PROPN
bam-12993	251	3	2021;40:3436	2021;40:3436	PROPN
bam-12993	251	4	-	-	SYM
bam-12993	251	5	47	47	NUM
bam-12993	251	6	.	.	PUNCT
bam-12993	252	1	27	27	NUM
bam-12993	252	2	.	.	PUNCT
bam-12993	253	1	dong	dong	PROPN
bam-12993	253	2	h	h	PROPN
bam-12993	253	3	,	,	PUNCT
bam-12993	253	4	asmolovaite	asmolovaite	PROPN
bam-12993	253	5	v	v	NOUN
bam-12993	253	6	,	,	PUNCT
bam-12993	253	7	marseal	marseal	ADJ
bam-12993	253	8	n.	n.	PROPN
bam-12993	253	9	vitamin	vitamin	NOUN
bam-12993	253	10	d	d	NOUN
bam-12993	253	11	status	status	NOUN
bam-12993	253	12	and	and	CCONJ
bam-12993	253	13	dietary	dietary	ADJ
bam-12993	253	14	intake	intake	NOUN
bam-12993	253	15	in	in	ADP
bam-12993	253	16	young	young	ADJ
bam-12993	253	17	university	university	NOUN
bam-12993	253	18	students	student	NOUN
bam-12993	253	19	in	in	ADP
bam-12993	253	20	the	the	DET
bam-12993	253	21	uk	uk	PROPN
bam-12993	253	22	.	.	PROPN
bam-12993	253	23	nutrition	nutrition	PROPN
bam-12993	253	24	food	food	PROPN
bam-12993	253	25	sci	sci	PROPN
bam-12993	253	26	2022;52:616	2022;52:616	PROPN
bam-12993	253	27	-	-	SYM
bam-12993	253	28	26	26	NUM
bam-12993	253	29	.	.	PUNCT
bam-12993	253	30	28	28	NUM
bam-12993	253	31	.	.	PUNCT
bam-12993	253	32	braidy	braidy	VERB
bam-12993	253	33	s	s	PROPN
bam-12993	253	34	,	,	PUNCT
bam-12993	253	35	matar	matar	PROPN
bam-12993	253	36	am	am	PROPN
bam-12993	253	37	,	,	PUNCT
bam-12993	253	38	borjac	borjac	PROPN
bam-12993	253	39	j.	j.	PROPN
bam-12993	253	40	association	association	PROPN
bam-12993	253	41	of	of	ADP
bam-12993	253	42	cyp27b1	cyp27b1	PROPN
bam-12993	253	43	polymorphism	polymorphism	NOUN
bam-12993	253	44	and	and	CCONJ
bam-12993	253	45	vitamin	vitamin	NOUN
bam-12993	253	46	d	d	PROPN
bam-12993	253	47	levels	level	NOUN
bam-12993	253	48	with	with	ADP
bam-12993	253	49	multiple	multiple	ADJ
bam-12993	253	50	sclerosis	sclerosis	NOUN
bam-12993	253	51	development	development	NOUN
bam-12993	253	52	in	in	ADP
bam-12993	253	53	lebanese	lebanese	ADJ
bam-12993	253	54	population	population	NOUN
bam-12993	253	55	of	of	ADP
bam-12993	253	56	bekaa	bekaa	PROPN
bam-12993	253	57	region	region	NOUN
bam-12993	253	58	:	:	PUNCT
bam-12993	253	59	a	a	DET
bam-12993	253	60	preliminary	preliminary	ADJ
bam-12993	253	61	study	study	NOUN
bam-12993	253	62	.	.	PUNCT
bam-12993	254	1	genetics	genetic	NOUN
bam-12993	254	2	applic	applic	VERB
bam-12993	254	3	2021;5:18	2021;5:18	PROPN
bam-12993	254	4	-	-	PUNCT
bam-12993	254	5	25	25	NUM
bam-12993	254	6	.	.	PUNCT
bam-12993	254	7	29	29	NUM
bam-12993	254	8	.	.	PUNCT
bam-12993	255	1	beecham	beecham	PROPN
bam-12993	255	2	ah	ah	INTJ
bam-12993	255	3	,	,	PUNCT
bam-12993	255	4	amezcua	amezcua	PROPN
bam-12993	255	5	l	l	NOUN
bam-12993	255	6	,	,	PUNCT
bam-12993	255	7	chinea	chinea	VERB
bam-12993	255	8	a	a	PRON
bam-12993	255	9	,	,	PUNCT
bam-12993	255	10	et	et	PROPN
bam-12993	255	11	al	al	PROPN
bam-12993	255	12	.	.	PUNCT
bam-12993	256	1	the	the	DET
bam-12993	256	2	genetic	genetic	ADJ
bam-12993	256	3	diversity	diversity	NOUN
bam-12993	256	4	of	of	ADP
bam-12993	256	5	multiple	multiple	ADJ
bam-12993	256	6	sclerosis	sclerosis	NOUN
bam-12993	256	7	risk	risk	NOUN
bam-12993	256	8	among	among	ADP
bam-12993	256	9	hispanic	hispanic	ADJ
bam-12993	256	10	and	and	CCONJ
bam-12993	256	11	african	african	ADJ
bam-12993	256	12	american	american	ADJ
bam-12993	256	13	populations	population	NOUN
bam-12993	256	14	living	live	VERB
bam-12993	256	15	in	in	ADP
bam-12993	256	16	the	the	DET
bam-12993	256	17	united	united	PROPN
bam-12993	256	18	states	states	PROPN
bam-12993	256	19	.	.	PUNCT
bam-12993	257	1	mult	mult	PROPN
bam-12993	257	2	scler	scler	PROPN
bam-12993	257	3	2020;26:1329	2020;26:1329	PROPN
bam-12993	257	4	-	-	SYM
bam-12993	257	5	39	39	NUM
bam-12993	257	6	.	.	PUNCT
bam-12993	257	7	30	30	NUM
bam-12993	257	8	.	.	PUNCT
bam-12993	258	1	al	al	PROPN
bam-12993	258	2	-	-	PUNCT
bam-12993	258	3	temaimi	temaimi	PROPN
bam-12993	258	4	ra	ra	PROPN
bam-12993	258	5	,	,	PUNCT
bam-12993	258	6	al	al	PROPN
bam-12993	258	7	-	-	PUNCT
bam-12993	258	8	enezi	enezi	PROPN
bam-12993	258	9	a	a	PROPN
bam-12993	258	10	,	,	PUNCT
bam-12993	258	11	al	al	PROPN
bam-12993	258	12	-	-	PUNCT
bam-12993	258	13	serri	serri	PROPN
bam-12993	258	14	a	a	NOUN
bam-12993	258	15	,	,	PUNCT
bam-12993	258	16	et	et	PROPN
bam-12993	258	17	al	al	PROPN
bam-12993	258	18	.	.	PUNCT
bam-12993	259	1	the	the	DET
bam-12993	259	2	association	association	NOUN
bam-12993	259	3	of	of	ADP
bam-12993	259	4	vitamin	vitamin	NOUN
bam-12993	259	5	d	d	NOUN
bam-12993	259	6	receptor	receptor	NOUN
bam-12993	259	7	polymorphisms	polymorphism	NOUN
bam-12993	259	8	with	with	ADP
bam-12993	259	9	multiple	multiple	ADJ
bam-12993	259	10	sclerosis	sclerosis	NOUN
bam-12993	259	11	in	in	ADP
bam-12993	259	12	a	a	DET
bam-12993	259	13	case	case	NOUN
bam-12993	259	14	-	-	PUNCT
bam-12993	259	15	control	control	NOUN
bam-12993	259	16	study	study	NOUN
bam-12993	259	17	from	from	ADP
bam-12993	259	18	kuwait	kuwait	PROPN
bam-12993	259	19	.	.	PUNCT
bam-12993	260	1	plos	plos	PROPN
bam-12993	260	2	one	one	NUM
bam-12993	260	3	2015;10	2015;10	NUM
bam-12993	260	4	:	:	PUNCT
bam-12993	260	5	e0142265	e0142265	VERB
bam-12993	260	6	.	.	PROPN
bam-12993	260	7	31	31	NUM
bam-12993	260	8	.	.	PUNCT
bam-12993	261	1	niino	niino	PROPN
bam-12993	261	2	m	m	PROPN
bam-12993	261	3	,	,	PUNCT
bam-12993	261	4	sato	sato	PROPN
bam-12993	261	5	s	s	PART
bam-12993	261	6	,	,	PUNCT
bam-12993	261	7	fukazawa	fukazawa	PROPN
bam-12993	261	8	t	t	PROPN
bam-12993	261	9	,	,	PUNCT
bam-12993	261	10	et	et	PROPN
bam-12993	261	11	al	al	PROPN
bam-12993	261	12	.	.	PROPN
bam-12993	261	13	decreased	decrease	VERB
bam-12993	261	14	serum	serum	NOUN
bam-12993	261	15	vitamin	vitamin	NOUN
bam-12993	261	16	d	d	PROPN
bam-12993	261	17	levels	level	NOUN
bam-12993	261	18	in	in	ADP
bam-12993	261	19	japanese	japanese	ADJ
bam-12993	261	20	patients	patient	NOUN
bam-12993	261	21	with	with	ADP
bam-12993	261	22	multiple	multiple	ADJ
bam-12993	261	23	sclerosis	sclerosis	NOUN
bam-12993	261	24	.	.	PUNCT
bam-12993	262	1	j	j	PROPN
bam-12993	262	2	neuroimmunol	neuroimmunol	PROPN
bam-12993	262	3	2015;279:40	2015;279:40	NUM
bam-12993	262	4	-	-	SYM
bam-12993	262	5	5	5	NUM
bam-12993	262	6	.	.	NOUN
bam-12993	262	7	32	32	NUM
bam-12993	262	8	.	.	PUNCT
bam-12993	263	1	vickaryous	vickaryous	ADJ
bam-12993	263	2	n	n	CCONJ
bam-12993	263	3	,	,	PUNCT
bam-12993	263	4	et	et	PROPN
bam-12993	263	5	al	al	PROPN
bam-12993	263	6	.	.	PROPN
bam-12993	264	1	remote	remote	ADJ
bam-12993	264	2	testing	testing	NOUN
bam-12993	264	3	of	of	ADP
bam-12993	264	4	vitamin	vitamin	NOUN
bam-12993	264	5	d	d	PROPN
bam-12993	264	6	levels	level	NOUN
bam-12993	264	7	across	across	ADP
bam-12993	264	8	the	the	DET
bam-12993	264	9	uk	uk	PROPN
bam-12993	264	10	ms	ms	PROPN
bam-12993	264	11	population	population	NOUN
bam-12993	264	12	—	—	PUNCT
bam-12993	264	13	a	a	DET
bam-12993	264	14	case	case	NOUN
bam-12993	264	15	control	control	NOUN
bam-12993	264	16	study	study	NOUN
bam-12993	264	17	.	.	PUNCT
bam-12993	265	1	plos	plos	PROPN
bam-12993	265	2	one	one	NUM
bam-12993	265	3	2020;15	2020;15	NUM
bam-12993	265	4	:	:	PUNCT
bam-12993	265	5	e0241459	e0241459	PROPN
bam-12993	265	6	.	.	PROPN
bam-12993	265	7	33	33	NUM
bam-12993	265	8	.	.	PUNCT
bam-12993	266	1	simpson	simpson	PROPN
bam-12993	266	2	s	s	PROPN
bam-12993	266	3	jr	jr	PROPN
bam-12993	266	4	,	,	PUNCT
bam-12993	266	5	taylor	taylor	PROPN
bam-12993	266	6	b	b	PROPN
bam-12993	266	7	,	,	PUNCT
bam-12993	266	8	blizzard	blizzard	PROPN
bam-12993	266	9	l	l	NOUN
bam-12993	266	10	,	,	PUNCT
bam-12993	266	11	et	et	PROPN
bam-12993	266	12	al	al	PROPN
bam-12993	266	13	.	.	PROPN
bam-12993	267	1	higher	high	ADJ
bam-12993	267	2	25‐hydroxyvitamin	25‐hydroxyvitamin	NUM
bam-12993	267	3	d	d	NOUN
bam-12993	267	4	is	be	AUX
bam-12993	267	5	associated	associate	VERB
bam-12993	267	6	with	with	ADP
bam-12993	267	7	lower	low	ADJ
bam-12993	267	8	relapse	relapse	NOUN
bam-12993	267	9	risk	risk	NOUN
bam-12993	267	10	in	in	ADP
bam-12993	267	11	multiple	multiple	ADJ
bam-12993	267	12	sclerosis	sclerosis	NOUN
bam-12993	267	13	.	.	PUNCT
bam-12993	268	1	ann	ann	PROPN
bam-12993	268	2	neurol	neurol	PROPN
bam-12993	268	3	2010;68:193	2010;68:193	NOUN
bam-12993	268	4	-	-	SYM
bam-12993	268	5	203	203	NUM
bam-12993	268	6	.	.	PUNCT
bam-12993	269	1	disclaimer	disclaimer	NOUN
bam-12993	269	2	all	all	DET
bam-12993	269	3	claims	claim	NOUN
bam-12993	269	4	expressed	express	VERB
bam-12993	269	5	in	in	ADP
bam-12993	269	6	this	this	DET
bam-12993	269	7	article	article	NOUN
bam-12993	269	8	are	be	AUX
bam-12993	269	9	solely	solely	ADV
bam-12993	269	10	those	those	PRON
bam-12993	269	11	of	of	ADP
bam-12993	269	12	the	the	DET
bam-12993	269	13	authors	author	NOUN
bam-12993	269	14	and	and	CCONJ
bam-12993	269	15	do	do	AUX
bam-12993	269	16	not	not	PART
bam-12993	269	17	necessarily	necessarily	ADV
bam-12993	269	18	represent	represent	VERB
bam-12993	269	19	those	those	PRON
bam-12993	269	20	of	of	ADP
bam-12993	269	21	their	their	PRON
bam-12993	269	22	affiliated	affiliated	ADJ
bam-12993	269	23	organizations	organization	NOUN
bam-12993	269	24	,	,	PUNCT
bam-12993	269	25	or	or	CCONJ
bam-12993	269	26	those	those	PRON
bam-12993	269	27	of	of	ADP
bam-12993	269	28	the	the	DET
bam-12993	269	29	publisher	publisher	NOUN
bam-12993	269	30	,	,	PUNCT
bam-12993	269	31	the	the	DET
bam-12993	269	32	editors	editor	NOUN
bam-12993	269	33	and	and	CCONJ
bam-12993	269	34	the	the	DET
bam-12993	269	35	reviewers	reviewer	NOUN
bam-12993	269	36	.	.	PUNCT
bam-12993	270	1	any	any	DET
bam-12993	270	2	product	product	NOUN
bam-12993	270	3	that	that	PRON
bam-12993	270	4	may	may	AUX
bam-12993	270	5	be	be	AUX
bam-12993	270	6	evaluated	evaluate	VERB
bam-12993	270	7	in	in	ADP
bam-12993	270	8	this	this	DET
bam-12993	270	9	article	article	NOUN
bam-12993	270	10	or	or	CCONJ
bam-12993	270	11	claim	claim	NOUN
bam-12993	270	12	that	that	PRON
bam-12993	270	13	may	may	AUX
bam-12993	270	14	be	be	AUX
bam-12993	270	15	made	make	VERB
bam-12993	270	16	by	by	ADP
bam-12993	270	17	its	its	PRON
bam-12993	270	18	manufacturer	manufacturer	NOUN
bam-12993	270	19	is	be	AUX
bam-12993	270	20	not	not	PART
bam-12993	270	21	guaranteed	guarantee	VERB
bam-12993	270	22	or	or	CCONJ
bam-12993	270	23	endorsed	endorse	VERB
bam-12993	270	24	by	by	ADP
bam-12993	270	25	the	the	DET
bam-12993	270	26	publisher	publisher	NOUN
bam-12993	270	27	.	.	PUNCT
bam-12993	271	1	submitted	submit	VERB
bam-12993	271	2	:	:	PUNCT
bam-12993	271	3	30	30	NUM
bam-12993	271	4	august	august	PROPN
bam-12993	271	5	2024	2024	NUM
bam-12993	271	6	.	.	PUNCT
bam-12993	272	1	accepted	accept	VERB
bam-12993	272	2	:	:	PUNCT
bam-12993	272	3	16	16	NUM
bam-12993	272	4	september	september	PROPN
bam-12993	272	5	2024	2024	NUM
bam-12993	272	6	.	.	PUNCT
bam-12993	273	1	early	early	ADJ
bam-12993	273	2	access	access	NOUN
bam-12993	273	3	:	:	PUNCT
bam-12993	273	4	21	21	NUM
bam-12993	273	5	november	november	PROPN
bam-12993	273	6	2024	2024	NUM
bam-12993	273	7	.	.	PUNCT
bam-12993	274	1	9	9	NUM